<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc> San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">09-PONE-RA-14124R2</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0010685</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Immunology/Antigen Processing and Recognition</subject><subject>Immunology/Immune Response</subject><subject>Immunology/Immunity to Infections</subject><subject>Immunology/Immunomodulation</subject><subject>Immunology/Leukocyte Activation</subject><subject>Immunology/Leukocyte Signaling and Gene Expression</subject><subject>Microbiology/Parasitology</subject><subject>Dermatology/Skin and Systemic Disease</subject><subject>Infectious Diseases/Protozoal Infections</subject><subject>Pathology/Immunology</subject><subject>Public Health and Epidemiology/Immunization</subject></subj-group></article-categories><title-group><article-title>Why Functional Pre-Erythrocytic and Bloodstage Malaria Vaccines Fail: A Meta-Analysis of Fully Protective Immunizations and Novel Immunological Model</article-title><alt-title alt-title-type="running-head">Skin and Malaria Tolerance</alt-title></title-group><contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guilbride</surname><given-names>D. Lys</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref><xref ref-type="fn" rid="fn1"><sup>¤</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gawlinski</surname><given-names>Pawel</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Guilbride</surname><given-names>Patrick D. L.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
</contrib-group><aff id="aff1"><label>1</label><addr-line>Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany</addr-line> </aff><aff id="aff2"><label>2</label><addr-line>Member of the Royal College of Veterinary Surgeons (MRCVS), London, United Kingdom</addr-line> </aff><contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Rodrigues</surname><given-names>Mauricio Martins</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group><aff id="edit1">Federal University of São Paulo, Brazil</aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">lys@malariaresearchfoundation.com</email></corresp>
<fn fn-type="con"><p>Conceived and designed the experiments: DLG. Performed the experiments: DLG PG. Analyzed the data: DLG PDG. Contributed reagents/materials/analysis tools: DLG PG PDG. Wrote the paper: DLG PDG. Also contributed to figure design and execution: DLG. Contributed significantly to database searches, data acquisition, figure design, figure execution, editing: PG. Contributed substantially to manuscript organization, analysis of data and editing, and expertise on Apicomplexa pathogenic to livestock: PDLG.</p></fn>
<fn fn-type="current-aff" id="fn1"><label>¤</label><p>Current address: Department of Biology, Institute of Microbiology and Genetics, Darmstadt University of Technology, Darmstadt, Germany</p></fn>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>19</day><month>5</month><year>2010</year></pub-date><volume>5</volume><issue>5</issue><elocation-id>e10685</elocation-id><history>
<date date-type="received"><day>9</day><month>11</month><year>2009</year></date>
<date date-type="accepted"><day>16</day><month>4</month><year>2010</year></date>
</history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2010</copyright-year><copyright-holder>Guilbride et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><sec>
<title>Background</title>
<p>Clinically protective malaria vaccines consistently fail to protect adults and children in endemic settings, and at best only partially protect infants.</p>
</sec><sec>
<title>Methodology/Principal Findings</title>
<p>We identify and evaluate 1916 immunization studies between 1965-February 2010, and exclude partially or nonprotective results to find 177 completely protective immunization experiments. Detailed reexamination reveals an unexpectedly mundane basis for selective vaccine failure: live malaria parasites in the skin inhibit vaccine function. We next show published molecular and cellular data support a testable, novel model where parasite-host interactions in the skin induce malaria-specific regulatory T cells, and subvert early antigen-specific immunity to parasite-specific immunotolerance. This ensures infection and tolerance to reinfection. Exposure to <italic>Plasmodium-</italic>infected mosquito bites therefore systematically triggers immunosuppression of endemic vaccine-elicited responses. The extensive vaccine trial data solidly substantiate this model experimentally.</p>
</sec><sec>
<title>Conclusions/Significance</title>
<p>We conclude skinstage-initiated immunosuppression, unassociated with bloodstage parasites, systematically blocks vaccine function in the field. Our model exposes novel molecular and procedural strategies to significantly and quickly increase protective efficacy in both pipeline and currently ineffective malaria vaccines, and forces fundamental reassessment of central precepts determining vaccine development. This has major implications for accelerated local eliminations of malaria, and significantly increases potential for eradication.</p>
</sec></abstract><funding-group><funding-statement>The Malaria Research Foundation (MRF, P.O. Box 10420, CO 81612 USA) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="1"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<sec id="s1a">
<title>The malaria vaccine paradoxes</title>
<p>A solitary subunit vaccine marginally <xref ref-type="bibr" rid="pone.0010685-Graves1">[1]</xref>, <xref ref-type="bibr" rid="pone.0010685-Matuschewski1">[2]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan1">[3]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wipasa1">[4]</xref>, <xref ref-type="bibr" rid="pone.0010685-Greenwood1">[5]</xref>, <xref ref-type="bibr" rid="pone.0010685-Moorthy1">[6]</xref> protects children in endemic areas <xref ref-type="bibr" rid="pone.0010685-Alonso1">[7]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sacarlal1">[8]</xref> against malaria, and only partially protects infants <xref ref-type="bibr" rid="pone.0010685-Bejon1">[9]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aponte1">[10]</xref>, <xref ref-type="bibr" rid="pone.0010685-Abdulla1">[11]</xref>, similarly to malaria-naïve adults <xref ref-type="bibr" rid="pone.0010685-Stoute1">[12]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kester1">[13]</xref>. Adults in endemic areas remain unprotected <xref ref-type="bibr" rid="pone.0010685-Bojang1">[14]</xref>, <xref ref-type="bibr" rid="pone.0010685-Polhemus1">[15]</xref>. These data crystallize the paradoxes central to 80 years of malaria vaccine research. Endemic populations display T cell <xref ref-type="bibr" rid="pone.0010685-Good1">[16]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hill1">[17]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan2">[18]</xref>, <xref ref-type="bibr" rid="pone.0010685-Plebanski1">[19]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aidoo1">[20]</xref>, <xref ref-type="bibr" rid="pone.0010685-Lee1">[21]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kabilan1">[22]</xref>, <xref ref-type="bibr" rid="pone.0010685-Flanagan1">[23]</xref> and antibody <xref ref-type="bibr" rid="pone.0010685-Nardin1">[24]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman1">[25]</xref>, <xref ref-type="bibr" rid="pone.0010685-MigotNabias1">[26]</xref>, <xref ref-type="bibr" rid="pone.0010685-Zhou1">[27]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bongfen1">[28]</xref>, <xref ref-type="bibr" rid="pone.0010685-Osier1">[29]</xref> responses to all malaria lifecycle stages and rapidly acquire immunity to bloodstage parasites, mitigating adult disease and death <xref ref-type="bibr" rid="pone.0010685-Osier1">[29]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roussilhon1">[30]</xref>, <xref ref-type="bibr" rid="pone.0010685-Michon1">[31]</xref>, <xref ref-type="bibr" rid="pone.0010685-Langhorne1">[32]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan3">[33]</xref>. Immunity to earlier skinstage parasites however does not develop, and endemic populations remain tolerant to continual reinfection <xref ref-type="bibr" rid="pone.0010685-Langhorne1">[32]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan3">[33]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hogh1">[34]</xref> remaining at risk for severe malaria should immunocompetence weaken. Similarly, potentially protective <xref ref-type="bibr" rid="pone.0010685-Hill1">[17]</xref>, <xref ref-type="bibr" rid="pone.0010685-Romero1">[35]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wizel1">[36]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sun1">[37]</xref>, <xref ref-type="bibr" rid="pone.0010685-Reece1">[38]</xref> T cell responses elicited by diverse attenuated-parasite <xref ref-type="bibr" rid="pone.0010685-Aidoo1">[20]</xref>, <xref ref-type="bibr" rid="pone.0010685-Nardin2">[39]</xref>, <xref ref-type="bibr" rid="pone.0010685-Herrington1">[40]</xref>, <xref ref-type="bibr" rid="pone.0010685-Malik1">[41]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rodrigues1">[42]</xref>, <xref ref-type="bibr" rid="pone.0010685-Moreno1">[43]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wizel2">[44]</xref>, <xref ref-type="bibr" rid="pone.0010685-Krzych1">[45]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sano1">[46]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller1">[48]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jobe1">[49]</xref>, <xref ref-type="bibr" rid="pone.0010685-Purcell1">[50]</xref>, <xref ref-type="bibr" rid="pone.0010685-Oliveira1">[51]</xref> and subunit <xref ref-type="bibr" rid="pone.0010685-Herrington2">[52]</xref>, <xref ref-type="bibr" rid="pone.0010685-Nardin3">[53]</xref>, <xref ref-type="bibr" rid="pone.0010685-Birkett1">[54]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wang1">[55]</xref>, <xref ref-type="bibr" rid="pone.0010685-Lalvani1">[56]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tartz1">[57]</xref>, <xref ref-type="bibr" rid="pone.0010685-Perlaza1">[58]</xref>, <xref ref-type="bibr" rid="pone.0010685-McConkey1">[59]</xref>, <xref ref-type="bibr" rid="pone.0010685-Moorthy2">[60]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pichyangkul1">[61]</xref>, <xref ref-type="bibr" rid="pone.0010685-CalvoCalle1">[62]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mettens1">[63]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pichyangkul2">[64]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schneider1">[65]</xref>, <xref ref-type="bibr" rid="pone.0010685-BenMohamed1">[66]</xref>, <xref ref-type="bibr" rid="pone.0010685-Weiss1">[67]</xref>, <xref ref-type="bibr" rid="pone.0010685-Daubersies1">[68]</xref>, <xref ref-type="bibr" rid="pone.0010685-Barbosa1">[69]</xref> malaria vaccines, and laboratory infections <xref ref-type="bibr" rid="pone.0010685-Romero1">[35]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rodrigues1">[42]</xref>, <xref ref-type="bibr" rid="pone.0010685-Oliveira1">[51]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chen1">[70]</xref>, <xref ref-type="bibr" rid="pone.0010685-Spitalny1">[71]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schofield1">[72]</xref>, <xref ref-type="bibr" rid="pone.0010685-Weiss2">[73]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tsuji1">[74]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan4">[75]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belnoue2">[76]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pombo1">[77]</xref> provide sterile immunity <xref ref-type="bibr" rid="pone.0010685-Reece1">[38]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Beaudoin1">[78]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hafalla1">[79]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hafalla2">[80]</xref> to infection, yet are ineffective in endemic populations <xref ref-type="bibr" rid="pone.0010685-Bojang1">[14]</xref>, <xref ref-type="bibr" rid="pone.0010685-Polhemus1">[15]</xref>, <xref ref-type="bibr" rid="pone.0010685-Moorthy3">[81]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bejon2">[82]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ogutu1">[83]</xref>, <xref ref-type="bibr" rid="pone.0010685-Graves2">[84]</xref> and are effectively blocked by the parasite <xref ref-type="bibr" rid="pone.0010685-Orjih1">[85]</xref>. Ostensibly, protection is blocked only in endemic areas, implying a conditional difference between laboratory and field infections which systematically triggers an immunological block to vaccine function in the field. This rationale pinpoints an activatable immune mechanism which blocks existing T cell responses. Obvious candidates are the normal immune mechanisms suppressing autoimmunity and allergy, or self- and nonself-tolerance. These mechanisms centre largely around suppressive function of regulatory T cell subsets (Tregs) <xref ref-type="bibr" rid="pone.0010685-Sakaguchi1">[86]</xref>, <xref ref-type="bibr" rid="pone.0010685-Horwitz1">[87]</xref>. Activated natural (nTreg) and induced (iTreg) Tregs suppress effector T cell <xref ref-type="bibr" rid="pone.0010685-Sakaguchi1">[86]</xref>, <xref ref-type="bibr" rid="pone.0010685-Horwitz1">[87]</xref> and B cell responses <xref ref-type="bibr" rid="pone.0010685-Mahnke1">[88]</xref>, <xref ref-type="bibr" rid="pone.0010685-Zhao1">[89]</xref>, <xref ref-type="bibr" rid="pone.0010685-LudwigPortugall1">[90]</xref>, <xref ref-type="bibr" rid="pone.0010685-CurottodeLafaille1">[91]</xref>, <xref ref-type="bibr" rid="pone.0010685-Lim1">[92]</xref> and tolerize dendritic cells (DC) <xref ref-type="bibr" rid="pone.0010685-Tang1">[93]</xref> to maintain self-tolerance and regulate inflammatory responses to injury <xref ref-type="bibr" rid="pone.0010685-Murphy1">[94]</xref>, tissue grafts <xref ref-type="bibr" rid="pone.0010685-Zhang1">[95]</xref>, <xref ref-type="bibr" rid="pone.0010685-Gondek1">[96]</xref>, <xref ref-type="bibr" rid="pone.0010685-CarvalhoGaspar1">[97]</xref>, pathogens and allergens <xref ref-type="bibr" rid="pone.0010685-Mills1">[98]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belkaid1">[99]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mellor1">[100]</xref>.</p>
<p>A major regulatory immune organ, rich in regulatory T cells <xref ref-type="bibr" rid="pone.0010685-Clark1">[101]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clark2">[102]</xref>, is human skin. This suggests the initial path of malarial infection will profoundly affect systemic host responses to subsequent lifecycle stages. Most experimental infections bypass the skin entirely. Natural malaria infection however, starts in the skin <xref ref-type="bibr" rid="pone.0010685-Boyd1">[103]</xref>, <xref ref-type="bibr" rid="pone.0010685-Griffiths1">[104]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sidjanski1">[105]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vanderberg1">[106]</xref>, <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>. Infected mosquitoes inject motile <xref ref-type="bibr" rid="pone.0010685-Vanderberg2">[108]</xref> skinstage (sporozoite) parasites; within minutes, a few migrate to proximal lymphatic vessels and skin-draining lymph nodes (LN) <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>. Another few <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref> invade blood vessels, rapidly <xref ref-type="bibr" rid="pone.0010685-Yamauchi1">[109]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jin1">[110]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref> migrating to the liver; the remainder linger in the skin <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>. Liver invading parasites differentiate <xref ref-type="bibr" rid="pone.0010685-Shortt1">[112]</xref> and multiply (for days) asymptomatically <xref ref-type="bibr" rid="pone.0010685-Langhorne1">[32]</xref> until bloodstage-filled vesicles bleb <xref ref-type="bibr" rid="pone.0010685-Laveran1">[113]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sturm1">[114]</xref> into the blood, causing the systemic inflammatory reaction <xref ref-type="bibr" rid="pone.0010685-Clark3">[115]</xref>, immunologically similar to sepsis <xref ref-type="bibr" rid="pone.0010685-Clark3">[115]</xref>, underlying initial symptoms of clinical malaria. We compile the immunobiology of Anopheline mosquito bites and human skin, with the molecular and behavioural characteristics of skinstage parasites, to show that natural infection leads inevitably to systemic immunotolerance. We further show, via comprehensive meta-analysis of fully protective vaccine trials, that bypassing or disrupting natural parasite-host immune interactions in the skin profoundly affects host responses to vaccine antigens, and leads to protective immunization against malaria.</p>
</sec></sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>Literature Searches for completely protective vaccine trials, for meta-analysis</title>
<p>Searches were performed following MOOSE (Meta-analysis of Observational Studies in Epidemiology) guidelines for conduct and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis) reporting protocol for Systematic Reviews and Meta-analysis <xref ref-type="bibr" rid="pone.0010685-Liberati1">[116]</xref>. Studies showing complete protection to malaria challenge in mammals were identified by searching the PubMed database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/" xlink:type="simple">www.ncbi.nlm.nih.gov/pubmed/</ext-link>) with search terms: malaria OR plasmodium &amp; (complete &amp;) protect* OR immuni* OR vaccine OR human/man/chimpanzee/monkey/mouse/rat/rabbit/dog/goat/OR</p>
<p>Aidoo/Ballou/Beaudoin/Clyde/Corradin/Daubersies/Druilhe/Doolan/Egan/Good/Herrington/Hafalla/Hill/Hoffman/Hollingdale/Heussler/Kappe/Kester/Krzych/Khusmith/Langhorne/MacColm/McCarthy/Marsh/Mazier/Miller/Most/</p>
<p>Matuschewski/Nardin/Nussenzweig/Playfair/Plebanski/Orjih/Orton/Patarroyo/</p>
<p>Renia/Rieckmann/Riley/Rodrigues/Sauerwein/Sedegah/Schofield/Siddiqui/</p>
<p>Snounou/Tartz/Tsuji/Urban/Vanderberg/Vaughan/Weiss/Weidanz/White/Yoshida/Zavala/&amp;/OR year (1965 – 2009). Searches were performed by adding two or three qualifiers at a time to the basic search string: [“malaria” OR “plasmodium” AND protect*” OR “immuni*”], and rerunning the search each time. We ran searches without, then with, qualifier term “complete” to allow wide retrieval sensitivity. Retrieved records were combined and replicates removed. Compiled single records were then screened by search term and abstract perusal for traveller, bednet, thalassemia, genetic, pharmacokinetic, drug intervention, insecticide, repellent or mosquito physiology content without reinfection follow-up, and excluded; we also contacted authors to verify conditions where necessary. This search strategy, (outlined in <xref ref-type="fig" rid="pone-0010685-g001">Figure 1</xref>), provided meticulous coverage, as determined by random spot-checks for coverage. Last complete database searches were carried out 9–13 September 2009; final update searches were run 13 February 2010. We also examined cited reference lists in studies and reviews identified. Late-breaking studies were manually added to this final database.</p>
<fig id="pone-0010685-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0010685.g001</object-id><label>Figure 1</label><caption>
<title>PRISMA Flow Diagram showing inclusion/exclusion criteria for studies documenting complete protection 1965-February 2010.</title>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0010685.g001" xlink:type="simple"/></fig></sec><sec id="s2b">
<title>Selection of studies for meta-analysis data–Inclusion/exclusion criteria</title>
<p>Inclusion criterion: Identified full-text immunization studies were then checked individually by full-text inspection for experimental immunization and challenge conditions, and results of challenge, and sorted with regard to complete protection criteria (defined below). Immunization studies showing complete protection of all immunized subjects and infectivity in all control infections (in any part of the study), were included in a final dataset for analysis (Defined in <xref ref-type="fig" rid="pone-0010685-g001">Figure 1</xref>; listed in <xref ref-type="supplementary-material" rid="pone.0010685.s001">Table S1</xref>). No other inclusion criterion was used. Studies in English, French, Spanish, Portuguese and German were assessed, and sufficient discriminatory data was available in English abstracts, for most studies identified published in further languages. Studies in Oriental languages without abstract (5) were not evaluated. Included studies were further sorted for analysis according to experimental data as described below in Validity and Sorting Criteria. Exclusion criteria: Studies showing incomplete protection in immunized subjects, or incomplete control infectivity, were excluded. No other exclusion criterion was used on the immunization studies identified by the search method described.</p>
</sec><sec id="s2c">
<title>Validity Assessment and Sorting Criteria</title>
<p>Complete protection criteria: bloodstage parasites undetectable after challenge in all immunized subjects AND 100% of non-immunized controls became parasitemic. Experiments documenting complete protection were further sorted into 8 categories, (a–h), defined first by route and method of immunization, and then route of challenge. Experimental data publications are listed by category in Supplementary <xref ref-type="supplementary-material" rid="pone.0010685.s001">Table S1</xref>. The route and conditions defining immunization in each category are represented graphically in <xref ref-type="fig" rid="pone-0010685-g002">Figure 2</xref> (and in written form in Supplementary <xref ref-type="supplementary-material" rid="pone.0010685.s002">Table S2</xref>) on green background, and explained in the legends to <xref ref-type="fig" rid="pone-0010685-g002">Figure 2</xref> and Supplementary <xref ref-type="supplementary-material" rid="pone.0010685.s002">Table S2</xref>. The route of challenge, either intravenous or via moquito bite, is indicated graphically on lilac background, (in written form in <xref ref-type="supplementary-material" rid="pone.0010685.s002">Table S2</xref>) and explained in legends for <xref ref-type="fig" rid="pone-0010685-g002">Figure 2</xref> and <xref ref-type="supplementary-material" rid="pone.0010685.s002">Table S2</xref>.</p>
<fig id="pone-0010685-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0010685.g002</object-id><label>Figure 2</label><caption>
<title>Protective vaccination physically bypasses skin at immunization or challenge (90%) or involves skin immunomodulation (10%).</title>
<p>A. Exposure to parasites in the skin coincides closely with vaccine failure. Green background- immunization procedures. Lilac background- challenge procedures and percent of total experiments showing complete protection (% total) formed by a subset of studies (category) using a given experimental procedure (categories a-i; supporting data in references listed below). Inclined syringe- administration route is intravenous (i.v.) for live parasites, or, the method does not involve live parasites, but uses dead parasites or purified antigen, antibody, or recombinant DNA (dead/Ag/Ab/subunit) and therefore bypasses parasite interactions with host skin. Multiple mosquitoes- live parasites administered by multiple simultaneous mosquito bites. Single mosquito- live parasites naturally transmitted by 4–15 bites. Mosquito in aromatic ring- live parasites administered by 12–15 bites/session with chloroquine. Vertical syringe- live parasites delivered subcutaneously (s.c) or intradermally (i.d.) or intramuscularly (i.m.); (i), uncontrolled exposure to endemic mosquitos. B. Protective immunization physically bypasses the skin at either immunization or challenge in 90% of cases (a,b,c,e,h). Protective immunization which transits skin during immunization (c,d,e,f,g,h) either: bypasses the skin physically at challenge (c,e,h); or, involves skin immunomodulation during immunization (d,g, 10% of cases). Within A and B: Red lines and numbers- experiment bypasses parasite-skin interactions at stage indicated by red lines; black lines and numbers- parasites interact with skin at stage indicated by black lines. Asterisk (*)- immunization via unmodified skin, limited to less-virulent <italic>P. berghei</italic> (f). Skin bypass- method physically avoids live parasite interactions in the host skin. Malaria exposure- skin exposure to infected mosquito bite before first immunization; naïve- no pre-exposure; exposed (endemic)- chronic exposure. x- this study shows complete protection of 40 of 41 mice challenged. y: one person in one study <xref ref-type="bibr" rid="pone.0010685-Hoffman2">[117]</xref> was infected one time via the skin prior to protective immunization and was therefore moderately tolerized. Data pertaining to experimental categories (a–h): a:<xref ref-type="bibr" rid="pone.0010685-Romero1">[35]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rodrigues1">[42]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jobe1">[49]</xref>, <xref ref-type="bibr" rid="pone.0010685-Purcell1">[50]</xref>, <xref ref-type="bibr" rid="pone.0010685-Oliveira1">[51]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tartz1">[57]</xref>, <xref ref-type="bibr" rid="pone.0010685-Daubersies1">[68]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chen1">[70]</xref>, <xref ref-type="bibr" rid="pone.0010685-Spitalny1">[71]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schofield1">[72]</xref>, <xref ref-type="bibr" rid="pone.0010685-Weiss2">[73]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tsuji1">[74]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan4">[75]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belnoue2">[76]</xref>, <xref ref-type="bibr" rid="pone.0010685-Beaudoin1">[78]</xref>, <xref ref-type="bibr" rid="pone.0010685-Orjih1">[85]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Spitalny2">[125]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kramer1">[126]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sedagah1">[130]</xref>, <xref ref-type="bibr" rid="pone.0010685-Collins1">[133]</xref>, <xref ref-type="bibr" rid="pone.0010685-Fandeur1">[137]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ting1">[138]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hirunpetcharat1">[139]</xref>, <xref ref-type="bibr" rid="pone.0010685-Puri1">[150]</xref>, <xref ref-type="bibr" rid="pone.0010685-Romero2">[151]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller2">[166]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mellouk1">[169]</xref>, <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref>, <xref ref-type="bibr" rid="pone.0010685-Orjih2">[173]</xref>, <xref ref-type="bibr" rid="pone.0010685-White1">[185]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tarun1">[267]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kumar1">[335]</xref>, <xref ref-type="bibr" rid="pone.0010685-Khusmith1">[336]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kumar2">[337]</xref>, <xref ref-type="bibr" rid="pone.0010685-Daubersies2">[346]</xref><xref ref-type="bibr" rid="pone.0010685-Martinez1">[355]</xref>, <xref ref-type="bibr" rid="pone.0010685-Amante1">[356]</xref>, <xref ref-type="bibr" rid="pone.0010685-Brahimi1">[357]</xref>, <xref ref-type="bibr" rid="pone.0010685-BrunaRomero1">[358]</xref>, <xref ref-type="bibr" rid="pone.0010685-Burns1">[359]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cabrera1">[360]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cao1">[361]</xref>, <xref ref-type="bibr" rid="pone.0010685-Charoenvit1">[362]</xref>, <xref ref-type="bibr" rid="pone.0010685-Charoenvit2">[363]</xref>, <xref ref-type="bibr" rid="pone.0010685-Charoenvit3">[364]</xref>, <xref ref-type="bibr" rid="pone.0010685-Charoenvit4">[365]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chatterjee1">[366]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chatterjee2">[367]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chatterjee3">[368]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chattopadhyay1">[369]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clark4">[370]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clark5">[371]</xref>, <xref ref-type="bibr" rid="pone.0010685-Daly1">[372]</xref>, <xref ref-type="bibr" rid="pone.0010685-Degano1">[373]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan8">[374]</xref>, <xref ref-type="bibr" rid="pone.0010685-Egan1">[375]</xref>, <xref ref-type="bibr" rid="pone.0010685-Gilbert1">[376]</xref>, <xref ref-type="bibr" rid="pone.0010685-Gramzinski1">[377]</xref>, <xref ref-type="bibr" rid="pone.0010685-Gruner1">[378]</xref>, <xref ref-type="bibr" rid="pone.0010685-GuebreXabier1">[379]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hirunpetcharat2">[380]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hirunpetcharat3">[381]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman4">[382]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman5">[383]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hunter1">[384]</xref>, <xref ref-type="bibr" rid="pone.0010685-Imai1">[385]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jaffe1">[386]</xref><xref ref-type="bibr" rid="pone.0010685-Aly1">[387]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aly2">[388]</xref>, <xref ref-type="bibr" rid="pone.0010685-Draper1">[389]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jobe2">[390]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jones1">[391]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kaba1">[392]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kaur1">[393]</xref>, <xref ref-type="bibr" rid="pone.0010685-Khan1">[394]</xref>, <xref ref-type="bibr" rid="pone.0010685-Khullar1">[395]</xref>, <xref ref-type="bibr" rid="pone.0010685-Khusmith2">[396]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kumar3">[397]</xref>, <xref ref-type="bibr" rid="pone.0010685-Lanar1">[398]</xref>, <xref ref-type="bibr" rid="pone.0010685-Li3">[399]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ling1">[400]</xref>, <xref ref-type="bibr" rid="pone.0010685-Marussig1">[401]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mauduit1">[402]</xref>, <xref ref-type="bibr" rid="pone.0010685-McColm1">[403]</xref>, <xref ref-type="bibr" rid="pone.0010685-McColm2">[404]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller3">[405]</xref>, <xref ref-type="bibr" rid="pone.0010685-Orjih3">[406]</xref>, <xref ref-type="bibr" rid="pone.0010685-Patterson1">[407]</xref>, <xref ref-type="bibr" rid="pone.0010685-Perlaza2">[408]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roberts1">[409]</xref><xref ref-type="bibr" rid="pone.0010685-Playfair1">[410]</xref>, <xref ref-type="bibr" rid="pone.0010685-Playfair2">[411]</xref>, <xref ref-type="bibr" rid="pone.0010685-Potocnjak1">[412]</xref>, <xref ref-type="bibr" rid="pone.0010685-Puri2">[413]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pye1">[414]</xref>, <xref ref-type="bibr" rid="pone.0010685-Reed1">[415]</xref>, <xref ref-type="bibr" rid="pone.0010685-Reed2">[416]</xref>, <xref ref-type="bibr" rid="pone.0010685-Renia1">[417]</xref>, <xref ref-type="bibr" rid="pone.0010685-ReyesSandoval1">[418]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rodrigues2">[419]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rodrigues3">[420]</xref>, <xref ref-type="bibr" rid="pone.0010685-Romero3">[421]</xref>, <xref ref-type="bibr" rid="pone.0010685-Romero4">[422]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sadoff1">[423]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schmidt1">[424]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schmidt2">[425]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schneider2">[426]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sedegah1">[427]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sedegah2">[428]</xref>, <xref ref-type="bibr" rid="pone.0010685-Siddiqui1">[429]</xref>, <xref ref-type="bibr" rid="pone.0010685-Spitalny3">[430]</xref>, <xref ref-type="bibr" rid="pone.0010685-TaylorRobinson1">[431]</xref>, <xref ref-type="bibr" rid="pone.0010685-TaylorRobinson2">[432]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tsuji2">[433]</xref>, <xref ref-type="bibr" rid="pone.0010685-Trimnell1">[434]</xref>, <xref ref-type="bibr" rid="pone.0010685-vanDijk1">[435]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vinetz1">[436]</xref>, <xref ref-type="bibr" rid="pone.0010685-Waki1">[437]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wang2">[438]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wang3">[439]</xref>, <xref ref-type="bibr" rid="pone.0010685-Weiss4">[440]</xref>, <xref ref-type="bibr" rid="pone.0010685-White2">[441]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wykes1">[442]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pacheco1">[443]</xref>, <xref ref-type="bibr" rid="pone.0010685-Nussenzweig1">[444]</xref>, <xref ref-type="bibr" rid="pone.0010685-Nussenzweig2">[445]</xref>, <xref ref-type="bibr" rid="pone.0010685-Orjih4">[446]</xref>, <xref ref-type="bibr" rid="pone.0010685-Renia2">[447]</xref>, <xref ref-type="bibr" rid="pone.0010685-FavilaCastillo1">[448]</xref>, <xref ref-type="bibr" rid="pone.0010685-Butler1">[449]</xref>, <xref ref-type="bibr" rid="pone.0010685-Yoshida1">[450]</xref>, <xref ref-type="bibr" rid="pone.0010685-Falae1">[451]</xref>. b: <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller1">[48]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ting1">[138]</xref>, <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aly1">[387]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sina2">[452]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sina3">[453]</xref>. c: <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>. d: <xref ref-type="bibr" rid="pone.0010685-Wizel1">[36]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wizel2">[44]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde1">[118]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde2">[119]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde3">[120]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann1">[121]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann2">[122]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann3">[123]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref>, <xref ref-type="bibr" rid="pone.0010685-McCarthy1">[135]</xref>, <xref ref-type="bibr" rid="pone.0010685-Edelman1">[136]</xref>, <xref ref-type="bibr" rid="pone.0010685-Palmer1">[172]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde4">[454]</xref>, <xref ref-type="bibr" rid="pone.0010685-Egan2">[455]</xref>, <xref ref-type="bibr" rid="pone.0010685-Herrington3">[456]</xref>. e: <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wong1">[132]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schmidt3">[457]</xref>. f: <xref ref-type="bibr" rid="pone.0010685-Sina1">[127]</xref>. g: <xref ref-type="bibr" rid="pone.0010685-Roestenberg1">[163]</xref>. h: <xref ref-type="bibr" rid="pone.0010685-Mueller1">[48]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aly2">[388]</xref>, <xref ref-type="bibr" rid="pone.0010685-Butcher1">[458]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hommel1">[459]</xref>. Studies containing data for multiple relevant experimental conditions are referenced accordingly in each appropriate category. Multiple experiments contributed by a single study are indicated beneath study reference number (eg. reference 124 X2) in Supplementary <xref ref-type="supplementary-material" rid="pone.0010685.s001">Table S1</xref>. (Meta-analysis data extended reference list).</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0010685.g002" xlink:type="simple"/></fig></sec><sec id="s2d">
<title>Data Abstraction</title>
<p>Final database searches as described were performed separately twice during a three month period (June-September 2009), and once in February 2010, by the same person, and a further search performed once by a second person. Four separate results databases were combined with longterm manual search archives from over 4 years, and replicates removed. Assessment of compliance with complete protection criteria for the final dataset was reconfirmed in all cases by one person. From this final dataset, by full-text inspection, we retrieved specific experimental data regarding method and route of immunization, and method and route of challenge.</p>
</sec><sec id="s2e">
<title>Analysis/Summary measures</title>
<p>We measured the percentages of our dataset of fully protective vaccination experiments, that involved either absence, or presence, of live parasite interaction within the skin, during immunization, during challenge, or during both.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>1. Selection of studies for vaccine trial meta-analysis</title>
<p>Literature search, final selection strategy and data retrieval were designed to return data completely unlinked to and irrespective of any criterion beyond complete protection. Searches targeted any immunization, in any mammal, generating a comprehensive database of immunizations from 1965-February 2010. Random spot-checks confirmed meticulous coverage. Search method, inclusion/exclusion, assessment and sorting criteria are fully described in the <xref ref-type="sec" rid="s2">Methods</xref> section. The probability of missing any important immunization study is therefore finite but exceedingly small. The probability of missing an entire class of vaccines is nil. Literature searches and resulting datasets of factors contributing to protective vaccine function were therefore comprehensive, and completely unfocused and unbiased with regard to parasite life-cycle stage, antigen character, proposed immune mechanism, mode of application or any other criterion beyond complete protection. Data for analysis (specific experimental data regarding method and route of immunization, and method and route of challenge) was included according to a rigorous definition of complete protection.</p>
<p>We identify 1916 immunization studies performed worldwide between 1965 and February 2010 (<xref ref-type="fig" rid="pone-0010685-g001">Fig. 1</xref>), and retrieve an unambiguous, comprehensive and unbiased data set of 177 experiments in 161 publications documenting completely protective immunization, versus 1627 nonprotective or partially protective immunization results (<xref ref-type="fig" rid="pone-0010685-g001">Fig. 1</xref>).</p>
</sec><sec id="s3b">
<title>2. Vaccine trial data implicates the skin in vaccine failure</title>
<sec id="s3b1">
<title>2-i. Meta-analysis shows complete protection against natural challenge, by immunization via unmodified skin, does not occur</title>
<p>Completely protective vaccinations (177 experiments, <xref ref-type="fig" rid="pone-0010685-g002">Fig. 2</xref>; see also Supplementary <xref ref-type="supplementary-material" rid="pone.0010685.s002">Table S2</xref>, and <xref ref-type="fig" rid="pone-0010685-g001">Fig. 1</xref>) employing diverse vaccines, fall into 8 categories (<xref ref-type="fig" rid="pone-0010685-g002">Fig. 2a–h</xref>) according to method, and routes of immunization and challenge. These reveal that, unlike endemic populations (<xref ref-type="fig" rid="pone-0010685-g002">Fig. 2i</xref>), all protected subjects (<xref ref-type="fig" rid="pone-0010685-g002">Fig. 2a–h</xref>, with verifiable exception of one individual <xref ref-type="bibr" rid="pone.0010685-Hoffman2">[117]</xref>) are malaria-naïve (unexposed to malaria-infected mosquitoes) prior to first immunization (<xref ref-type="fig" rid="pone-0010685-g002">Fig. 2A</xref>). Most protective vaccinations also physically bypass live parasite interactions in the skin at either immunization or challenge (90%, <xref ref-type="fig" rid="pone-0010685-g002">Fig. 2B, a,b,c,e,h</xref>). Bypass is either by intravenous (i.v.) injection, or use of dead parasites, purified antibody or protein, or recombinant DNA, at immunization (84%, <xref ref-type="fig" rid="pone-0010685-g002">Fig. 2a,b</xref>), or i.v. injection at challenge (84%, <xref ref-type="fig" rid="pone-0010685-g002">Fig. 2a,c,e,h</xref>), usually by i.v. injection at both (78.5% <xref ref-type="fig" rid="pone-0010685-g002">Fig. 2a</xref>). Skin-based immunization (via infected mosquito bite), completely protective against virulent natural challenge (<xref ref-type="fig" rid="pone-0010685-g002">Fig. 2d,g</xref>) in humans <xref ref-type="bibr" rid="pone.0010685-Clyde1">[118]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde2">[119]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde3">[120]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann1">[121]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann2">[122]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann3">[123]</xref> and mice <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref> occurs only under conditions significantly altering the immune context in the skin during immunization. These immunomodulary conditions are illuminating and are examined in detail in Sections 3 and 4, and entirely account for the remaining 10% of completely protective immunization.</p>
</sec><sec id="s3b2">
<title>2-ii. Partially and non-protective studies strongly suggest parasite skin interactions actively depress host immunity</title>
<p>Otherwise, in mice, live-parasite immunization “via the skin” (this includes subcutaneous injection (s.c.) which bypasses, but inevitably contaminates, the skin) is usually non-protective <xref ref-type="bibr" rid="pone.0010685-Spitalny2">[125]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kramer1">[126]</xref>. Where documented, skin-based immunization provides complete <xref ref-type="bibr" rid="pone.0010685-Sina1">[127]</xref> (<xref ref-type="fig" rid="pone-0010685-g002">Fig. 2f</xref>) or substantial <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref> immunity only against less infective <italic>Plasmodium berghei</italic> natural challenge, but not against ∼100-fold more infective <xref ref-type="bibr" rid="pone.0010685-Sedagah1">[130]</xref> <italic>P. yoelii</italic> natural challenge <xref ref-type="bibr" rid="pone.0010685-Sina1">[127]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>. Intravenous immunization with <italic>P. yoelii</italic> protects completely against intravenous challenge <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref>, but mosquito delivered <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref>, or high-dose injected intradermal <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref> immunization does not. This suggests skin-immunization generates immunity less efficiently <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, or increases intrinsic parasite infectivity <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, <xref ref-type="bibr" rid="pone.0010685-Frischknecht1">[131]</xref>.</p>
<p>However, after identical intravenous infective challenge (bypassing the skin) <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, diminished immunity with high dose skin immunization (compared to intravenous) <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref> must derive from deficient host responses (activated less efficiently, or actively depressed, or both), not parasite-intrinsic changes.</p>
<p>Therefore, since skin immunization with less infective <xref ref-type="bibr" rid="pone.0010685-Sedagah1">[130]</xref> <italic>P. berghei</italic> protects completely against intravenous infection (20,000–50,000 parasites) <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wong1">[132]</xref>, but not against a 20–200X lesser skin challenge (10 bites) <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, (roughly 250–1000 parasites <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jin1">[110]</xref>) the data argue strongly for parasite-skin interactions increasing host susceptibility by actively depressing host immunity.</p>
</sec><sec id="s3b3">
<title>2-iii. Immunity generated via unmodified skin is easily broken</title>
<p>Intravenous mouse <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref> and primate <xref ref-type="bibr" rid="pone.0010685-Daubersies1">[68]</xref>, <xref ref-type="bibr" rid="pone.0010685-Collins1">[133]</xref> attenuated-sporozoite immunizations withstand repeated intravenous challenge. Immunity generated by live parasites via skin however, is reversed by small increments (5 additional bites, or 125–500 more parasites) in natural challenge dose <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, but withstands heavy intravenous challenge (20,000–100,000 parasites) <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Spitalny2">[125]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kramer1">[126]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wong1">[132]</xref> (see also <xref ref-type="fig" rid="pone-0010685-g002">Fig. 2c,e,h</xref>). Likewise, skin-generated immunity in humans <xref ref-type="bibr" rid="pone.0010685-Clyde2">[119]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref> (see also <xref ref-type="fig" rid="pone-0010685-g002">Fig. 2d</xref>) despite immunizing doses 100-fold greater than challenge, succumbs to increased <xref ref-type="bibr" rid="pone.0010685-Clyde2">[119]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref>, and usually, sequential <xref ref-type="bibr" rid="pone.0010685-Clyde2">[119]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann3">[123]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref>, <xref ref-type="bibr" rid="pone.0010685-McCarthy1">[135]</xref>, <xref ref-type="bibr" rid="pone.0010685-Edelman1">[136]</xref> natural challenge. Immunity generated transiting skin, therefore, is marginal, and reversible.</p>
</sec><sec id="s3b4">
<title>2-iv. Bloodstage vaccines do not protect against challenge via the skin</title>
<p>Finally, intravenous immunization with bloodstage parasites <xref ref-type="bibr" rid="pone.0010685-Belnoue2">[76]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pombo1">[77]</xref>, <xref ref-type="bibr" rid="pone.0010685-Fandeur1">[137]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ting1">[138]</xref>, fully protects against intravenous bloodstage challenge in humans <xref ref-type="bibr" rid="pone.0010685-Pombo1">[77]</xref> and monkeys <xref ref-type="bibr" rid="pone.0010685-Fandeur1">[137]</xref> and both bloodstage <xref ref-type="bibr" rid="pone.0010685-Ting1">[138]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hirunpetcharat1">[139]</xref> and sporozoite <xref ref-type="bibr" rid="pone.0010685-Belnoue2">[76]</xref> intravenous, but not mosquito-bite, challenge <xref ref-type="bibr" rid="pone.0010685-Ting1">[138]</xref> in skinstage-naïve mice. Similarly, major bloodstage-antigen vaccines (eg. MSP-1<sub>42</sub>, AMA-1), show strong antibody-correlated <xref ref-type="bibr" rid="pone.0010685-Pichyangkul1">[61]</xref>, <xref ref-type="bibr" rid="pone.0010685-Weiss1">[67]</xref>, <xref ref-type="bibr" rid="pone.0010685-Stowers1">[140]</xref> efficacy against symptomatic malaria after intravenous challenge in monkeys <xref ref-type="bibr" rid="pone.0010685-Weiss1">[67]</xref>, <xref ref-type="bibr" rid="pone.0010685-Stowers1">[140]</xref> and induce similar antibody responses in people from endemic areas <xref ref-type="bibr" rid="pone.0010685-Ogutu1">[83]</xref>, <xref ref-type="bibr" rid="pone.0010685-Thera1">[141]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sagara1">[142]</xref>. Protective efficacy against infection however, is negligible, despite some evidence of reducing risk of symptom severity and parastaemia density <xref ref-type="bibr" rid="pone.0010685-Stanisic1">[143]</xref>, <xref ref-type="bibr" rid="pone.0010685-Fowkes1">[144]</xref>. No bloodstage antigen in over 16 trials and 10,300 humans vaccinated to date, protects against infection by mosquito bites <xref ref-type="bibr" rid="pone.0010685-Ogutu1">[83]</xref>, <xref ref-type="bibr" rid="pone.0010685-Graves2">[84]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sagara1">[142]</xref>, <xref ref-type="bibr" rid="pone.0010685-Stanisic1">[143]</xref>, <xref ref-type="bibr" rid="pone.0010685-Graves3">[145]</xref>, <xref ref-type="bibr" rid="pone.0010685-Thompson1">[146]</xref>, <xref ref-type="bibr" rid="pone.0010685-Spring1">[147]</xref> (and <xref ref-type="fig" rid="pone-0010685-g002">Figure 2i</xref>).</p>
</sec><sec id="s3b5">
<title>2-v. Summary: Vaccine trial data implicates the skin in vaccine failure</title>
<p>Collectively, these data show that in malaria-naïve subjects, (which excludes bloodstage immunosuppressive effects) live-parasite immunization transiting unmodified skin is inefficient. Immunity diminishes after unmodified skin-parasite interactions and is significantly less robust generated via skin than if intravenously. The bulk of experimentation shows immunization avoiding parasite-skin interaction withstands heavy, repeated intravenous challenge, but only limited challenge transiting the epidermis. Importantly, the data imply parasite-skin interactions actively diminish host protective responses. Avoiding parasite/host skin interactions during both immunization and challenge however, associates solidly with immunity.</p>
</sec></sec><sec id="s3c">
<title>3. Altered immune context in the skin during immunization protects against natural challenge and suggests a skin-linked immunosuppressive mechanism</title>
<sec id="s3c1">
<title>3-i. Immunization under pro-inflammatory skin conditions confers protection</title>
<p>Complete human protection with irradiation-attenuated <xref ref-type="bibr" rid="pone.0010685-Herrington1">[40]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde1">[118]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde3">[120]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann2">[122]</xref>, <xref ref-type="bibr" rid="pone.0010685-Edelman1">[136]</xref> <italic>P. falciparum</italic> or <italic>P. vivax</italic> requires 1000 or more mosquito bites <xref ref-type="bibr" rid="pone.0010685-Clyde3">[120]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref> (usually 80–240 bites/session). This causes coalescing skin inflammation <xref ref-type="bibr" rid="pone.0010685-Herrington1">[40]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref>, lasting several hours <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref>. Immunity is reversed by relatively small increases <xref ref-type="bibr" rid="pone.0010685-Clyde2">[119]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref> in challenge dose, as for mice <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>. Fewer total immunizing bites (&lt;1000) are not reliably <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref>, or (&lt;700) not at all <xref ref-type="bibr" rid="pone.0010685-Herrington2">[52]</xref>, <xref ref-type="bibr" rid="pone.0010685-McCarthy1">[135]</xref> protective when delivered in low density bites/session <xref ref-type="bibr" rid="pone.0010685-Herrington2">[52]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde1">[118]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde2">[119]</xref>, <xref ref-type="bibr" rid="pone.0010685-McCarthy1">[135]</xref>, or with strongly anti-inflammatory topical cream <xref ref-type="bibr" rid="pone.0010685-Herrington1">[40]</xref> and/or heavier parasite irradiation <xref ref-type="bibr" rid="pone.0010685-Herrington1">[40]</xref>, <xref ref-type="bibr" rid="pone.0010685-Herrington2">[52]</xref>. However, 440 infected bites, delivered with additional uninfected bites, increasing bite density, is protective <xref ref-type="bibr" rid="pone.0010685-Rieckmann3">[123]</xref>. Rather than parasite dose alone <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref>, <xref ref-type="bibr" rid="pone.0010685-Luke1">[148]</xref>, therefore, protection appears influenced by degree of parasite attenuation (limiting liverstages <xref ref-type="bibr" rid="pone.0010685-Vanderberg3">[149]</xref>), density of simultaneous bites, and pro-inflammatory local context.</p>
</sec><sec id="s3c2">
<title>3-ii. Immunization via unmodified skin suppresses available protective responses</title>
<p>Systemic proinflammatory context confers resistance to malaria infection in mice <xref ref-type="bibr" rid="pone.0010685-Puri1">[150]</xref>, <xref ref-type="bibr" rid="pone.0010685-Romero2">[151]</xref>, <xref ref-type="bibr" rid="pone.0010685-Donovan1">[152]</xref> and correlates strongly with human resistance <xref ref-type="bibr" rid="pone.0010685-Luty1">[153]</xref>, <xref ref-type="bibr" rid="pone.0010685-Farouk1">[154]</xref>, <xref ref-type="bibr" rid="pone.0010685-Torcia1">[155]</xref>. In uninflamed mouse skin, increasing immunizing dose from 2 mosquito bites (roughly 50–200 parasites <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jin1">[110]</xref>) to 4 bites, significantly increases parasite-specific (CD8+) T cell responses <xref ref-type="bibr" rid="pone.0010685-Hafalla1">[79]</xref>. More immunizing bites yield no further increases <xref ref-type="bibr" rid="pone.0010685-Hafalla1">[79]</xref>. Yet, 100-fold higher immunizing doses (20 000 parasites) delivered directly (i.v.) to the liver, provide almost twice the protection of 10 000 parasites <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, proportionally increasing specific T cell responses <xref ref-type="bibr" rid="pone.0010685-Hafalla1">[79]</xref>. This reveals higher protective responses to direct liverstage infection are available, which become unavailable when parasites transit uninflamed skin. An intravenous immunizing dose completely protective against i.v. challenge of 20,000 parasites, but not against 10 bites <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref> (20-80-fold fewer parasites), is further consistent with skin-linked immunosuppression.</p>
<p>These data suggest inflammatory skin context potentiates immunization via skin, implying inflammation relieves a skin-linked suppression of immunity to liverstage malaria unassociated with prior bloodstage infection.</p>
</sec><sec id="s3c3">
<title>3-iii Skin-immunization under chloroquine (CQ) immunomodulation also confers protection</title>
<p>CQ, a widely immunomodulatory 4-aminoquinolone, accumulates preferentially in human skin and lymphocytes <xref ref-type="bibr" rid="pone.0010685-Bergqvist1">[156]</xref>, to levels 200–20,000 -fold those in the liver, and remains in human skin, (not plasma) for 6 months <xref ref-type="bibr" rid="pone.0010685-Kalia1">[157]</xref>. Prophylactic <italic>in vivo</italic> concentrations (100–500 ng/ml liver plasma <xref ref-type="bibr" rid="pone.0010685-Kalia1">[157]</xref>, <xref ref-type="bibr" rid="pone.0010685-Lee2">[158]</xref>) inhibit antigen presentation in human antigen-presenting dendritic (DC) and B cells <italic>in vitro</italic> <xref ref-type="bibr" rid="pone.0010685-Reid1">[159]</xref>, <xref ref-type="bibr" rid="pone.0010685-DiPucchio1">[160]</xref>, <xref ref-type="bibr" rid="pone.0010685-Burgdorf1">[161]</xref>.</p>
<p>Immunization via skin with a drastically lower (but normally 100% infective <xref ref-type="bibr" rid="pone.0010685-Verhage1">[162]</xref>) dose of unattenuated <italic>P. falciparum</italic> (15 infected bites/session, x3), if co-administered with prophylactic chloroquine (CQ), instead protects malaria-naïve individuals from challenge (5 infective bites) <xref ref-type="bibr" rid="pone.0010685-Roestenberg1">[163]</xref>. CQ provides greater immunity than parasite attenuation: considerably greater immunizing doses of irradiated parasites without CQ do not protect mice <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref> or humans <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref> against natural challenge. CQ treatment either allows greater and/or antigenically broader immune responses consequent to robust expression of liverstage antigens <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roestenberg1">[163]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sauerwein1">[164]</xref>, or lowers a barrier to immunity, or both. We examine the evidence for both, below.</p>
</sec></sec><sec id="s3d">
<title>4. Protective effects of skin inflammation and CQ immunomodulatory mechanisms implicate early, skin-induced Tregs in systemic immunotolerance</title>
<sec id="s3d1">
<title>4-i. The liverstage antigen concept for protective immunity</title>
<p>That protection requires robust expression of liverstage-antigens has significant correlative support. Primaquine (PQ) eliminates all forms of liverstage parasites <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Scheller1">[165]</xref> and concomitantly abrogates protection <xref ref-type="bibr" rid="pone.0010685-Scheller1">[165]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller2">[166]</xref>; incremental parasite irradiation increasingly limits parasite liverstage proliferation <xref ref-type="bibr" rid="pone.0010685-Vanderberg3">[149]</xref>, <xref ref-type="bibr" rid="pone.0010685-Scheller1">[165]</xref> and corresponds to decreasing antigen synthesis <xref ref-type="bibr" rid="pone.0010685-Suhrbier1">[167]</xref> (implying decreased antigen presentation) and diminished protectivity <xref ref-type="bibr" rid="pone.0010685-Scheller1">[165]</xref>, <xref ref-type="bibr" rid="pone.0010685-Suhrbier1">[167]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sigler1">[168]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mellouk1">[169]</xref>, <xref ref-type="bibr" rid="pone.0010685-Silvie1">[170]</xref>. CQ attenuation however, does not affect parasite liver stages <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, allowing fullscale liver infections, abrogated after emerging from the liver <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>. These data imply robustly expressed mid-lateliverstage parasite antigens provide immunity <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Silvie1">[170]</xref> to subsequent natural challenge.</p>
</sec><sec id="s3d2">
<title>4-ii. The liverstage antigen concept does not explain all the data</title>
<p>Although widely accepted <xref ref-type="bibr" rid="pone.0010685-Roestenberg1">[163]</xref>, this concept does not reconcile important data. Genetically attenuated liverstage parasites (p52/36, delivered i.v.), persisting in hepatocytes less than 6 hrs <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref> (minimizing antigen presentation) nonetheless protect against stringent <italic>P. yoelii</italic> <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref> natural challenge. Similarly, protective responses to liverstage infection (delivered i.v.) are swift <xref ref-type="bibr" rid="pone.0010685-Sano1">[46]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref>, but do not increase with prolonged antigen presentation <xref ref-type="bibr" rid="pone.0010685-Hafalla1">[79]</xref>. Stable, protective <xref ref-type="bibr" rid="pone.0010685-Palmer1">[172]</xref> memory T cell populations to skinstage parasites are induced and maintained by exposure to sporozoite and bloodstage parasites in skinstage immunized, (malaria-naïve) people <xref ref-type="bibr" rid="pone.0010685-Palmer1">[172]</xref>. Finally, endemic populations remain susceptible to reinfection, despite multiple fullscale liverstage infections, widespread use of CQ in adults, and evidence for unimpaired development and recall of liverstage-cognate memory responses during <xref ref-type="bibr" rid="pone.0010685-Hafalla2">[80]</xref>, <xref ref-type="bibr" rid="pone.0010685-Orjih2">[173]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bejon3">[174]</xref> and after <xref ref-type="bibr" rid="pone.0010685-Bejon3">[174]</xref> bloodstage infection. These discrepancies suggest CQ co-administered with skin-infecting parasites in malaria-naïve people, confers protection in some way beyond allowing a fullscale liverstage antigenic repertoire.</p>
</sec><sec id="s3d3">
<title>4-iii. CQ inhibits antigen presentation pathways vital to Treg induction in skin</title>
<p>CQ disrupts all MHC II antigen presentation <xref ref-type="bibr" rid="pone.0010685-Kalia1">[157]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ziegler1">[175]</xref>, <xref ref-type="bibr" rid="pone.0010685-Nowell1">[176]</xref> to CD4+ T cells. CQ also specifically blocks <xref ref-type="bibr" rid="pone.0010685-DiPucchio1">[160]</xref> the rapid, seconds-to-15-minute <xref ref-type="bibr" rid="pone.0010685-Reid1">[159]</xref> noncanonical MHC I recycling pathway <xref ref-type="bibr" rid="pone.0010685-DiPucchio1">[160]</xref>, <xref ref-type="bibr" rid="pone.0010685-Burgdorf1">[161]</xref> for extracellular antigen cross-presentation to cytotoxic (CD8+) T cells, which in human plasmacytoid-DC (pDC) <xref ref-type="bibr" rid="pone.0010685-DiPucchio1">[160]</xref> enables very rapid cytotoxic responses <xref ref-type="bibr" rid="pone.0010685-DiPucchio1">[160]</xref>. CQ does <italic>not</italic> block classical MHC I antigen cross-presentation <xref ref-type="bibr" rid="pone.0010685-Burgdorf1">[161]</xref>, which takes 6-18 hrs <xref ref-type="bibr" rid="pone.0010685-DiPucchio1">[160]</xref> for optimal presentation.</p>
<p>Therefore, only slow, classical MHC I cross-presentation, (efficiently functional in human skin-resident epidermal Langerhans DC (L-DC) <xref ref-type="bibr" rid="pone.0010685-Stoitzner1">[177]</xref>, <xref ref-type="bibr" rid="pone.0010685-Klechevsky1">[178]</xref>, dermal DC (d-DC) <xref ref-type="bibr" rid="pone.0010685-Flacher1">[179]</xref> and other immune and parenchymal cells <xref ref-type="bibr" rid="pone.0010685-Dzierszinski1">[180]</xref> such as traversed <xref ref-type="bibr" rid="pone.0010685-Bongfen2">[181]</xref> skin or malaria-infected liver cells <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bongfen3">[182]</xref>), is available to generate protective cytotoxic (CD8<sup>+</sup>, MHC I) responses to malaria antigens presented at the skinstage <xref ref-type="bibr" rid="pone.0010685-Doolan2">[18]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bongfen1">[28]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan5">[183]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan6">[184]</xref> in humans. In agreement, protection provided by attenuated sporozoites against intravenous challenge in mice, requires MHC I cross-presentation <xref ref-type="bibr" rid="pone.0010685-White1">[185]</xref>. Also, in humans, one therapeutic dose of CQ strongly inhibits CD4+ T cell responses while strongly inducing CD8+ effector responses <italic>in vivo</italic> to a particulate viral antigen <xref ref-type="bibr" rid="pone.0010685-Accapezzato1">[186]</xref>. Malaria parasites constitute particulate antigen. Evidently, CQ treatment will affect antigen presentation in the skin during the earliest stages of malaria infection: the mosquito bite. Antigen-specific responses dependent on rapid cross-presentation of exogenous MHC I, and all MHC II antigen presentation, including any regulatory T cell induction or activation, will be blocked. CQ therefore, affects the balance of earliest host immune responses triggered to malaria antigens, which are first encountered in the skin.</p>
</sec><sec id="s3d4">
<title>4-iv. Normal host response to mosquito-bite inflammation triggers tolerizing cascades, facilitating parasite-cognate Treg induction early in infection</title>
<p>Mosquito bites cause severe local or systemic allergic inflammation <xref ref-type="bibr" rid="pone.0010685-Peng1">[187]</xref>, unless rapidly dampened by <italic>in situ</italic> suppressive activity induced in antigen-cognate T cells (iTregs) <xref ref-type="bibr" rid="pone.0010685-CurottodeLafaille1">[91]</xref>. Human skin is rich (∼100,000 per cm<sup>2</sup>) <xref ref-type="bibr" rid="pone.0010685-Clark1">[101]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clark2">[102]</xref> in suppressive <xref ref-type="bibr" rid="pone.0010685-Clark2">[102]</xref>, skin-resident <xref ref-type="bibr" rid="pone.0010685-Clark1">[101]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clark2">[102]</xref>, circulating <xref ref-type="bibr" rid="pone.0010685-Iellem1">[188]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hirahara1">[189]</xref> and LN-homing <xref ref-type="bibr" rid="pone.0010685-Clark2">[102]</xref> nTregs, and local inflammation, which recruits DCs and T cells <xref ref-type="bibr" rid="pone.0010685-CurottodeLafaille1">[91]</xref>, <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref> preferentially increases Treg infiltration <xref ref-type="bibr" rid="pone.0010685-CurottodeLafaille1">[91]</xref>, <xref ref-type="bibr" rid="pone.0010685-Iellem2">[191]</xref>, <xref ref-type="bibr" rid="pone.0010685-Selvaraj1">[192]</xref>. Tregs further accumulate at inflammatory sites <xref ref-type="bibr" rid="pone.0010685-CurottodeLafaille1">[91]</xref>, <xref ref-type="bibr" rid="pone.0010685-Huehn1">[193]</xref>, <xref ref-type="bibr" rid="pone.0010685-Campanelli1">[194]</xref> via DC (antigen-presenting) dependent and independent <xref ref-type="bibr" rid="pone.0010685-Clark2">[102]</xref> mechanisms.</p>
<p>In skin, sunlight and allergen induced inflammations cause keratinocyte signalling molecules <xref ref-type="bibr" rid="pone.0010685-Loser1">[195]</xref> to interact with densely interwoven epidermal <xref ref-type="bibr" rid="pone.0010685-Romani1">[196]</xref> L-DC. This increases antigen scavenging <xref ref-type="bibr" rid="pone.0010685-Loser1">[195]</xref> in L-DC, and induces L-DC to generate <italic>de novo,</italic> and proliferate, antigen-specific Tregs <xref ref-type="bibr" rid="pone.0010685-Loser1">[195]</xref>. These skin-triggered Tregs repress allergic inflammatory reactions both locally, in skin and draining LNs, and systemically <xref ref-type="bibr" rid="pone.0010685-Loser1">[195]</xref>.</p>
<p>Mosquito saliva allergens <xref ref-type="bibr" rid="pone.0010685-Peng1">[187]</xref>, in sensitized subjects <xref ref-type="bibr" rid="pone.0010685-Donovan1">[152]</xref> such as endemic populations also trigger <xref ref-type="bibr" rid="pone.0010685-Hudson1">[197]</xref> almost instantaneous <xref ref-type="bibr" rid="pone.0010685-Peng2">[198]</xref> inflammatory extravasation <xref ref-type="bibr" rid="pone.0010685-Donovan1">[152]</xref>, <xref ref-type="bibr" rid="pone.0010685-Peng1">[187]</xref>, <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref>, IgE-mediated <xref ref-type="bibr" rid="pone.0010685-Jawdat1">[199]</xref> and independent mast-cell TNF-α <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref> and local IFN-γ and inflammatory cytokine secretion <xref ref-type="bibr" rid="pone.0010685-Donovan1">[152]</xref>, <xref ref-type="bibr" rid="pone.0010685-Peng1">[187]</xref>, <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref>. This induces chemokines <xref ref-type="bibr" rid="pone.0010685-LeBorgne1">[200]</xref> enabling <xref ref-type="bibr" rid="pone.0010685-Williams1">[201]</xref> local skin inflammations to rapidly recruit leukocytes <xref ref-type="bibr" rid="pone.0010685-Donovan1">[152]</xref>, <xref ref-type="bibr" rid="pone.0010685-Peng1">[187]</xref>, <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref>, including circulating immature monocyte-derived DC (mDC) <xref ref-type="bibr" rid="pone.0010685-LeBorgne1">[200]</xref>, pDC <xref ref-type="bibr" rid="pone.0010685-LeBorgne1">[200]</xref>, <xref ref-type="bibr" rid="pone.0010685-Urosevic1">[202]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ueno1">[203]</xref>, <xref ref-type="bibr" rid="pone.0010685-Randolph1">[204]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wollenberg1">[205]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vermi1">[206]</xref>, <xref ref-type="bibr" rid="pone.0010685-Albanesi1">[207]</xref> not normally present in skin, and skin-resident dDC and immature L-DC <xref ref-type="bibr" rid="pone.0010685-LeBorgne1">[200]</xref>. While immature L-DC are initially tolerogenic <xref ref-type="bibr" rid="pone.0010685-Hawiger1">[208]</xref>, <xref ref-type="bibr" rid="pone.0010685-Steinman1">[209]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kaplan1">[210]</xref>, secreting high levels of TGF-β <xref ref-type="bibr" rid="pone.0010685-Klechevsky1">[178]</xref>, <xref ref-type="bibr" rid="pone.0010685-Morelli1">[211]</xref>, strong inflammatory stimuli mature L-DC <xref ref-type="bibr" rid="pone.0010685-Klechevsky1">[178]</xref> to preferentially <xref ref-type="bibr" rid="pone.0010685-Klechevsky1">[178]</xref> crosspresent <xref ref-type="bibr" rid="pone.0010685-Stoitzner1">[177]</xref>, <xref ref-type="bibr" rid="pone.0010685-Klechevsky1">[178]</xref> MHC I epitopes. This drives high avidity, antigen-specific cytotoxic T cell responses against epidermally acquired antigens <xref ref-type="bibr" rid="pone.0010685-Klechevsky1">[178]</xref>; human dDC preferentially stimulate antibody responses <xref ref-type="bibr" rid="pone.0010685-Klechevsky1">[178]</xref>.</p>
<p>However, in Anopheline mosquito-bites, infiltrating mast cells rapidly degranulate <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref>, releasing stored TGF-β1 <xref ref-type="bibr" rid="pone.0010685-Li1">[212]</xref> and bioactivating molecules <xref ref-type="bibr" rid="pone.0010685-Li1">[212]</xref>, activating TGF-β signalling <xref ref-type="bibr" rid="pone.0010685-Lindstedt1">[213]</xref>. Exogenous bioactive TGF-β inhibits maturation and endogenous antigen presentation by immature human L-DC after antigen uptake <xref ref-type="bibr" rid="pone.0010685-Li1">[212]</xref>, <xref ref-type="bibr" rid="pone.0010685-Geissmann1">[214]</xref>, and upregulates IL-10 secretion in T cells <xref ref-type="bibr" rid="pone.0010685-Kitani1">[215]</xref> and mDC <xref ref-type="bibr" rid="pone.0010685-Levings1">[216]</xref> subsets (this includes L-DC <xref ref-type="bibr" rid="pone.0010685-Ginhoux1">[217]</xref>).</p>
<p>Immature human mDC <xref ref-type="bibr" rid="pone.0010685-Levings1">[216]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jonuleit1">[218]</xref>, <xref ref-type="bibr" rid="pone.0010685-Dhodapkar1">[219]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mahnke2">[220]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roncarolo1">[221]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cools1">[222]</xref> and antigen-activated human pDC <xref ref-type="bibr" rid="pone.0010685-Cools1">[222]</xref>, <xref ref-type="bibr" rid="pone.0010685-Gilliet1">[223]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ito1">[224]</xref>, (which also secrete chemokines that attract circulating T cells <xref ref-type="bibr" rid="pone.0010685-Urosevic1">[202]</xref>), prime IL-10-secreting, immunosuppressive iTregs from interacting antigen-cognate T cells. Suboptimal <xref ref-type="bibr" rid="pone.0010685-Kretschmer1">[225]</xref>, or immature DC antigen presentation <xref ref-type="bibr" rid="pone.0010685-Jonuleit1">[218]</xref>, <xref ref-type="bibr" rid="pone.0010685-Dhodapkar1">[219]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roncarolo2">[226]</xref> and low antigen dose <xref ref-type="bibr" rid="pone.0010685-Kretschmer1">[225]</xref>, <xref ref-type="bibr" rid="pone.0010685-George1">[227]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sarris1">[228]</xref> preferentially <xref ref-type="bibr" rid="pone.0010685-Tang2">[229]</xref> activate Tregs over effectors, and increasing local TGF-β and IL-10 concentrations further activate Tregs <xref ref-type="bibr" rid="pone.0010685-Tang1">[93]</xref>, <xref ref-type="bibr" rid="pone.0010685-Dieckmann1">[230]</xref>, <xref ref-type="bibr" rid="pone.0010685-vonBoehmer1">[231]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belkaid2">[232]</xref>. This tolerogenic cascade will act on recruited T cells and Tregs, potentially including malaria-crossreacting specificities <xref ref-type="bibr" rid="pone.0010685-Robson1">[233]</xref> present in malaria-naïve people <xref ref-type="bibr" rid="pone.0010685-Wang1">[55]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pombo1">[77]</xref>, <xref ref-type="bibr" rid="pone.0010685-Okitsu1">[234]</xref>.</p>
<p>Once activated, nTregs also secrete bioactive <xref ref-type="bibr" rid="pone.0010685-Horwitz1">[87]</xref> TGF-β1 <xref ref-type="bibr" rid="pone.0010685-Horwitz1">[87]</xref>, <xref ref-type="bibr" rid="pone.0010685-Miller1">[235]</xref>, <xref ref-type="bibr" rid="pone.0010685-Zheng1">[236]</xref>, <xref ref-type="bibr" rid="pone.0010685-Li2">[237]</xref>, and most iTregs produce high levels of IL-10 <xref ref-type="bibr" rid="pone.0010685-Roncarolo1">[221]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cools1">[222]</xref>, <xref ref-type="bibr" rid="pone.0010685-Groux1">[238]</xref>, <xref ref-type="bibr" rid="pone.0010685-Maynard1">[239]</xref> and/or TGF-β <xref ref-type="bibr" rid="pone.0010685-Campanelli1">[194]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cools1">[222]</xref>. These cytokines mediate multiple Treg activation <xref ref-type="bibr" rid="pone.0010685-Horwitz1">[87]</xref>, <xref ref-type="bibr" rid="pone.0010685-Levings1">[216]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roncarolo1">[221]</xref>, <xref ref-type="bibr" rid="pone.0010685-vonBoehmer1">[231]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cottrez1">[240]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chen2">[241]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chen3">[242]</xref>, <xref ref-type="bibr" rid="pone.0010685-Fahlen1">[243]</xref>, induction <xref ref-type="bibr" rid="pone.0010685-CurottodeLafaille1">[91]</xref>, <xref ref-type="bibr" rid="pone.0010685-Levings1">[216]</xref>, <xref ref-type="bibr" rid="pone.0010685-Groux1">[238]</xref>, <xref ref-type="bibr" rid="pone.0010685-Maynard1">[239]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chen4">[244]</xref>, <xref ref-type="bibr" rid="pone.0010685-Horwitz2">[245]</xref>, <xref ref-type="bibr" rid="pone.0010685-Apostolou1">[246]</xref>, <xref ref-type="bibr" rid="pone.0010685-Andersson1">[247]</xref> and suppression mechanisms both antigen specific <xref ref-type="bibr" rid="pone.0010685-Zhang1">[95]</xref>, <xref ref-type="bibr" rid="pone.0010685-vonBoehmer1">[231]</xref> and non-specific <xref ref-type="bibr" rid="pone.0010685-Horwitz1">[87]</xref>. Also, independently of DCs, accumulating human antigen-activated CD4+ Tregs can themselves generate suppressive iTreg via TGF-β-dependent <xref ref-type="bibr" rid="pone.0010685-Andersson1">[247]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jonuleit2">[248]</xref>, <xref ref-type="bibr" rid="pone.0010685-Filaci1">[249]</xref> or IL-10 dependent <xref ref-type="bibr" rid="pone.0010685-Dieckmann1">[230]</xref>, <xref ref-type="bibr" rid="pone.0010685-Groux1">[238]</xref> infectious tolerance. These cascading mechanisms will efficiently expand miniscule numbers of cognate Tregs <xref ref-type="bibr" rid="pone.0010685-Tang1">[93]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mellor1">[100]</xref>, <xref ref-type="bibr" rid="pone.0010685-Andersson1">[247]</xref> initially activated or induced in location, such as an Anopheline bite-site or draining LN.</p>
</sec><sec id="s3d5">
<title>4-v. Antigen presentation during mosquito bites provides for opportunistic systemic subversion to malaria- specific tolerance</title>
<p>Critically, Tregs normally home to inflamed tissue <xref ref-type="bibr" rid="pone.0010685-Huehn1">[193]</xref> and LNs <xref ref-type="bibr" rid="pone.0010685-Lau1">[250]</xref> according to homing molecules expressed <xref ref-type="bibr" rid="pone.0010685-Zhang2">[251]</xref>, and in inflamed skin <xref ref-type="bibr" rid="pone.0010685-CurottodeLafaille1">[91]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clark2">[102]</xref>, <xref ref-type="bibr" rid="pone.0010685-Loser1">[195]</xref> and LNs <xref ref-type="bibr" rid="pone.0010685-Haribhai1">[252]</xref>, rapidly out-proliferate <xref ref-type="bibr" rid="pone.0010685-Haribhai1">[252]</xref> and suppress priming <xref ref-type="bibr" rid="pone.0010685-Tang2">[229]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tadokoro1">[253]</xref> and proliferation <xref ref-type="bibr" rid="pone.0010685-Haribhai1">[252]</xref> of same-specificity effector T cells. Under such Treg-dominated <xref ref-type="bibr" rid="pone.0010685-Mahnke1">[88]</xref>, <xref ref-type="bibr" rid="pone.0010685-Veldhoen1">[254]</xref>, or tolerogenic IL-10-rich microenvironments <xref ref-type="bibr" rid="pone.0010685-Groux1">[238]</xref>, <xref ref-type="bibr" rid="pone.0010685-Steinbrink1">[255]</xref>, mature human mDC will also generate iTregs <xref ref-type="bibr" rid="pone.0010685-Groux1">[238]</xref>, <xref ref-type="bibr" rid="pone.0010685-Steinbrink1">[255]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bellinghausen1">[256]</xref>. This further facilitates specific systemic tolerization to skin-encountered antigens. High, tolerogenic IL-10 levels normally prevail within 8 hours in LNs draining uninfected Anopheline mosquito bites <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref>, <xref ref-type="bibr" rid="pone.0010685-Depinay1">[257]</xref>. The normal response to Anopheline bites therefore, provides a tolerogenically predisposed microenvironment, in which parasites, when transmitted, will drive parasite-specific tolerization.</p>
<p>Evidently, antigen presentation in skin during malaria-infected mosquito bites provides major sources of antigen-specific Tregs capable of repressing local <xref ref-type="bibr" rid="pone.0010685-CurottodeLafaille1">[91]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mellor1">[100]</xref>, LN and systemic <xref ref-type="bibr" rid="pone.0010685-Loser1">[195]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mbs1">[258]</xref> inflammatory reactions to bite-site antigens. T cell repertoires in malaria-naïve people include malaria-cognate specificities <xref ref-type="bibr" rid="pone.0010685-Wang1">[55]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pombo1">[77]</xref>, <xref ref-type="bibr" rid="pone.0010685-Okitsu1">[234]</xref>. Malaria proteins contain amino acid sequences highly conserved in human housekeeping proteins <xref ref-type="bibr" rid="pone.0010685-Robson1">[233]</xref>, implying the pre-existence of malaria-cognate nTregs. These T cell and Treg repertoires, responding to mosquito-allergen inflammation, and the minimal malaria antigen doses transmitted in bites, provide amply for <italic>de novo</italic> malaria-specific suppressive iTreg generation, and expansion of pre-existing, potentially cognate <xref ref-type="bibr" rid="pone.0010685-Robson1">[233]</xref> nTregs, via Treg induction and expansion mechanisms <xref ref-type="bibr" rid="pone.0010685-Kretschmer1">[225]</xref> documented in the basic literature (see above Section <italic>4-iv</italic>). Existing mechanisms for rapidly expanding Treg number <xref ref-type="bibr" rid="pone.0010685-Roncarolo1">[221]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cools1">[222]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kretschmer1">[225]</xref>, <xref ref-type="bibr" rid="pone.0010685-Filaci1">[249]</xref> and specificity spectrum <xref ref-type="bibr" rid="pone.0010685-Tang1">[93]</xref> clearly support rapid induction of antigen-specific Tregs and systemic tolerance <xref ref-type="bibr" rid="pone.0010685-Tang1">[93]</xref>. These conditions (part of the normal host response to mosquito bites), occur in malaria infections at earliest skinstage, well before bloodstages emerge. This facilitates opportunistic Treg induction triggered at the skinstage by transmitted parasites. In corroboration, in naïve animals, sand-fly transmitted skinstage <italic>Leishmania</italic> parasites induce <italic>de novo</italic> parasite-specific Tregs (previously undetectable in the animal) <xref ref-type="bibr" rid="pone.0010685-Suffia1">[259]</xref> which inactivate robust, protective cytotoxic responses <xref ref-type="bibr" rid="pone.0010685-Anderson1">[260]</xref> concomitantly elicited by parasite infection. Conversely, and significantly, people in endemic areas deficient in basic functions driving Treg induction (TGF-β production, TGF-β receptors, FOXP3, CTLA-4) resist infection <xref ref-type="bibr" rid="pone.0010685-Torcia1">[155]</xref>, not just bloodstage disease, specifically implicating the mechanisms of Treg induction and expansion described, in host susceptibility.</p>
</sec><sec id="s3d6">
<title>4-vi. CQ specifically blocks Treg-inducing antigen presentation: this prevents malaria-specific tolerance induction via bite-site parasite interactions in the skin</title>
<p>Skin-accumulating CQ disrupts bite-site antigen presentation leading to Treg-induction and activation. Malaria-naïve people treated simultaneously with CQ develop strong immunity via infected bites <xref ref-type="bibr" rid="pone.0010685-Roestenberg1">[163]</xref>. A malaria-naïve person therefore, develops protection against natural challenge when rapid cross-presentation of exogenous MHC I, and all MHC II antigen presentation, and consequently also, major sources of rapid antigen-specific activation and <italic>de novo</italic> induction of tolerogenic CD4+ and CD8+ regulatory T cells in the skin and skin-draining LN, are blocked at the skinstage during immunizing skin infections. Slower, protective CD8+ responses to liverstages, also primed in the peripheral lymph nodes <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bowen1">[261]</xref> are uninhibited. As seen (Section 4-ii), protection due to expression of a broader liverstage antigen repertoire permitted by CQ, as proposed by others <xref ref-type="bibr" rid="pone.0010685-Roestenberg1">[163]</xref> is inconsistent with lifelong susceptibility in populations from endemic areas, and other, experimental data. Therefore, live parasite immunization via the skin under CQ immunomodulation, results in protection <xref ref-type="bibr" rid="pone.0010685-Roestenberg1">[163]</xref> because CQ coadministered with naturally transmitted parasites, in malaria-naïve people, effects an immunological bypass of rapid, initial skinstage antigen-specific tolerization and suppression, enhancing slower-developing immunity, and memory responses.</p>
</sec><sec id="s3d7">
<title>4-vii. Enhancing inflammation also counteracts tolerization via the skin</title>
<p>Multiple-bite immunizations deliver unnaturally high allergen/parasite-antigen doses, provoking strongly pro-inflammatory microenvironments. Pro-inflammatory conditions counteract <xref ref-type="bibr" rid="pone.0010685-Mellor1">[100]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wei1">[262]</xref>, and inhibit <xref ref-type="bibr" rid="pone.0010685-George1">[227]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kapp1">[263]</xref> DC tolerization and directly disrupt Treg-induction and activation in mucosal skin <xref ref-type="bibr" rid="pone.0010685-Oldenhove1">[264]</xref>, and can convert Tregs to effectors <xref ref-type="bibr" rid="pone.0010685-Littman1">[265]</xref>. Multiple-bite immunizations therefore, support immediate, predominantly cytotoxic <xref ref-type="bibr" rid="pone.0010685-Klechevsky1">[178]</xref> malaria-specific protective immune responses, effectively disrupting skinstage tolerization, and enhancing protective memory responses.</p>
</sec></sec><sec id="s3e">
<title>5. A role for the skin accommodates conflicting data</title>
<p>Consistent with this perspective, genetically attenuated immunizing parasites, (p52/36 <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref> or p36 <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>) administered intravenously, entirely bypass skinstage interactions. Multiple short immunizing liverstage infections, of sufficient dosage <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref>, accumulate enough antigen exposure to establish protective responses. Without inhibitory skinstage interactions, intravenous immunization eliciting swift <xref ref-type="bibr" rid="pone.0010685-Sano1">[46]</xref> limited <xref ref-type="bibr" rid="pone.0010685-Sano1">[46]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hafalla1">[79]</xref> responses to incipient liverstage infection will protect <xref ref-type="bibr" rid="pone.0010685-Hafalla1">[79]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hafalla3">[266]</xref> against natural challenge without antigen persistence <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tarun1">[267]</xref>, reconciling these (and other <xref ref-type="bibr" rid="pone.0010685-Scheller1">[165]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller2">[166]</xref>, see Supplementary <xref ref-type="supplementary-material" rid="pone.0010685.s003">Text S1</xref>) contradictory data.</p>
<p>In strong support, multiple cycles of intravenous infection and subsequent elimination with primaquine (PQ), a parasiticidal drug cure, administered during liverstage development (allowing limited antigen presentation by infected hepatocyte <xref ref-type="bibr" rid="pone.0010685-Weiss3">[268]</xref> before PQ-cure) builds robust protection to natural challenge <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref>. Immunization via skin, however, with identical PQ-cure cycles, reduces protection <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref> even against intravenous challenge, again implicating the skin in inefficient development of immunity.</p>
<p>Finally, 56% <xref ref-type="bibr" rid="pone.0010685-Bejon1">[9]</xref> −66% <xref ref-type="bibr" rid="pone.0010685-Aponte1">[10]</xref>, <xref ref-type="bibr" rid="pone.0010685-Abdulla1">[11]</xref> of infants (3–17 and 2–4 months old, respectively) from seasonal <xref ref-type="bibr" rid="pone.0010685-Saute1">[269]</xref>, high transmission areas can be immunized against natural challenge <xref ref-type="bibr" rid="pone.0010685-Bejon1">[9]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aponte1">[10]</xref> with a skinstage antigen (CSP) vaccine, that negligibly protects, or does not protect adults from endemic areas <xref ref-type="bibr" rid="pone.0010685-Bojang1">[14]</xref>, <xref ref-type="bibr" rid="pone.0010685-Polhemus1">[15]</xref>.</p>
<p>Adult endemic-region populations are largely pre-exposed <xref ref-type="bibr" rid="pone.0010685-Guerra1">[270]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hay1">[271]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hay2">[272]</xref> to malaria parasites in the skin: high-transmission areas provide over 2 infected bites per night <xref ref-type="bibr" rid="pone.0010685-Roussilhon1">[30]</xref>, <xref ref-type="bibr" rid="pone.0010685-Beier1">[273]</xref>, <xref ref-type="bibr" rid="pone.0010685-Reyburn1">[274]</xref>. However, neonates are skinstage malaria-naïve. Babies 0–6 months old, enrolled in medical trials, have significant chances of being skinstage-naïve upon immunization, and remaining so for 3–6 months. Urbanizing environments <xref ref-type="bibr" rid="pone.0010685-Hay1">[271]</xref>, increased bednet use (about 80% compliance <xref ref-type="bibr" rid="pone.0010685-Bejon1">[9]</xref>) and seasonal transmission relative to birthdate, all reduce exposure to mosquitoes. This allows many intramuscularly immunized infants to pre-establish robust protective responses before encountering skinstage parasites.</p>
</sec><sec id="s3f">
<title>6. A critical role for immune mechanisms within the skin in malaria vaccine malfunction</title>
<p>Chronic pre-exposure of skin to live parasites coincides closely with failure of clinically functional vaccines (<xref ref-type="fig" rid="pone-0010685-g002">Figure 2A</xref>). Immunization reliably protects against natural challenge only in skinstage-naïve individuals where robust responses are established <italic>before</italic> infective parasites ever interact with unmodified skin (<xref ref-type="fig" rid="pone-0010685-g002">Figure 2b,d,g</xref>). Available epidemiological and vaccine trial data strongly implicate the skin in a block to protective immunity dependent on the presence of skinstage parasites and functional CD4+ and rapid CD8+ exogenous-antigen presentation in the skin, and independent of prior bloodstage infection. T cell memory responses develop normally during <xref ref-type="bibr" rid="pone.0010685-Hafalla2">[80]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bejon3">[174]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wyler1">[275]</xref> and after <xref ref-type="bibr" rid="pone.0010685-Wyler1">[275]</xref> bloodstage infection, and human bloodstage-induced immunosuppression <xref ref-type="bibr" rid="pone.0010685-Greenwood2">[276]</xref>, <xref ref-type="bibr" rid="pone.0010685-Whittle1">[277]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cook1">[278]</xref>, <xref ref-type="bibr" rid="pone.0010685-Williamson1">[279]</xref> is usually limited to acute malaria <xref ref-type="bibr" rid="pone.0010685-Williamson1">[279]</xref>, <xref ref-type="bibr" rid="pone.0010685-BradleyMoore1">[280]</xref>, <xref ref-type="bibr" rid="pone.0010685-Riley1">[281]</xref>. The low incidence of acute malaria in semi-immune <xref ref-type="bibr" rid="pone.0010685-Langhorne1">[32]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan3">[33]</xref> endemic adults cannot, therefore, account for unmitigated susceptibility to reinfection, nor uniform inability of diverse clinically functional vaccines to protect healthy, endemic adults.</p>
<p>We conclude potentially protective liverstage and vaccine-generated T cell responses, which indisputably exist, are disabled by parasites in the skin.</p>
</sec><sec id="s3g">
<title>7. Timing, behaviour and molecular characteristics of the malaria parasite skin stage are aggressively tolerogenic</title>
<sec id="s3g1">
<title>7-i. A role for the bite-site and parasite behaviour in early systemic tolerization</title>
<p>Malaria-infected mosquito bites of 1 minute deposit around 20 <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref> sporozoites in nanolitres <xref ref-type="bibr" rid="pone.0010685-Donovan1">[152]</xref> of saliva into epidermal <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jin1">[110]</xref> and dermal <xref ref-type="bibr" rid="pone.0010685-Jin1">[110]</xref> skin. Within an hour, in mice, about 10–15% <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref> (normally, 2–3) of deposited sporozoites enter proximal skin-draining lymph nodes (LN) <xref ref-type="bibr" rid="pone.0010685-Boyd1">[103]</xref>, <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref>, rapidly metamorphosing into bloodstage-like forms <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, (we propose the term “pseudomorphs”) expressing antigens <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sacci1">[282]</xref> characteristic of later liver and bloodstages <xref ref-type="bibr" rid="pone.0010685-Sacci1">[282]</xref>. After 7 hours <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, most LN parasites are inside <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref> or entwined around CD11c+ <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref> (cross-presenting) dendritic cells. Some parasites (∼10) remain in the skin <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, and their exact fate is formally unclear. Antigens draining from these will initially reflect the skinstage. However, host cell environment differentially affects expression profile in malaria parasites <xref ref-type="bibr" rid="pone.0010685-Mikolajczak1">[283]</xref>, <xref ref-type="bibr" rid="pone.0010685-Siau1">[284]</xref>. Given the metamorphic propensity of LN parasites, antigenic representation of further lifecycle stages in skin-lingering parasites cannot be excluded.</p>
<p>These data are crucial: they reveal the very earliest stages of natural infection immediately expose the host immune system, via skin and rapidly developing “pseudomorphs” in skin-draining LN, to very low doses of (minimally) both skinstage and liverstage antigens. These conditions anad location are highly conducive to antigen-specific Treg induction and activation, and particularly rapid induction of systemic tolerance <xref ref-type="bibr" rid="pone.0010685-Senti1">[285]</xref>, and therefore, rapid systemic tolerance to parasite antigens arriving in the LN.</p>
</sec><sec id="s3g2">
<title>7-ii. Normal bite-site responses lead rapidly to systemic tolerance</title>
<p>Tregs activated in skin bite-sites and LN by migrating parasites and draining antigens will rapidly orchestrate systemic tolerance. Tregs tolerize surrounding microenvironments <xref ref-type="bibr" rid="pone.0010685-Mahnke1">[88]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mellor1">[100]</xref>, <xref ref-type="bibr" rid="pone.0010685-Veldhoen1">[254]</xref>, downregulating mDC antigen presentation <xref ref-type="bibr" rid="pone.0010685-Houot1">[286]</xref> and upregulating mDC TGF-β and IL-10 secretion <xref ref-type="bibr" rid="pone.0010685-Veldhoen1">[254]</xref>, <xref ref-type="bibr" rid="pone.0010685-Houot1">[286]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bayry1">[287]</xref>. This favours further Treg activation. Tregs also reverse TLR activation of strong proinflammatory responses in human mDC <xref ref-type="bibr" rid="pone.0010685-Houot1">[286]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bayry1">[287]</xref>, <xref ref-type="bibr" rid="pone.0010685-Anderson2">[288]</xref>, normally triggered by pathogen ligands <xref ref-type="bibr" rid="pone.0010685-Krishnegowda1">[289]</xref>. Contact with accumulating Tregs induces immature human L-DC and mDC to remain semi-immature <xref ref-type="bibr" rid="pone.0010685-Houot1">[286]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bayry1">[287]</xref> and migrate to draining LNs <xref ref-type="bibr" rid="pone.0010685-Bayry1">[287]</xref>. LN-migrating mDC can transfer peripheral antigen to LN-resident DC <xref ref-type="bibr" rid="pone.0010685-Allan1">[290]</xref> such as human pDCs, which congregate in densely packed <xref ref-type="bibr" rid="pone.0010685-Lammermann1">[291]</xref> naïve T cell regions <xref ref-type="bibr" rid="pone.0010685-Rothenfusser1">[292]</xref>. More immediately, pDC cross-presentation will induce IL-10-secreting Tregs <xref ref-type="bibr" rid="pone.0010685-Gilliet1">[223]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ito1">[224]</xref> in response to rapidly draining skin-located antigens <xref ref-type="bibr" rid="pone.0010685-Lammermann1">[291]</xref> (eg. from bite-site) and LN-migrating parasite antigens, potentially within an hour of the mosquito bite. Later arriving <xref ref-type="bibr" rid="pone.0010685-Kissenpfennig1">[293]</xref> semi-mature L-DC, trafficking antigen <xref ref-type="bibr" rid="pone.0010685-Kissenpfennig1">[293]</xref> to naive T cell regions of the LN <xref ref-type="bibr" rid="pone.0010685-Macatonia1">[294]</xref>, <xref ref-type="bibr" rid="pone.0010685-Randolph2">[295]</xref> will therefore encounter pre-established, tolerizing microenvironments. Accordingly, skin inflammations <xref ref-type="bibr" rid="pone.0010685-Geissmann2">[296]</xref>, Anopheline mosquito-bites <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref>, <xref ref-type="bibr" rid="pone.0010685-Depinay1">[257]</xref>, and activated TNF-α producing mast cells <xref ref-type="bibr" rid="pone.0010685-Jawdat1">[199]</xref>, all increase immature <xref ref-type="bibr" rid="pone.0010685-Geissmann2">[296]</xref> L-DC migration and accumulation in the LN <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref>, <xref ref-type="bibr" rid="pone.0010685-Depinay1">[257]</xref>, <xref ref-type="bibr" rid="pone.0010685-Geissmann2">[296]</xref>. Also, for isolated Anopheline mosquito bites leukocyte infiltration <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref> cross-presenting DCs <xref ref-type="bibr" rid="pone.0010685-Demeure1">[190]</xref> carrying sporozoite antigen <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref> and IL-10 concentration <xref ref-type="bibr" rid="pone.0010685-Depinay1">[257]</xref> rapidly increase in draining LNs.</p>
<p>These data strongly suggest skinstage parasites capitalize on host responses to isolated, uninfected Anopheline bites, (which are normally immunosuppressive <xref ref-type="bibr" rid="pone.0010685-Depinay1">[257]</xref>), efficiently misdirecting systemic responses to ensure tolerance to subsequently developing parasites.</p>
</sec><sec id="s3g3">
<title>7-iii. Skinstage parasite molecules are intrinsically tolerogenic</title>
<p>Malaria parasites also display aggressive molecular intervention strategies. Critically, gliding sporozoites <xref ref-type="bibr" rid="pone.0010685-Stewart1">[297]</xref> transiting skin cells <xref ref-type="bibr" rid="pone.0010685-Mota1">[298]</xref>, <xref ref-type="bibr" rid="pone.0010685-Amino2">[299]</xref> the LN lumen <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref> and invading LN DCs <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, will shed circumsporozoite protein (CSP) and thrombospondin-related-adhesive protein (TRAP) <xref ref-type="bibr" rid="pone.0010685-Stewart1">[297]</xref>, <xref ref-type="bibr" rid="pone.0010685-Stewart2">[300]</xref>. Cytoplasmic CSP, shed by infecting parasites, inhibits host transcription activator NF-Kβ <xref ref-type="bibr" rid="pone.0010685-Singh1">[301]</xref>, strongly downregulating multiple pleiotropic pro-inflammatory (anti-parasitic <xref ref-type="bibr" rid="pone.0010685-Doolan7">[302]</xref>) activities including IL-6 <xref ref-type="bibr" rid="pone.0010685-Singh1">[301]</xref> during plasmodial liver infection. It is well established in non-malarial systems that IL-6 averts CD4+ iTreg formation <xref ref-type="bibr" rid="pone.0010685-Veldhoen2">[303]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bettelli1">[304]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chen5">[305]</xref>, <xref ref-type="bibr" rid="pone.0010685-Piconese1">[306]</xref> and crucially, suppresses the antigen-specific CD4+ Treg activity <xref ref-type="bibr" rid="pone.0010685-Pasare1">[307]</xref>, <xref ref-type="bibr" rid="pone.0010685-Longhi1">[308]</xref>, which inhibits both T cell activation to foreign antigen <xref ref-type="bibr" rid="pone.0010685-Pasare1">[307]</xref> and CD4+ and CD8+ T cell memory development <xref ref-type="bibr" rid="pone.0010685-Longhi1">[308]</xref>, <xref ref-type="bibr" rid="pone.0010685-Heit1">[309]</xref>. This directly infers IL-6 blockade by malarial CSP <xref ref-type="bibr" rid="pone.0010685-Singh1">[301]</xref> prevents immediate protective T cell activation and memory responses in the skin, LN and infected hepatocytes, simultaneously stimulating in these locations antigen-specific Treg formation <xref ref-type="bibr" rid="pone.0010685-Veldhoen2">[303]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bettelli1">[304]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chen5">[305]</xref>, <xref ref-type="bibr" rid="pone.0010685-Piconese1">[306]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tan1">[310]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cong1">[311]</xref> and expansion <xref ref-type="bibr" rid="pone.0010685-Chen5">[305]</xref>, triggered by malaria antigens. This will limit any malaria-specific responses arising. Accordingly, immediate <italic>in vivo</italic> T cell responses to malaria-infected hepatocytes <xref ref-type="bibr" rid="pone.0010685-Sano1">[46]</xref> are “self-limiting” <xref ref-type="bibr" rid="pone.0010685-Hafalla1">[79]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hafalla3">[266]</xref>, and plasmodial liver infection, (an extensive tissue insult), is non-inflammatory and asymptomatic <xref ref-type="bibr" rid="pone.0010685-Sturm1">[114]</xref>. Further, high dose antigen-presentation, which counteracts Treg suppression <xref ref-type="bibr" rid="pone.0010685-George1">[227]</xref>, in the case of malaria-antigens <xref ref-type="bibr" rid="pone.0010685-Cockburn1">[312]</xref> relieves self-limitation of malaria-specific responses <xref ref-type="bibr" rid="pone.0010685-Cockburn1">[312]</xref>, implicating malaria-specific Tregs in self-limiting immune responses to infected hepatocytes.</p>
<p>Also, <italic>P. falciparum</italic> TRAP (expressed in both skin and blood stages <xref ref-type="bibr" rid="pone.0010685-Cowan1">[313]</xref>), like human thrombospondin, bioactivates latent human TGF-β <xref ref-type="bibr" rid="pone.0010685-Omer1">[314]</xref> via the TSR-1 domain <xref ref-type="bibr" rid="pone.0010685-Lawler1">[315]</xref>. Thrombospondin, by a TGF-β-dependent <xref ref-type="bibr" rid="pone.0010685-Futagami1">[316]</xref> mechanism <xref ref-type="bibr" rid="pone.0010685-Li1">[212]</xref>, <xref ref-type="bibr" rid="pone.0010685-Maynard1">[239]</xref>, converts cognate CD4+ T cells into suppressive iTregs <italic>in situ</italic> <xref ref-type="bibr" rid="pone.0010685-Futagami1">[316]</xref> conferring localized tissue tolerance in mice <xref ref-type="bibr" rid="pone.0010685-Futagami1">[316]</xref>. In humans, parasite-driven TGF-β bioactivation <xref ref-type="bibr" rid="pone.0010685-Omer1">[314]</xref>, <xref ref-type="bibr" rid="pone.0010685-Walther1">[317]</xref> precedes and correlates strongly with significantly increased Treg numbers and parasitaemia densities <xref ref-type="bibr" rid="pone.0010685-Walther1">[317]</xref>, and suppresses proinflammatory responses in humans <xref ref-type="bibr" rid="pone.0010685-Walther1">[317]</xref> and mice <xref ref-type="bibr" rid="pone.0010685-Omer2">[318]</xref>. In unimmunized mice, co-inhibition of TGF-β and IL-10 early <xref ref-type="bibr" rid="pone.0010685-Omer2">[318]</xref> in infection, or depletion of Treg <xref ref-type="bibr" rid="pone.0010685-Hisaeda1">[319]</xref>, restores proinflammatory responses and parasite clearance. Correlative, functional data therefore strongly suggest Treg-inducing skinstage function for TRAP molecules.</p>
</sec><sec id="s3g4">
<title>7-iv. Skinstage parasite behaviour is potently tolerogenic</title>
<p>Human allergen therapy boosts antigen-specific systemic tolerance by chronic low doses applied via the skin <xref ref-type="bibr" rid="pone.0010685-Senti1">[285]</xref>, <xref ref-type="bibr" rid="pone.0010685-Birch1">[320]</xref>, and requires Treg induction and activation <xref ref-type="bibr" rid="pone.0010685-Mbs1">[258]</xref>, <xref ref-type="bibr" rid="pone.0010685-Birch1">[320]</xref>. Tolerization is drastically accelerated by low-dose antigen frequently introduced directly into skin-draining LNs <xref ref-type="bibr" rid="pone.0010685-Senti1">[285]</xref>.</p>
<p>Similarly, people constantly exposed to infected bites inevitably collect frequent low numbers of CSP/TRAP-shedding, LN-migrating, and skin-lingering “pseudomorphic” parasites. This directly infers parasite instigation of continuous Treg activation and induction in both skin and LN, and inevitably, potent intralymphatic, antigen-specific systemic tolerization to exposed malaria antigens.</p>
</sec></sec><sec id="s3h">
<title>8. A model for skinstage-initiated immune subversion incorporates normal immunobiology of Treg induction and mechanism, and the cadence, behaviour and cellular biology of the parasite lifecycle stages</title>
<sec id="s3h1">
<title>8-i. The model</title>
<p>Cellular and molecular data indicate isolated malaria-infected mosquito bites drive rapid systemic tolerization to malaria antigens at the skinstage. Since naturally transmitted parasites progress from skin to liver to blood, liver infections inevitably present malaria sporozoite <xref ref-type="bibr" rid="pone.0010685-Bongfen3">[182]</xref>, <xref ref-type="bibr" rid="pone.0010685-Weiss3">[268]</xref> and liverstage antigens to an already efficiently compromised host immune system.</p>
<p>Tregs from human skin are highly proliferative <italic>in vivo</italic>, develop alongside effector responses at the site of a skin inflammation <xref ref-type="bibr" rid="pone.0010685-VukmanovicStejic1">[321]</xref>, and can be induced <italic>in vivo</italic> and <italic>ex vivo</italic> from highly differentiated memory T cells, by antigen reencounter <xref ref-type="bibr" rid="pone.0010685-VukmanovicStejic1">[321]</xref>, <xref ref-type="bibr" rid="pone.0010685-Akbar1">[322]</xref>. Tregs <italic>in vivo</italic> are preferentially <xref ref-type="bibr" rid="pone.0010685-Clark2">[102]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sarris1">[228]</xref> induced and activated, and have an <italic>in vivo</italic> proliferative advantage <xref ref-type="bibr" rid="pone.0010685-Clark2">[102]</xref>, <xref ref-type="bibr" rid="pone.0010685-Haribhai1">[252]</xref>, <xref ref-type="bibr" rid="pone.0010685-VukmanovicStejic2">[323]</xref> over non-Tregs. These properties provide a clear systemic advantage to any suppressive malaria-specific Tregs generated at the skinstage, over simultaneously elicited malaria-specific <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref> protective cytotoxic T cell responses.</p>
<p>Skinstage pre-exposure of later life-cycle antigens <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref> provides an additional temporal advantage: liverstage infections subsequently presenting CSP <xref ref-type="bibr" rid="pone.0010685-Weiss3">[268]</xref> and pre-exposed liverstage epitopes (eg TRAP, EXP-1) will enhance pre-established parasite-protective Treg populations, suppressing swift cytotoxic responses initiated against infected hepatocytes. B cells require activated T cell help to initiate IgG antibody responses, and Tregs will also directly, antigen-specifically and non-specifically, inhibit or kill activated B cells <xref ref-type="bibr" rid="pone.0010685-Zhao1">[89]</xref>, <xref ref-type="bibr" rid="pone.0010685-LudwigPortugall1">[90]</xref>, <xref ref-type="bibr" rid="pone.0010685-Lim1">[92]</xref>, <xref ref-type="bibr" rid="pone.0010685-Janssens1">[324]</xref>. Antibody responses and B cell function will therefore also be vulnerable to repression by skin-induced, malaria-specific Tregs, from the skinstage onwards. Infection, and reinfection, not sterile immunity, will prevail in natural transmission.</p>
<p>Induction of broad-spectrum malaria-specific Tregs in the skin therefore, ensures liverstage infections always develop into transmissible blood stages. At least 281 bloodstage proteins are expressed at the skin stage, including AMA-1, PfEMP and STEVOR proteins <xref ref-type="bibr" rid="pone.0010685-Florens1">[325]</xref>. More than one liver- and bloodstage-expressed antigen (eg TRAP, EXP-1) <xref ref-type="bibr" rid="pone.0010685-Cowan1">[313]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hope1">[326]</xref>, <xref ref-type="bibr" rid="pone.0010685-Meraldi1">[327]</xref> is definitely exposed at the skinstage <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cowan1">[313]</xref>, and therefore to the skin-based tolerizing mechanisms we define. <italic>Once Tregs are induced, numerous mechanisms (see Sections 4-iv, 4-v, 7-iii) exist allowing small numbers of Tregs of one specificity to expand, outgrow, convert non-Tregs of different specificities to suppressive function (infectious tolerance), and also non-specifically suppress responses to other antigens (bystander suppression) </italic><xref ref-type="bibr" rid="pone.0010685-Tang1">[<italic>93</italic>]</xref><italic>.</italic> Therefore, a Treg response specific and suppressive to one liverstage or bloodstage antigen (eg. TRAP or EXP-1), triggered initially during skinstage, can later re-expand upon specific antigen re-encounter at the liver or bloodstage, and non-specifically suppress T cell (or ablate memory B cell) responses to further parasite antigens co-expressed only at the later stage, eg. responses to MSP-1, specific to late-liver and bloodstages. Pre-induction of bloodstage-specific Tregs provides an obvious protective advantage promoting the establishment of bloodstage parasites emerging from the liver. Re-expansion of pre-induced Tregs will initiate a tolerogenic cascade and immunosuppressive environment conducive to bloodstage expansion, which is further enhanced by the bloodstage parasite themselves. Bloodstage parasites generate Treg activity <xref ref-type="bibr" rid="pone.0010685-Walther1">[317]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hisaeda1">[319]</xref>, <xref ref-type="bibr" rid="pone.0010685-Couper1">[328]</xref>, <xref ref-type="bibr" rid="pone.0010685-Scholzen1">[329]</xref> and nonspecific immunosuppressive conditions <xref ref-type="bibr" rid="pone.0010685-Orjih1">[85]</xref>, <xref ref-type="bibr" rid="pone.0010685-Omer1">[314]</xref>, <xref ref-type="bibr" rid="pone.0010685-Scholzen1">[329]</xref>, <xref ref-type="bibr" rid="pone.0010685-Urban1">[330]</xref>, <xref ref-type="bibr" rid="pone.0010685-OcaaMorgner1">[331]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wilson1">[332]</xref>, enhancing systemic tolerance <xref ref-type="bibr" rid="pone.0010685-Couper1">[328]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belkaid3">[333]</xref> conducive to multiple parasitaemia cycles, thereby increasing probability of gametocyte transmission, and also reinfection <xref ref-type="bibr" rid="pone.0010685-Orjih1">[85]</xref>, <xref ref-type="bibr" rid="pone.0010685-Todryk1">[334]</xref>.</p>
</sec><sec id="s3h2">
<title>8-ii. Model outcomes: experimental versus field infections</title>
<p>Experimental, intravenous sporozoite infections bypass skin/LN Treg activation (<xref ref-type="fig" rid="pone-0010685-g003">Figure 3B</xref>). Consequently, predominant immune responses to liverstage infection, which prime in the peripheral LN <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bowen1">[261]</xref> are unhindered, rendering the immunodominant CSP molecule and also TRAP, experimentally protective <xref ref-type="bibr" rid="pone.0010685-Kumar1">[335]</xref>, <xref ref-type="bibr" rid="pone.0010685-Khusmith1">[336]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kumar2">[337]</xref>.</p>
<fig id="pone-0010685-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0010685.g003</object-id><label>Figure 3</label><caption>
<title>All protective immunization circumvents initial malaria-specific Treg activation in the skin: a functional model.</title>
<p>A: Natural transmission (mosquito bite) allows skinstage parasites (sporozoites, spz, green fragments) to migrate (dotted gray arrows) through skin cells to both lymph nodes (LN) and liver (via blood vessels, bv), and induce malaria-specific regulatory T cells in the skin and LN that suppress (red blocker lines) local and systemic protective immune responses (green arrows), resulting in bloodstage infections (gray fragments below liver), and amplification cycles within red blood cells (rbc). B, C, D: Protective immunity develops where immunization and/or challenge avoids parasite-skin interaction and Treg activation/induction; B: Physical bypass of the skin, (by intravenous (i.v.) attenuated parasites, purified antigen, antibody or intramuscular or intranasal subunit vaccine) at immunization, or i.v. challenge with unattenuated infective parasites, avoids all induction or activation of skin and liverstage-specific Tregs. C: Chloroquine (CQ) accumulates and blocks all MHC II and rapid, (but not classical, slow) MHC I malaria-antigen presentation in the skin, which would otherwise immediately induce/activate antigen-specific Tregs. D: Multiple simultaneous mosquito bites create a strongly pro-inflammatory local skin and/or systemic milieu which inhibit Treg activation and induction processes. LN Inset: Inside LN, metamorphosing skinstage sporozoite parasites (spz) are in close contact with, or invade, host antigen presenting dendritic cells (DC).</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0010685.g003" xlink:type="simple"/></fig>
<p>Like physical bypass of immune interactions in the skin at immunization or challenge (<xref ref-type="fig" rid="pone-0010685-g003">Fig. 3B</xref>), immunological bypass by CQ inhibition of antigen presentation (<xref ref-type="fig" rid="pone-0010685-g003">Fig. 3C</xref>), or inflammatory inhibition of tolerizing cellular cascades (<xref ref-type="fig" rid="pone-0010685-g003">Fig. 3D</xref>) during immunization, consistently result in protection to natural skinstage challenge for malaria-naïve subjects.</p>
<p>Natural, skin-initiated infections however, pre-establish antigen-specific tolerance to parasite antigens presented in the skin and LN (<xref ref-type="fig" rid="pone-0010685-g003">Fig. 3A</xref>). In fundamental opposition to current opinion <xref ref-type="bibr" rid="pone.0010685-Overstreet1">[338]</xref> and vaccine dogma, this model shows CSP and TRAP are pleiopotently immunosuppressive molecules when deployed within the cadence of natural infection. Other lifecycle-stage antigens pre-exposed by skinstage “pseudomorphs” <xref ref-type="bibr" rid="pone.0010685-Amino1">[107]</xref>, such as liver and bloodstage antigens, broaden the scope of immunosuppressive systemic responses to parasite antigens subsequently encountered during liverstage or bloodstage infection (or immunization). Critically, again directly opposing prevailing opinion, further exposure to infected mosquitoes will boost tolerance, and suppression of protective responses, not immunity.</p>
</sec><sec id="s3h3">
<title>8-iii. Selective vaccine failure: who, where and why</title>
<p>Adults chronically exposed to infected mosquitoes from birth will accumulate broad repertoires of regulatory T cells, becoming potently pretolerized. Vaccination deploying skinstage-exposed or bloodstage antigens will activate both pre-existing cognate Tregs <xref ref-type="bibr" rid="pone.0010685-Kretschmer1">[225]</xref>, <xref ref-type="bibr" rid="pone.0010685-Haribhai1">[252]</xref>, <xref ref-type="bibr" rid="pone.0010685-Klein1">[339]</xref> as shown for foreign antigen in mouse systems, and malaria-specific T cells, (effector and other subsets) as shown in humans <xref ref-type="bibr" rid="pone.0010685-Moorthy4">[340]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hill2">[341]</xref>; challenge by mosquito bite will preferentially boost pre-existing Treg-based tolerance <xref ref-type="bibr" rid="pone.0010685-Kretschmer1">[225]</xref>, <xref ref-type="bibr" rid="pone.0010685-Klein1">[339]</xref>, suppressing protective concomitantly elicited and recall responses <xref ref-type="bibr" rid="pone.0010685-Klein1">[339]</xref>. Vaccines which substantially protect malaria-naïve adults <xref ref-type="bibr" rid="pone.0010685-Stoute1">[12]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kester1">[13]</xref> will negligibly, or not, protect endemic-area adults <xref ref-type="bibr" rid="pone.0010685-Bojang1">[14]</xref>, <xref ref-type="bibr" rid="pone.0010685-Polhemus1">[15]</xref>, as solidly evidenced by adult vaccine field trials.</p>
<p>Neonates, initially skinstage-malaria-naïve, are easier to protect from mosquito bite. Accumulation of skinstage-induced regulatory T cells specific for malaria will be negligible, and immunization will (potentially unrestrictedly) favour <xref ref-type="bibr" rid="pone.0010685-Barbosa1">[69]</xref> immunity. Endemic-area infants, like malaria-naïve adults, should be better protected by formulations that negligibly protect endemic-area adults. This profile is precisely corroborated by results for leading CSP-containing RTS,S, vaccine formulations. These protect malaria-naïve adults partially <xref ref-type="bibr" rid="pone.0010685-Stoute1">[12]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kester1">[13]</xref>, endemic-area infants (2–17 month-old) similarly partially <xref ref-type="bibr" rid="pone.0010685-Bejon1">[9]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aponte1">[10]</xref>, <xref ref-type="bibr" rid="pone.0010685-Abdulla1">[11]</xref>, older children poorly <xref ref-type="bibr" rid="pone.0010685-Alonso1">[7]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sacarlal1">[8]</xref>, <xref ref-type="bibr" rid="pone.0010685-Macete1">[342]</xref> and endemic-area adults negligibly <xref ref-type="bibr" rid="pone.0010685-Graves1">[1]</xref>, <xref ref-type="bibr" rid="pone.0010685-Bojang1">[14]</xref>, <xref ref-type="bibr" rid="pone.0010685-Polhemus1">[15]</xref>.</p>
</sec></sec></sec><sec id="s4">
<title>Discussion</title>
<sec id="s4a">
<title>Limitations of the study</title>
<p>Using rigorous systematic literature search, and individual screening with unambiguous criteria on nearly 2000 studies, we have identified the great majority of peer-reviewed, experimental evidence documenting complete protection to malaria infection. Meta-analysis of experimental conditions involved shows only immunizations that avoid live parasite interaction in the skin, or inhibit regulatory T cell induction within the skin during skin-immunization, fully protect against infected mosquito bites. Our main conclusion, that very early, skinstage-induced, antigen-specific regulatory T cells block malaria vaccine function therefore rests empirically but solidly on a straightforward meta-analysis of unbiased experimental data. The data were retrieved from experiments carried out worldwide, by hundreds of groups, using many different protocols over many decades, and drawn from extensive literature reporting skinstage, liverstage and bloodstage vaccine trials. This minimizes both experimental bias and the impact inherent in overlooking any one published study, but does not specify a mechanism. However, detailed molecular/cellular immunological data from experiments carried out independently, in the main by basic research groups unconcerned with malaria (and therefore unbiased), define a mechanism of tolerogenic induction via the skin which strongly supports this conclusion. Combined with the cadence of the parasite lifecycle stages, and the behaviour and detailed cellular and molecular character of skinstage parasites during transmission, we define a novel immuno-epidemiological model for vaccine success/failure. This identifies differential exposure to infected mosquitos and malaria-specific Treg accumulation as the basis for selective vaccine failure in endemic-area populations, and defines a skin-triggered immunological mechanism for early tolerance induction, preceding and independent of later bloodstage immunosuppression. The available epidemiological and experimental vaccine trial data are entirely consistent with the immunological mechanism and model we propose. The model specified by these combined data easily explains myriad long-standing incongruities, paradoxes and contradictions in the malaria literature. In 1916 studies, we could find no experimental immunization or natural infection data which contradict or weaken our conclusions.</p>
</sec><sec id="s4b">
<title>Fundamental implications for vaccine efficacy</title>
<p>Circumvention of malaria-specific regulatory T cell activation in the skin fits all identified instances of protective immunization against virulent experimental challenge, and selective protection in endemic skinstage challenge. Fundamental immediate and longterm implications for vaccine development and strategy are highlighted below.</p>
<sec id="s4b1">
<title>i. Live parasite vaccines</title>
<p>Unmodified intradermal delivery <xref ref-type="bibr" rid="pone.0010685-Luke1">[148]</xref> will obliterate efficacy in otherwise outstandingly successful attenuated-parasite vaccines, advocating optimization of immune context for dermal delivery.</p>
</sec><sec id="s4b2">
<title>ii. Antigen selection</title>
<p>Intrinsically tolerogenic antigens (eg. CSP, TRAP), or those enriching skinstage and/or bloodstage-cognate Tregs (eg. TRAP, EXP-1), (or abundant bloodstream antigens, eg. AMA-1, MSP-1, which will almost inevitably induce homeostatic regulatory T cell activity), are counter-productive in pre-tolerized individuals, although initially effective in malaria-naïve individuals, such as neonates. With age, increasing bite exposure and skin-induced malaria-specific Treg accumulation will repress T cell and B cell responses, eroding <xref ref-type="bibr" rid="pone.0010685-LudwigPortugall1">[90]</xref>, <xref ref-type="bibr" rid="pone.0010685-Lim1">[92]</xref> skinstage-specific, antibody-correlated <xref ref-type="bibr" rid="pone.0010685-Aponte1">[10]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kester2">[343]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kester3">[344]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kester4">[345]</xref> infant protection elicited by leading vaccines such as RTS,S. Of particular concern, vaccination with intrinsically tolerogenic antigens although initially protective in malaria-naïve infants, will also predispose bite-exposed growing children to severe malaria, increasing individual risk of later childhood death. Late-midliverstage antigens (unexposed at skinstage) however, should initially escape significant Treg induction and memory inhibition in the skinstage, and do show protectivity <xref ref-type="bibr" rid="pone.0010685-Hill1">[17]</xref>, <xref ref-type="bibr" rid="pone.0010685-MigotNabias1">[26]</xref>, <xref ref-type="bibr" rid="pone.0010685-Zhou1">[27]</xref>, <xref ref-type="bibr" rid="pone.0010685-Daubersies1">[68]</xref>, <xref ref-type="bibr" rid="pone.0010685-Daubersies2">[346]</xref>, <xref ref-type="bibr" rid="pone.0010685-ToureBalde1">[347]</xref> into adolescence <xref ref-type="bibr" rid="pone.0010685-ToureBalde1">[347]</xref>. This makes late-midliverstage antigens rationally preferred candidates for more universally applicable subunit vaccines with less hindered immune memory.</p>
</sec><sec id="s4b3">
<title>iii. Infant mortality</title>
<p>Neonates protected from mosquitoes will not accumulate skinstage-specific Tregs. Immunization under Treg pre-emptive conditions from birth (non-tolerogenic antigen, CQ accumulation in the skin, scrupulous use of bed-nets/insect-repellent), inducing abundant skinstage-specific antibodies should substantially reduce infant infections beyond currently obtainable protection. Additional early-infancy immunization with liverstage <xref ref-type="bibr" rid="pone.0010685-ToureBalde1">[347]</xref> and bloodstage antigens <xref ref-type="bibr" rid="pone.0010685-Osier1">[29]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roussilhon1">[30]</xref> will rapidly <xref ref-type="bibr" rid="pone.0010685-Osier1">[29]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roussilhon1">[30]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan3">[33]</xref>, <xref ref-type="bibr" rid="pone.0010685-McCallum1">[348]</xref>, <xref ref-type="bibr" rid="pone.0010685-Guinovart1">[349]</xref> provide robust <xref ref-type="bibr" rid="pone.0010685-Osier1">[29]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roussilhon1">[30]</xref> bloodstage immunity. This provides critical protection against increased risk of severe malaria <xref ref-type="bibr" rid="pone.0010685-Reyburn1">[274]</xref> due to decreased exposure to bloodstage disease. Substantially reduced childhood morbidity and mortality, and shrinking transmission reservoirs, should result.</p>
</sec><sec id="s4b4">
<title>iv. Eradication</title>
<p>Discarded vaccines, ineffective in endemic adults but pretested for safety, immunogenicity and tolerability can be rapidly retested (given voluntary patent rescindication <xref ref-type="bibr" rid="pone.0010685-Whalen1">[350]</xref>) for protectivity in neonates under Treg pre-emptive conditions. Bednets and CQ are cheap, CQ is usually well-tolerated, including during pregnancy <xref ref-type="bibr" rid="pone.0010685-Lee2">[158]</xref>, <xref ref-type="bibr" rid="pone.0010685-Law1">[351]</xref>, and is transmitted transplacentally at therapeutic doses and via breast milk at subtherapeutic dosages <xref ref-type="bibr" rid="pone.0010685-Law1">[351]</xref>. CQ accumulates preferentially in the skin, so significantly reduced, subtherapeutic dosage may suffice. Treg-blocking (immunomodulary) pharmacological effects of CQ are on the host, not parasite, eliminating parasite-resistance obstacles. Current infrastructure (<ext-link ext-link-type="uri" xlink:href="http://www.theglobalfund.org" xlink:type="simple">http://www.theglobalfund.org</ext-link>) allows largescale immunization across (primarily African) endemic regions worldwide.</p>
<p>Malaria outside Africa is mostly hypoendemic <xref ref-type="bibr" rid="pone.0010685-Guerra1">[270]</xref>, and not all Africa is holoendemic <xref ref-type="bibr" rid="pone.0010685-Guerra1">[270]</xref>. With increasing bednet/insecticide use, transmission drops <xref ref-type="bibr" rid="pone.0010685-Guerra1">[270]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hay2">[272]</xref>, <xref ref-type="bibr" rid="pone.0010685-Okiro1">[352]</xref>, <xref ref-type="bibr" rid="pone.0010685-OMeara1">[353]</xref>. Coordinated neonate vaccination generating additional concerted widespread reductions (herd effects) in infectious reservoirs is feasible, even with low efficacy vaccines <xref ref-type="bibr" rid="pone.0010685-Penny1">[354]</xref>. Conditions pre-empting Treg induction at early skin stage will amplify trends leading to interrupted transmission, catalyzing <xref ref-type="bibr" rid="pone.0010685-Hay2">[272]</xref> significantly accelerated local elimination, and facilitating worldwide eradication of malaria.</p>
<p>Existing adult transmission reservoirs however, will counteract shrinking infant reservoirs <xref ref-type="bibr" rid="pone.0010685-Hay2">[272]</xref>, <xref ref-type="bibr" rid="pone.0010685-Penny1">[354]</xref>. Skinstage-induced-Treg evasion and memory enhancing vaccines, preventing adult re-infection, and transmission-blocking vaccines targeting parasite development within the mosquito, and antimalarials blocking bloodstage transmission, are therefore essential to fast-track eradication.</p>
</sec></sec><sec id="s4c">
<title>Wider perspective</title>
<p>Skinstage activation of parasite-specific Treg-based systemic immunosuppression provides a fundamentally new, experimentally widely substantiated, immunological rationale, and precise focus, for research and vaccination strategy leading to potentially accelerated malaria eradication. The concept, and implications for vaccination, apply to closely related and economically important (<italic>Toxoplasma, Theileria</italic>, <italic>Babesia</italic> spp.) pathogens.</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0010685.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0010685.s001" xlink:type="simple"><label>Table S1</label><caption>
<p>Complete protection data (177 experiments) reference list for meta-analysis.</p>
<p>(0.24 MB DOC)</p>
</caption></supplementary-material><supplementary-material id="pone.0010685.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0010685.s002" xlink:type="simple"><label>Table S2</label><caption>
<p>Protective vaccination physically bypasses the skin at immunization or challenge (90%) or involves skin immunomodulation (10%). A. Exposure to parasites in the skin coincides closely with vaccine failure. Green background- immunization procedures. Lilac background- challenge procedures and percent of total experiments showing complete protection (% total) formed by a subset of studies (category) using a given experimental procedure (categories a-i; supporting experimental data for each category is in references listed below; also Supplementary <xref ref-type="supplementary-material" rid="pone.0010685.s001">Table S1</xref>). Parasite immunization administration routes: (a,b): live parasites given intravenously (i.v.), or the method does not involve live parasites, but uses dead parasites or purified antigen, antibody, or recombinant DNA (subunit) and therefore bypasses parasite interactions with host skin; (c,d,e,f,g,h): live parasites are administered via the skin; (c,d): by multiple simultaneous mosquito bites/session; (e,f): live parasites are naturally transmitted by 4–15 bites; (g): live parasites are administered by 12–15 bites/session with chloroquine; (h): live parasites delivered subcutaneously (s.c) or intradermally (i.d.) or intramuscularly (i.m.); (i): uncontrolled exposure to endemic mosquitos. Challenge route is either i.v. or by mosquito bite, as indicated. B. Protective immunization bypasses the skin at either immunization or challenge in 90% of cases: categories (a,b,c,e,h) shaded blue with red crosses. Protective immunization which transits skin during immunization (c,d,e,f,g,h) either: bypasses the skin physically at challenge (c,e,h) (red cross); or, involves skin immunomodulation during immunization (d,g, 10% of cases). Asterisk (*)- immunization via unmodified skin, limited to P. berghei (f). Skin bypass (red cross)- method physically avoids live parasite interactions in the host skin. Malaria exposure- skin exposure to infected mosquito bite before first immunization; naïve- no pre-exposure; exposed (endemic)- chronic exposure. x- this study shows complete protection of 40 of 41 mice challenged. y: one person in one study <xref ref-type="bibr" rid="pone.0010685-Hoffman2">[117]</xref> was infected one time via the skin prior to protective immunization and was therefore moderately tolerized. Data pertaining to experimental categories (a–h): a:<xref ref-type="bibr" rid="pone.0010685-Romero1">[35]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rodrigues1">[42]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jobe1">[49]</xref>, <xref ref-type="bibr" rid="pone.0010685-Purcell1">[50]</xref>, <xref ref-type="bibr" rid="pone.0010685-Oliveira1">[51]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tartz1">[57]</xref>, <xref ref-type="bibr" rid="pone.0010685-Daubersies1">[68]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chen1">[70]</xref>, <xref ref-type="bibr" rid="pone.0010685-Spitalny1">[71]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schofield1">[72]</xref>, <xref ref-type="bibr" rid="pone.0010685-Weiss2">[73]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tsuji1">[74]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan4">[75]</xref>, <xref ref-type="bibr" rid="pone.0010685-Belnoue2">[76]</xref>, <xref ref-type="bibr" rid="pone.0010685-Beaudoin1">[78]</xref>, <xref ref-type="bibr" rid="pone.0010685-Orjih1">[85]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Spitalny2">[125]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kramer1">[126]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sedagah1">[130]</xref>, <xref ref-type="bibr" rid="pone.0010685-Collins1">[133]</xref>, <xref ref-type="bibr" rid="pone.0010685-Fandeur1">[137]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ting1">[138]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hirunpetcharat1">[139]</xref>, <xref ref-type="bibr" rid="pone.0010685-Puri1">[150]</xref>, <xref ref-type="bibr" rid="pone.0010685-Romero2">[151]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller2">[166]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mellouk1">[169]</xref>, <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref>, <xref ref-type="bibr" rid="pone.0010685-Orjih2">[173]</xref>, <xref ref-type="bibr" rid="pone.0010685-White1">[185]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tarun1">[267]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kumar1">[335]</xref>, <xref ref-type="bibr" rid="pone.0010685-Khusmith1">[336]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kumar2">[337]</xref>, <xref ref-type="bibr" rid="pone.0010685-Daubersies2">[346]</xref> <xref ref-type="bibr" rid="pone.0010685-Martinez1">[355]</xref>, <xref ref-type="bibr" rid="pone.0010685-Amante1">[356]</xref>, <xref ref-type="bibr" rid="pone.0010685-Brahimi1">[357]</xref>, <xref ref-type="bibr" rid="pone.0010685-BrunaRomero1">[358]</xref>, <xref ref-type="bibr" rid="pone.0010685-Burns1">[359]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cabrera1">[360]</xref>, <xref ref-type="bibr" rid="pone.0010685-Cao1">[361]</xref>, <xref ref-type="bibr" rid="pone.0010685-Charoenvit1">[362]</xref>, <xref ref-type="bibr" rid="pone.0010685-Charoenvit2">[363]</xref>, <xref ref-type="bibr" rid="pone.0010685-Charoenvit3">[364]</xref>, <xref ref-type="bibr" rid="pone.0010685-Charoenvit4">[365]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chatterjee1">[366]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chatterjee2">[367]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chatterjee3">[368]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chattopadhyay1">[369]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clark4">[370]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clark5">[371]</xref>, <xref ref-type="bibr" rid="pone.0010685-Daly1">[372]</xref>, <xref ref-type="bibr" rid="pone.0010685-Degano1">[373]</xref>, <xref ref-type="bibr" rid="pone.0010685-Doolan8">[374]</xref>, <xref ref-type="bibr" rid="pone.0010685-Egan1">[375]</xref>, <xref ref-type="bibr" rid="pone.0010685-Gilbert1">[376]</xref>, <xref ref-type="bibr" rid="pone.0010685-Gramzinski1">[377]</xref>, <xref ref-type="bibr" rid="pone.0010685-Gruner1">[378]</xref>, <xref ref-type="bibr" rid="pone.0010685-GuebreXabier1">[379]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hirunpetcharat2">[380]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hirunpetcharat3">[381]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman4">[382]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman5">[383]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hunter1">[384]</xref>, <xref ref-type="bibr" rid="pone.0010685-Imai1">[385]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jaffe1">[386]</xref><xref ref-type="bibr" rid="pone.0010685-Aly1">[387]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aly2">[388]</xref>, <xref ref-type="bibr" rid="pone.0010685-Draper1">[389]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jobe2">[390]</xref>, <xref ref-type="bibr" rid="pone.0010685-Jones1">[391]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kaba1">[392]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kaur1">[393]</xref>, <xref ref-type="bibr" rid="pone.0010685-Khan1">[394]</xref>, <xref ref-type="bibr" rid="pone.0010685-Khullar1">[395]</xref>, <xref ref-type="bibr" rid="pone.0010685-Khusmith2">[396]</xref>, <xref ref-type="bibr" rid="pone.0010685-Kumar3">[397]</xref>, <xref ref-type="bibr" rid="pone.0010685-Lanar1">[398]</xref>, <xref ref-type="bibr" rid="pone.0010685-Li3">[399]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ling1">[400]</xref>, <xref ref-type="bibr" rid="pone.0010685-Marussig1">[401]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mauduit1">[402]</xref>, <xref ref-type="bibr" rid="pone.0010685-McColm1">[403]</xref>, <xref ref-type="bibr" rid="pone.0010685-McColm2">[404]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller3">[405]</xref>, <xref ref-type="bibr" rid="pone.0010685-Orjih3">[406]</xref>, <xref ref-type="bibr" rid="pone.0010685-Patterson1">[407]</xref>, <xref ref-type="bibr" rid="pone.0010685-Perlaza2">[408]</xref>, <xref ref-type="bibr" rid="pone.0010685-Roberts1">[409]</xref><xref ref-type="bibr" rid="pone.0010685-Playfair1">[410]</xref>, <xref ref-type="bibr" rid="pone.0010685-Playfair2">[411]</xref>, <xref ref-type="bibr" rid="pone.0010685-Potocnjak1">[412]</xref>, <xref ref-type="bibr" rid="pone.0010685-Puri2">[413]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pye1">[414]</xref>, <xref ref-type="bibr" rid="pone.0010685-Reed1">[415]</xref>, <xref ref-type="bibr" rid="pone.0010685-Reed2">[416]</xref>, <xref ref-type="bibr" rid="pone.0010685-Renia1">[417]</xref>, <xref ref-type="bibr" rid="pone.0010685-ReyesSandoval1">[418]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rodrigues2">[419]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rodrigues3">[420]</xref>, <xref ref-type="bibr" rid="pone.0010685-Romero3">[421]</xref>, <xref ref-type="bibr" rid="pone.0010685-Romero4">[422]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sadoff1">[423]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schmidt1">[424]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schmidt2">[425]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schneider2">[426]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sedegah1">[427]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sedegah2">[428]</xref>, <xref ref-type="bibr" rid="pone.0010685-Siddiqui1">[429]</xref>, <xref ref-type="bibr" rid="pone.0010685-Spitalny3">[430]</xref>, <xref ref-type="bibr" rid="pone.0010685-TaylorRobinson1">[431]</xref>, <xref ref-type="bibr" rid="pone.0010685-TaylorRobinson2">[432]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tsuji2">[433]</xref>, <xref ref-type="bibr" rid="pone.0010685-Trimnell1">[434]</xref>, <xref ref-type="bibr" rid="pone.0010685-vanDijk1">[435]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vinetz1">[436]</xref>, <xref ref-type="bibr" rid="pone.0010685-Waki1">[437]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wang2">[438]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wang3">[439]</xref>, <xref ref-type="bibr" rid="pone.0010685-Weiss4">[440]</xref>, <xref ref-type="bibr" rid="pone.0010685-White2">[441]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wykes1">[442]</xref>, <xref ref-type="bibr" rid="pone.0010685-Pacheco1">[443]</xref>, <xref ref-type="bibr" rid="pone.0010685-Nussenzweig1">[444]</xref>, <xref ref-type="bibr" rid="pone.0010685-Nussenzweig2">[445]</xref>, <xref ref-type="bibr" rid="pone.0010685-Orjih4">[446]</xref>, <xref ref-type="bibr" rid="pone.0010685-Renia2">[447]</xref>, <xref ref-type="bibr" rid="pone.0010685-FavilaCastillo1">[448]</xref>, <xref ref-type="bibr" rid="pone.0010685-Butler1">[449]</xref>, <xref ref-type="bibr" rid="pone.0010685-Yoshida1">[450]</xref>, <xref ref-type="bibr" rid="pone.0010685-Falae1">[451]</xref>. b: <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller1">[48]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Douradinha1">[128]</xref>, <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref>, <xref ref-type="bibr" rid="pone.0010685-Ting1">[138]</xref>, <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aly1">[387]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sina2">[452]</xref>, <xref ref-type="bibr" rid="pone.0010685-Sina3">[453]</xref>. c: <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>. d: <xref ref-type="bibr" rid="pone.0010685-Wizel1">[36]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wizel2">[44]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde1">[118]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde2">[119]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde3">[120]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann1">[121]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann2">[122]</xref>, <xref ref-type="bibr" rid="pone.0010685-Rieckmann3">[123]</xref>, <xref ref-type="bibr" rid="pone.0010685-Vaughan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hoffman3">[134]</xref>, <xref ref-type="bibr" rid="pone.0010685-McCarthy1">[135]</xref>, <xref ref-type="bibr" rid="pone.0010685-Edelman1">[136]</xref>, <xref ref-type="bibr" rid="pone.0010685-Palmer1">[172]</xref>, <xref ref-type="bibr" rid="pone.0010685-Clyde4">[454]</xref>, <xref ref-type="bibr" rid="pone.0010685-Egan2">[455]</xref>, <xref ref-type="bibr" rid="pone.0010685-Herrington3">[456]</xref>. e: <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref>, <xref ref-type="bibr" rid="pone.0010685-Wong1">[132]</xref>, <xref ref-type="bibr" rid="pone.0010685-Schmidt3">[457]</xref>. f: <xref ref-type="bibr" rid="pone.0010685-Sina1">[127]</xref>. g: <xref ref-type="bibr" rid="pone.0010685-Roestenberg1">[163]</xref>. h: <xref ref-type="bibr" rid="pone.0010685-Mueller1">[48]</xref>, <xref ref-type="bibr" rid="pone.0010685-Chakravarty1">[111]</xref>, <xref ref-type="bibr" rid="pone.0010685-Aly2">[388]</xref>, <xref ref-type="bibr" rid="pone.0010685-Butcher1">[458]</xref>, <xref ref-type="bibr" rid="pone.0010685-Hommel1">[459]</xref>. Studies containing data for multiple relevant experimental conditions are referenced accordingly in each appropriate category. Multiple experiments contributed by a single study are indicated beneath study reference number (eg. reference 124 X2) in Supplementary <xref ref-type="supplementary-material" rid="pone.0010685.s001">Table S1</xref>. (Meta-analysis data extended reference list).</p>
<p>(8.70 MB TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0010685.s003" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0010685.s003" xlink:type="simple"><label>Text S1</label><caption>
<p>Antigen persistence in liverstages is not required for protection. Directly contradictory data <xref ref-type="bibr" rid="pone.0010685-Scheller1">[165]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller2">[166]</xref>, <xref ref-type="bibr" rid="pone.0010685-Labaied1">[171]</xref>, <xref ref-type="bibr" rid="pone.0010685-Tarun1">[267]</xref> is also easily reconciled. Like increasing irradiation <xref ref-type="bibr" rid="pone.0010685-Vanderberg3">[149]</xref>, <xref ref-type="bibr" rid="pone.0010685-Scheller1">[165]</xref>, the drug primaquine (PQ) eliminates liverstages <xref ref-type="bibr" rid="pone.0010685-Belnoue1">[47]</xref>, <xref ref-type="bibr" rid="pone.0010685-Mueller2">[166]</xref>. PQ however, also disrupts membrane and vesicular trafficking <xref ref-type="bibr" rid="pone.0010685-Reid1">[159]</xref>, <xref ref-type="bibr" rid="pone.0010685-Weiss3">[268]</xref>, temporarily eliminating all antigen presentation. This prevents immunity if used during immunization <xref ref-type="bibr" rid="pone.0010685-Mueller2">[166]</xref>, creating an apparent correlation between protection and parasite persistence <xref ref-type="bibr" rid="pone.0010685-Mueller2">[166]</xref>. Used after intravenous immunization <xref ref-type="bibr" rid="pone.0010685-Putrianti1">[129]</xref>, allowing early liverstage antigen presentation, however, multiple PQ-cure cycles provide sufficient cumulative antigen presentation to build immunity, without antigen persistence.</p>
<p>(0.07 MB DOC)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>We thank Bernd Bukau (Zentrum für Molekulare Biologie der Universität-Heidelberg, Germany), Uli Göringer (Technical University of Darmstadt, Germany), Theresa Shapiro (Johns Hopkins School of Medicine, USA), Derrick Robinson (CNRS, University of Bordeaux, France) Alvaro Acosta-Serrano (Liverpool School of Tropical Medicine) and Bernie Cohen (University of Glasgow, UK) for critical reading of the manuscript and incisive discussion. D.L.G. thanks Freddy Frischknecht (Universität-Heidelberg, Germany), Kai Matuschewski (MPI-Berlin, Germany) and Volker Schirrmacher (Emeritus; DKFZ, Germany) for supportive discussion over the past five years. We particularly thank the Directors of the Malaria Research Foundation, (MRF) Simon Pinneger, and Carolyne Roehm, and MRF donors for enabling continued support during financial crisis years.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0010685-Graves1"><label>1</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Graves</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Gelband</surname><given-names>H</given-names></name>
</person-group> <year>2006</year> <article-title>Vaccines for preventing malaria (pre-erythrocytic).</article-title> <source>Cochrane Database Syst Rev:</source> <fpage>CD006198</fpage> </element-citation></ref>
<ref id="pone.0010685-Matuschewski1"><label>2</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Matuschewski</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Mueller</surname><given-names>AK</given-names></name>
</person-group> <year>2007</year> <article-title>Vaccines against malaria - an update.</article-title> <source>FEBS J</source> <volume>274</volume> <fpage>4680</fpage> <lpage>4687</lpage> </element-citation></ref>
<ref id="pone.0010685-Doolan1"><label>3</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Stewart</surname><given-names>AA</given-names></name>
</person-group> <year>2007</year> <article-title>Status of Malaria Vaccine R&amp;D in 2007- Malaria vaccines for the World 2007, September 17 –19th, 2007, London, UK.</article-title> <source>Expert Rev Vaccines</source> <volume>6</volume> <fpage>903</fpage> <lpage>905</lpage> </element-citation></ref>
<ref id="pone.0010685-Wipasa1"><label>4</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wipasa</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Riley</surname><given-names>EM</given-names></name>
</person-group> <year>2007</year> <article-title>The immunological challenges of malaria vaccine development.</article-title> <source>Expert Opin Biol Ther</source> <volume>7</volume> <fpage>1841</fpage> <lpage>1852</lpage> </element-citation></ref>
<ref id="pone.0010685-Greenwood1"><label>5</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Greenwood</surname><given-names>BM</given-names></name>
<name name-style="western"><surname>Fidock</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Kyle</surname><given-names>DE</given-names></name>
<name name-style="western"><surname>Kappe</surname><given-names>SH</given-names></name>
<name name-style="western"><surname>Alonso</surname><given-names>PL</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Malaria: progress, perils, and prospects for eradication.</article-title> <source>J Clin Invest</source> <volume>118</volume> <fpage>1266</fpage> <lpage>1276</lpage> </element-citation></ref>
<ref id="pone.0010685-Moorthy1"><label>6</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Moorthy</surname><given-names>VS</given-names></name>
<name name-style="western"><surname>Diggs</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Ferro</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Good</surname><given-names>MF</given-names></name>
<name name-style="western"><surname>Herrera</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18–19 March 2009, Bethesda, MD, USA.</article-title> <source>Vaccine</source> <volume>27</volume> <fpage>5719</fpage> <lpage>5725</lpage> </element-citation></ref>
<ref id="pone.0010685-Alonso1"><label>7</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Alonso</surname><given-names>PL</given-names></name>
<name name-style="western"><surname>Sacarlal</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Aponte</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Leach</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Macete</surname><given-names>E</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.</article-title> <source>Lancet</source> <volume>364</volume> <fpage>1411</fpage> <lpage>1420</lpage> </element-citation></ref>
<ref id="pone.0010685-Sacarlal1"><label>8</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sacarlal</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Aide</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Aponte</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Renom</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Leach</surname><given-names>A</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children.</article-title> <source>J Infect Dis</source> <volume>200</volume> <fpage>329</fpage> <lpage>336</lpage> </element-citation></ref>
<ref id="pone.0010685-Bejon1"><label>9</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bejon</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Lusingu</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Olotu</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Leach</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lievens</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.</article-title> <source>N Engl J Med</source> <volume>359</volume> <fpage>2521</fpage> <lpage>2532</lpage> </element-citation></ref>
<ref id="pone.0010685-Aponte1"><label>10</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Aponte</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Aide</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Renom</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Mandomando</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Bassat</surname><given-names>Q</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.</article-title> <source>Lancet</source> <volume>370</volume> <fpage>1543</fpage> <lpage>1551</lpage> </element-citation></ref>
<ref id="pone.0010685-Abdulla1"><label>11</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Abdulla</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Oberholzer</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Juma</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Kubhoja</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Machera</surname><given-names>F</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants.</article-title> <source>N Engl J Med</source> <volume>359</volume> <fpage>2533</fpage> <lpage>2544</lpage> </element-citation></ref>
<ref id="pone.0010685-Stoute1"><label>12</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Stoute</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Slaoui</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Heppner</surname><given-names>DG</given-names></name>
<name name-style="western"><surname>Momin</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Kester</surname><given-names>KE</given-names></name>
<etal/></person-group> <year>1997</year> <article-title>A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria.</article-title> <source>N Engl J Med</source> <volume>336</volume> <fpage>86</fpage> <lpage>91</lpage> </element-citation></ref>
<ref id="pone.0010685-Kester1"><label>13</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kester</surname><given-names>KE</given-names></name>
<name name-style="western"><surname>Cummings</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Ofori-Anyinam</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Ockenhouse</surname><given-names>CF</given-names></name>
<name name-style="western"><surname>Krzych</surname><given-names>U</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.</article-title> <source>J Infect Dis</source> <volume>200</volume> <fpage>337</fpage> <lpage>346</lpage> </element-citation></ref>
<ref id="pone.0010685-Bojang1"><label>14</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bojang</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>Milligan</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Pinder</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Vigneron</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Alloueche</surname><given-names>A</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.</article-title> <source>Lancet</source> <volume>358</volume> <fpage>1927</fpage> <lpage>1934</lpage> </element-citation></ref>
<ref id="pone.0010685-Polhemus1"><label>15</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Polhemus</surname><given-names>ME</given-names></name>
<name name-style="western"><surname>Remich</surname><given-names>SA</given-names></name>
<name name-style="western"><surname>Ogutu</surname><given-names>BR</given-names></name>
<name name-style="western"><surname>Waitumbi</surname><given-names>JN</given-names></name>
<name name-style="western"><surname>Otieno</surname><given-names>L</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.</article-title> <source>PLoS One</source> <volume>4</volume> <fpage>e6465</fpage> </element-citation></ref>
<ref id="pone.0010685-Good1"><label>16</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Good</surname><given-names>MF</given-names></name>
<name name-style="western"><surname>Pombo</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Quakyi</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Riley</surname><given-names>EM</given-names></name>
<name name-style="western"><surname>Houghten</surname><given-names>RA</given-names></name>
<etal/></person-group> <year>1988</year> <article-title>Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>85</volume> <fpage>1199</fpage> <lpage>1203</lpage> </element-citation></ref>
<ref id="pone.0010685-Hill1"><label>17</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hill</surname><given-names>AV</given-names></name>
<name name-style="western"><surname>Elvin</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Willis</surname><given-names>AC</given-names></name>
<name name-style="western"><surname>Aidoo</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Allsopp</surname><given-names>CE</given-names></name>
<etal/></person-group> <year>1992</year> <article-title>Molecular analysis of the association of HLA-B53 and resistance to severe malaria.</article-title> <source>Nature</source> <volume>360</volume> <fpage>434</fpage> <lpage>439</lpage> </element-citation></ref>
<ref id="pone.0010685-Doolan2"><label>18</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Southwood</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Wentworth</surname><given-names>PA</given-names></name>
<name name-style="western"><surname>Sidney</surname><given-names>J</given-names></name>
<etal/></person-group> <year>1997</year> <article-title>Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles.</article-title> <source>Immunity</source> <volume>7</volume> <fpage>97</fpage> <lpage>112</lpage> </element-citation></ref>
<ref id="pone.0010685-Plebanski1"><label>19</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Plebanski</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Aidoo</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Whittle</surname><given-names>HC</given-names></name>
<name name-style="western"><surname>Hill</surname><given-names>AV</given-names></name>
</person-group> <year>1997</year> <article-title>Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa.</article-title> <source>J Immunol</source> <volume>158</volume> <fpage>2849</fpage> <lpage>2855</lpage> </element-citation></ref>
<ref id="pone.0010685-Aidoo1"><label>20</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Aidoo</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Lalvani</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name>
<name name-style="western"><surname>Hu</surname><given-names>JT</given-names></name>
<name name-style="western"><surname>Daubersies</surname><given-names>P</given-names></name>
<etal/></person-group> <year>2000</year> <article-title>Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3.</article-title> <source>Infect Immun</source> <volume>68</volume> <fpage>227</fpage> <lpage>232</lpage> </element-citation></ref>
<ref id="pone.0010685-Lee1"><label>21</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Lee</surname><given-names>EAM</given-names></name>
<name name-style="western"><surname>Flanagan Katie</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Odhiambo</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Reece</surname><given-names>WHH</given-names></name>
<name name-style="western"><surname>Potter</surname><given-names>Colin</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Identification of frequently recognized dimorphicepitopes in plasmodium falciparum merozoitesurface protein-1in West and East Africans: lack of correlation of immune recognition and allelic preference.</article-title> <source>Am J Trop Med Hyg</source> <volume>64</volume> <fpage>194</fpage> <lpage>203</lpage> </element-citation></ref>
<ref id="pone.0010685-Kabilan1"><label>22</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kabilan</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Troye-Blomberg</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Perlmann</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Andersson</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Hogh</surname><given-names>B</given-names></name>
<etal/></person-group> <year>1988</year> <article-title>T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>85</volume> <fpage>5659</fpage> <lpage>5663</lpage> </element-citation></ref>
<ref id="pone.0010685-Flanagan1"><label>23</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Flanagan</surname><given-names>KL</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>EA</given-names></name>
<name name-style="western"><surname>Gravenor</surname><given-names>MB</given-names></name>
<name name-style="western"><surname>Reece</surname><given-names>WH</given-names></name>
<name name-style="western"><surname>Urban</surname><given-names>BC</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays.</article-title> <source>J Immunol</source> <volume>167</volume> <fpage>4729</fpage> <lpage>4737</lpage> </element-citation></ref>
<ref id="pone.0010685-Nardin1"><label>24</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Nardin</surname><given-names>EH</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>McGregor</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Bryan</surname><given-names>JH</given-names></name>
</person-group> <year>1979</year> <article-title>Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria.</article-title> <source>Science</source> <volume>206</volume> <fpage>597</fpage> <lpage>599</lpage> </element-citation></ref>
<ref id="pone.0010685-Hoffman1"><label>25</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Oster</surname><given-names>CN</given-names></name>
<name name-style="western"><surname>Plowe</surname><given-names>CV</given-names></name>
<name name-style="western"><surname>Woollett</surname><given-names>GR</given-names></name>
<name name-style="western"><surname>Beier</surname><given-names>JC</given-names></name>
<etal/></person-group> <year>1987</year> <article-title>Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.</article-title> <source>Science</source> <volume>237</volume> <fpage>639</fpage> <lpage>642</lpage> </element-citation></ref>
<ref id="pone.0010685-MigotNabias1"><label>26</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Migot-Nabias</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Deloron</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Ringwald</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Dubois</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Mayombo</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2000</year> <article-title>Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria.</article-title> <source>Trans R Soc Trop Med Hyg</source> <volume>94</volume> <fpage>557</fpage> <lpage>562</lpage> </element-citation></ref>
<ref id="pone.0010685-Zhou1"><label>27</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name>
<name name-style="western"><surname>Xiao</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Branch</surname><given-names>OH</given-names></name>
<name name-style="western"><surname>Kariuki</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Nahlen</surname><given-names>BL</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.</article-title> <source>Am J Trop Med Hyg</source> <volume>66</volume> <fpage>7</fpage> <lpage>12</lpage> </element-citation></ref>
<ref id="pone.0010685-Bongfen1"><label>28</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bongfen</surname><given-names>SE</given-names></name>
<name name-style="western"><surname>Ntsama</surname><given-names>PM</given-names></name>
<name name-style="western"><surname>Offner</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Smith</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Felger</surname><given-names>I</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.</article-title> <source>Vaccine</source> <volume>27</volume> <fpage>328</fpage> <lpage>335</lpage> </element-citation></ref>
<ref id="pone.0010685-Osier1"><label>29</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Osier</surname><given-names>FH</given-names></name>
<name name-style="western"><surname>Fegan</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Polley</surname><given-names>SD</given-names></name>
<name name-style="western"><surname>Murungi</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Verra</surname><given-names>F</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.</article-title> <source>Infect Immun</source> <volume>76</volume> <fpage>2240</fpage> <lpage>2248</lpage> </element-citation></ref>
<ref id="pone.0010685-Roussilhon1"><label>30</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Roussilhon</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Oeuvray</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Muller-Graf</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Tall</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Rogier</surname><given-names>C</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.</article-title> <source>PLoS Med</source> <volume>4</volume> <fpage>e320</fpage> </element-citation></ref>
<ref id="pone.0010685-Michon1"><label>31</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Michon</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Cole-Tobian</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Dabod</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Schoepflin</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Igu</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>The risk of malarial infections and disease in Papua New Guinean children.</article-title> <source>Am J Trop Med Hyg</source> <volume>76</volume> <fpage>997</fpage> <lpage>1008</lpage> </element-citation></ref>
<ref id="pone.0010685-Langhorne1"><label>32</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Langhorne</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ndungu</surname><given-names>FM</given-names></name>
<name name-style="western"><surname>Sponaas</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Marsh</surname><given-names>K</given-names></name>
</person-group> <year>2008</year> <article-title>Immunity to malaria: more questions than answers.</article-title> <source>Nat Immunol</source> <volume>9</volume> <fpage>725</fpage> <lpage>732</lpage> </element-citation></ref>
<ref id="pone.0010685-Doolan3"><label>33</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Dobano</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Baird</surname><given-names>JK</given-names></name>
</person-group> <year>2009</year> <article-title>Acquired immunity to malaria.</article-title> <source>Clin Microbiol Rev</source> <volume>22</volume> <fpage>13</fpage> <lpage>36</lpage> </element-citation></ref>
<ref id="pone.0010685-Hogh1"><label>34</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hogh</surname><given-names>B</given-names></name>
</person-group> <year>1996</year> <article-title>Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.</article-title> <source>Scand J Infect</source> <volume>Dis</volume> <supplement>Suppl 102</supplement> <fpage>1</fpage> <lpage>53</lpage> </element-citation></ref>
<ref id="pone.0010685-Romero1"><label>35</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Romero</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Maryanski</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Corradin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>V</given-names></name>
<etal/></person-group> <year>1989</year> <article-title>Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.</article-title> <source>Nature</source> <volume>341</volume> <fpage>323</fpage> <lpage>325</lpage> </element-citation></ref>
<ref id="pone.0010685-Wizel1"><label>36</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wizel</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Houghten</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Church</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Tine</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Lanar</surname><given-names>DE</given-names></name>
<etal/></person-group> <year>1995</year> <article-title>HLA-A2–restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.</article-title> <source>J Immunol</source> <volume>155</volume> <fpage>766</fpage> <lpage>775</lpage> </element-citation></ref>
<ref id="pone.0010685-Sun1"><label>37</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sun</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Schwenk</surname><given-names>R</given-names></name>
<name name-style="western"><surname>White</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Stoute</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Cohen</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma.</article-title> <source>J Immunol</source> <volume>171</volume> <fpage>6961</fpage> <lpage>6967</lpage> </element-citation></ref>
<ref id="pone.0010685-Reece1"><label>38</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Reece</surname><given-names>WH</given-names></name>
<name name-style="western"><surname>Pinder</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Gothard</surname><given-names>PK</given-names></name>
<name name-style="western"><surname>Milligan</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Bojang</surname><given-names>K</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.</article-title> <source>Nat Med</source> <volume>10</volume> <fpage>406</fpage> <lpage>410</lpage> </element-citation></ref>
<ref id="pone.0010685-Nardin2"><label>39</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Nardin</surname><given-names>EH</given-names></name>
<name name-style="western"><surname>Herrington</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Davis</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Levine</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Stuber</surname><given-names>D</given-names></name>
<etal/></person-group> <year>1989</year> <article-title>Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer.</article-title> <source>Science</source> <volume>246</volume> <fpage>1603</fpage> <lpage>1606</lpage> </element-citation></ref>
<ref id="pone.0010685-Herrington1"><label>40</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Herrington</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Davis</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Nardin</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Beier</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Cortese</surname><given-names>J</given-names></name>
<etal/></person-group> <year>1991</year> <article-title>Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.</article-title> <source>Am J Trop Med Hyg</source> <volume>45</volume> <fpage>539</fpage> <lpage>547</lpage> </element-citation></ref>
<ref id="pone.0010685-Malik1"><label>41</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Malik</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Egan</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Houghten</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Sadoff</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
</person-group> <year>1991</year> <article-title>Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>88</volume> <fpage>3300</fpage> <lpage>3304</lpage> </element-citation></ref>
<ref id="pone.0010685-Rodrigues1"><label>42</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Rodrigues</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Zavala</surname><given-names>F</given-names></name>
</person-group> <year>1993</year> <article-title>The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria.</article-title> <source>Immunology</source> <volume>80</volume> <fpage>1</fpage> <lpage>5</lpage> </element-citation></ref>
<ref id="pone.0010685-Moreno1"><label>43</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Moreno</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Clavijo</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Edelman</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Davis</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Sztein</surname><given-names>M</given-names></name>
<etal/></person-group> <year>1993</year> <article-title>CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein.</article-title> <source>J Immunol</source> <volume>151</volume> <fpage>489</fpage> <lpage>499</lpage> </element-citation></ref>
<ref id="pone.0010685-Wizel2"><label>44</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wizel</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Houghten</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Parker</surname><given-names>KC</given-names></name>
<name name-style="western"><surname>Coligan</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Church</surname><given-names>P</given-names></name>
<etal/></person-group> <year>1995</year> <article-title>Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.</article-title> <source>J Exp Med</source> <volume>182</volume> <fpage>1435</fpage> <lpage>1445</lpage> </element-citation></ref>
<ref id="pone.0010685-Krzych1"><label>45</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Krzych</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Lyon</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Jareed</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Hollingdale</surname><given-names>MR</given-names></name>
<etal/></person-group> <year>1995</year> <article-title>T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens.</article-title> <source>J Immunol</source> <volume>155</volume> <fpage>4072</fpage> <lpage>4077</lpage> </element-citation></ref>
<ref id="pone.0010685-Sano1"><label>46</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sano</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Hafalla</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Morrot</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Abe</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Lafaille</surname><given-names>JJ</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages.</article-title> <source>J Exp Med</source> <volume>194</volume> <fpage>173</fpage> <lpage>180</lpage> </element-citation></ref>
<ref id="pone.0010685-Belnoue1"><label>47</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Belnoue</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Costa</surname><given-names>FT</given-names></name>
<name name-style="western"><surname>Frankenberg</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Vigario</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Voza</surname><given-names>T</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment.</article-title> <source>J Immunol</source> <volume>172</volume> <fpage>2487</fpage> <lpage>2495</lpage> </element-citation></ref>
<ref id="pone.0010685-Mueller1"><label>48</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mueller</surname><given-names>AK</given-names></name>
<name name-style="western"><surname>Labaied</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kappe</surname><given-names>SH</given-names></name>
<name name-style="western"><surname>Matuschewski</surname><given-names>K</given-names></name>
</person-group> <year>2005</year> <article-title>Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.</article-title> <source>Nature</source> <volume>433</volume> <fpage>164</fpage> <lpage>167</lpage> </element-citation></ref>
<ref id="pone.0010685-Jobe1"><label>49</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Jobe</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Lumsden</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Mueller</surname><given-names>AK</given-names></name>
<name name-style="western"><surname>Williams</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Silva-Rivera</surname><given-names>H</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells.</article-title> <source>J Infect Dis</source> <volume>196</volume> <fpage>599</fpage> <lpage>607</lpage> </element-citation></ref>
<ref id="pone.0010685-Purcell1"><label>50</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Purcell</surname><given-names>LA</given-names></name>
<name name-style="western"><surname>Wong</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>Yanow</surname><given-names>SK</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Spithill</surname><given-names>TW</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.</article-title> <source>Vaccine</source> <volume>26</volume> <fpage>4880</fpage> <lpage>4884</lpage> </element-citation></ref>
<ref id="pone.0010685-Oliveira1"><label>51</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Oliveira</surname><given-names>GA</given-names></name>
<name name-style="western"><surname>Kumar</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>Calvo-Calle</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Othoro</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Altszuler</surname><given-names>D</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Class II-restricted protective immunity induced by malaria sporozoites.</article-title> <source>Infect Immun</source> <volume>76</volume> <fpage>1200</fpage> <lpage>1206</lpage> </element-citation></ref>
<ref id="pone.0010685-Herrington2"><label>52</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Herrington</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Clyde</surname><given-names>DF</given-names></name>
<name name-style="western"><surname>Davis</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Baqar</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Murphy</surname><given-names>JR</given-names></name>
<etal/></person-group> <year>1990</year> <article-title>Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.</article-title> <source>Bull World Health Organ</source> <volume>68</volume> <supplement>Suppl</supplement> <fpage>33</fpage> <lpage>37</lpage> </element-citation></ref>
<ref id="pone.0010685-Nardin3"><label>53</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Nardin</surname><given-names>EH</given-names></name>
<name name-style="western"><surname>Calvo-Calle</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Oliveira</surname><given-names>GA</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.</article-title> <source>J Immunol</source> <volume>166</volume> <fpage>481</fpage> <lpage>489</lpage> </element-citation></ref>
<ref id="pone.0010685-Birkett1"><label>54</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Birkett</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lyons</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Schmidt</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Boyd</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Oliveira</surname><given-names>GA</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.</article-title> <source>Infect Immun</source> <volume>70</volume> <fpage>6860</fpage> <lpage>6870</lpage> </element-citation></ref>
<ref id="pone.0010685-Wang1"><label>55</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Le</surname><given-names>TP</given-names></name>
<name name-style="western"><surname>Hedstrom</surname><given-names>RC</given-names></name>
<name name-style="western"><surname>Coonan</surname><given-names>KM</given-names></name>
<etal/></person-group> <year>1998</year> <article-title>Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.</article-title> <source>Science</source> <volume>282</volume> <fpage>476</fpage> <lpage>480</lpage> </element-citation></ref>
<ref id="pone.0010685-Lalvani1"><label>56</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Lalvani</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Moris</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Voss</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Pathan</surname><given-names>AA</given-names></name>
<name name-style="western"><surname>Kester</surname><given-names>KE</given-names></name>
<etal/></person-group> <year>1999</year> <article-title>Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.</article-title> <source>J Infect Dis</source> <volume>180</volume> <fpage>1656</fpage> <lpage>1664</lpage> </element-citation></ref>
<ref id="pone.0010685-Tartz1"><label>57</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Tartz</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Russmann</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Kamanova</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Sebo</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Sturm</surname><given-names>A</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.</article-title> <source>Vaccine</source> <volume>26</volume> <fpage>5935</fpage> <lpage>5943</lpage> </element-citation></ref>
<ref id="pone.0010685-Perlaza1"><label>58</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Perlaza</surname><given-names>BL</given-names></name>
<name name-style="western"><surname>Zapata</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Valencia</surname><given-names>AZ</given-names></name>
<name name-style="western"><surname>Hurtado</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Quintero</surname><given-names>G</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>Immunogenicity and protective efficacy of Plasmodium falciparum liver-stage Ag-3 in Aotus lemurinus griseimembra monkeys.</article-title> <source>Eur J Immunol</source> <volume>33</volume> <fpage>1321</fpage> <lpage>1327</lpage> </element-citation></ref>
<ref id="pone.0010685-McConkey1"><label>59</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>McConkey</surname><given-names>SJ</given-names></name>
<name name-style="western"><surname>Reece</surname><given-names>WH</given-names></name>
<name name-style="western"><surname>Moorthy</surname><given-names>VS</given-names></name>
<name name-style="western"><surname>Webster</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Dunachie</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.</article-title> <source>Nat Med</source> <volume>9</volume> <fpage>729</fpage> <lpage>735</lpage> </element-citation></ref>
<ref id="pone.0010685-Moorthy2"><label>60</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Moorthy</surname><given-names>VS</given-names></name>
<name name-style="western"><surname>Imoukhuede</surname><given-names>EB</given-names></name>
<name name-style="western"><surname>Keating</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Pinder</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Webster</surname><given-names>D</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.</article-title> <source>J Infect Dis</source> <volume>189</volume> <fpage>2213</fpage> <lpage>2219</lpage> </element-citation></ref>
<ref id="pone.0010685-Pichyangkul1"><label>61</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Pichyangkul</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Gettayacamin</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Miller</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Lyon</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Angov</surname><given-names>E</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP142 formulated with novel adjuvants or with alum.</article-title> <source>Vaccine</source> <volume>22</volume> <fpage>3831</fpage> <lpage>3840</lpage> </element-citation></ref>
<ref id="pone.0010685-CalvoCalle1"><label>62</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Calvo-Calle</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Oliveira</surname><given-names>GA</given-names></name>
<name name-style="western"><surname>Nardin</surname><given-names>EH</given-names></name>
</person-group> <year>2005</year> <article-title>Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites.</article-title> <source>J Immunol</source> <volume>175</volume> <fpage>7575</fpage> <lpage>7585</lpage> </element-citation></ref>
<ref id="pone.0010685-Mettens1"><label>63</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mettens</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Dubois</surname><given-names>PM</given-names></name>
<name name-style="western"><surname>Demoitie</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Bayat</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Donner</surname><given-names>MN</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen.</article-title> <source>Vaccine</source> <volume>26</volume> <fpage>1072</fpage> <lpage>1082</lpage> </element-citation></ref>
<ref id="pone.0010685-Pichyangkul2"><label>64</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Pichyangkul</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Kum-Arb</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Yongvanitchit</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Limsalakpetch</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Gettayacamin</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primates.</article-title> <source>Infect Immun</source> <volume>76</volume> <fpage>229</fpage> <lpage>238</lpage> </element-citation></ref>
<ref id="pone.0010685-Schneider1"><label>65</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Schneider</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Langermans</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name>
<name name-style="western"><surname>Blanchard</surname><given-names>TJ</given-names></name>
<name name-style="western"><surname>Twigg</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.</article-title> <source>Vaccine</source> <volume>19</volume> <fpage>4595</fpage> <lpage>4602</lpage> </element-citation></ref>
<ref id="pone.0010685-BenMohamed1"><label>66</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>BenMohamed</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Thomas</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Druilhe</surname><given-names>P</given-names></name>
</person-group> <year>2004</year> <article-title>Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides.</article-title> <source>Infect Immun</source> <volume>72</volume> <fpage>4376</fpage> <lpage>4384</lpage> </element-citation></ref>
<ref id="pone.0010685-Weiss1"><label>67</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Weiss</surname><given-names>WR</given-names></name>
<name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Jiang</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Williams</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Bostick</surname><given-names>A</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.</article-title> <source>PLoS One</source> <volume>2</volume> <fpage>e1063</fpage> </element-citation></ref>
<ref id="pone.0010685-Daubersies1"><label>68</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Daubersies</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Ollomo</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Sauzet</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Brahimi</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Perlaza</surname><given-names>BL</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Genetic immunisation by liver stage antigen 3 protects chimpanzees against malaria despite low immune responses.</article-title> <source>PLoS One</source> <volume>3</volume> <fpage>e2659</fpage> </element-citation></ref>
<ref id="pone.0010685-Barbosa1"><label>69</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Barbosa</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Naniche</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Aponte</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Manaca</surname><given-names>MN</given-names></name>
<name name-style="western"><surname>Mandomando</surname><given-names>I</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>P. falciparum specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique.</article-title> <source>Infect Immun</source> </element-citation></ref>
<ref id="pone.0010685-Chen1"><label>70</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chen</surname><given-names>DH</given-names></name>
<name name-style="western"><surname>Tigelaar</surname><given-names>RE</given-names></name>
<name name-style="western"><surname>Weinbaum</surname><given-names>FI</given-names></name>
</person-group> <year>1977</year> <article-title>Immunity to sporozoite-induced malaria infeciton in mice. I. The effect of immunization of T and B cell-deficient mice.</article-title> <source>J Immunol</source> <volume>118</volume> <fpage>1322</fpage> <lpage>1327</lpage> </element-citation></ref>
<ref id="pone.0010685-Spitalny1"><label>71</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Spitalny</surname><given-names>GL</given-names></name>
<name name-style="western"><surname>Verhave</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Meuwissen</surname><given-names>JH</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
</person-group> <year>1977</year> <article-title>Plasmodium berghei: T cell dependence of sporozoite-induced immunity in rodents.</article-title> <source>Exp Parasitol</source> <volume>42</volume> <fpage>73</fpage> <lpage>81</lpage> </element-citation></ref>
<ref id="pone.0010685-Schofield1"><label>72</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Schofield</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Villaquiran</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ferreira</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Schellekens</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>R</given-names></name>
<etal/></person-group> <year>1987</year> <article-title>Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites.</article-title> <source>Nature</source> <volume>330</volume> <fpage>664</fpage> <lpage>666</lpage> </element-citation></ref>
<ref id="pone.0010685-Weiss2"><label>73</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Weiss</surname><given-names>WR</given-names></name>
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Beaudoin</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Miller</surname><given-names>LH</given-names></name>
<name name-style="western"><surname>Good</surname><given-names>MF</given-names></name>
</person-group> <year>1988</year> <article-title>CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>85</volume> <fpage>573</fpage> <lpage>576</lpage> </element-citation></ref>
<ref id="pone.0010685-Tsuji1"><label>74</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Tsuji</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Romero</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Zavala</surname><given-names>F</given-names></name>
</person-group> <year>1990</year> <article-title>CD4+ cytolytic T cell clone confers protection against murine malaria.</article-title> <source>J Exp Med</source> <volume>172</volume> <fpage>1353</fpage> <lpage>1357</lpage> </element-citation></ref>
<ref id="pone.0010685-Doolan4"><label>75</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
</person-group> <year>2000</year> <article-title>The complexity of protective immunity against liver-stage malaria.</article-title> <source>J Immunol</source> <volume>165</volume> <fpage>1453</fpage> <lpage>1462</lpage> </element-citation></ref>
<ref id="pone.0010685-Belnoue2"><label>76</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Belnoue</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Voza</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Costa</surname><given-names>FT</given-names></name>
<name name-style="western"><surname>Gruner</surname><given-names>AC</given-names></name>
<name name-style="western"><surname>Mauduit</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.</article-title> <source>J Immunol</source> <volume>181</volume> <fpage>8552</fpage> <lpage>8558</lpage> </element-citation></ref>
<ref id="pone.0010685-Pombo1"><label>77</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Pombo</surname><given-names>DJ</given-names></name>
<name name-style="western"><surname>Lawrence</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Hirunpetcharat</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Rzepczyk</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Bryden</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.</article-title> <source>Lancet</source> <volume>360</volume> <fpage>610</fpage> <lpage>617</lpage> </element-citation></ref>
<ref id="pone.0010685-Beaudoin1"><label>78</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Beaudoin</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Strome</surname><given-names>CP</given-names></name>
<name name-style="western"><surname>Mitchell</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Tubergen</surname><given-names>TA</given-names></name>
</person-group> <year>1977</year> <article-title>Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen.</article-title> <source>Exp Parasitol</source> <volume>42</volume> <fpage>1</fpage> <lpage>5</lpage> </element-citation></ref>
<ref id="pone.0010685-Hafalla1"><label>79</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hafalla</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Sano</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Carvalho</surname><given-names>LH</given-names></name>
<name name-style="western"><surname>Morrot</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Zavala</surname><given-names>F</given-names></name>
</person-group> <year>2002</year> <article-title>Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>99</volume> <fpage>11819</fpage> <lpage>11824</lpage> </element-citation></ref>
<ref id="pone.0010685-Hafalla2"><label>80</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hafalla</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Rai</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Bernal-Rubio</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Rodriguez</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Zavala</surname><given-names>F</given-names></name>
</person-group> <year>2007</year> <article-title>Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection.</article-title> <source>J Infect Dis</source> <volume>196</volume> <fpage>1827</fpage> <lpage>1835</lpage> </element-citation></ref>
<ref id="pone.0010685-Moorthy3"><label>81</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Moorthy</surname><given-names>VS</given-names></name>
<name name-style="western"><surname>Imoukhuede</surname><given-names>EB</given-names></name>
<name name-style="western"><surname>Milligan</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Bojang</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Keating</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults.</article-title> <source>PLoS Med</source> <volume>1</volume> <fpage>e33</fpage> </element-citation></ref>
<ref id="pone.0010685-Bejon2"><label>82</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bejon</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Mwacharo</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kai</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Mwangi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Milligan</surname><given-names>P</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>A phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA METRAP among children in Kenya.</article-title> <source>PLoS Clin Trials</source> <volume>1</volume> <fpage>e29</fpage> </element-citation></ref>
<ref id="pone.0010685-Ogutu1"><label>83</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Ogutu</surname><given-names>BR</given-names></name>
<name name-style="western"><surname>Apollo</surname><given-names>OJ</given-names></name>
<name name-style="western"><surname>McKinney</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Okoth</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Siangla</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.</article-title> <source>PLoS One</source> <volume>4</volume> <fpage>e4708</fpage> </element-citation></ref>
<ref id="pone.0010685-Graves2"><label>84</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Graves</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Gelband</surname><given-names>H</given-names></name>
</person-group> <year>2006</year> <article-title>Vaccines for preventing malaria (SPf66).</article-title> <source>Cochrane Database Syst Rev</source> <fpage>CD005966</fpage> </element-citation></ref>
<ref id="pone.0010685-Orjih1"><label>85</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Orjih</surname><given-names>AU</given-names></name>
</person-group> <year>1985</year> <article-title>Acute malaria prolongs susceptibility of mice to Plasmodium berghei sporozoite infection.</article-title> <source>Clin Exp Immunol</source> <volume>61</volume> <fpage>67</fpage> <lpage>71</lpage> </element-citation></ref>
<ref id="pone.0010685-Sakaguchi1"><label>86</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sakaguchi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Yamaguchi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Nomura</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Ono</surname><given-names>M</given-names></name>
</person-group> <year>2008</year> <article-title>Regulatory T Cells and Immune Tolerance.</article-title> <source>Cell</source> <volume>133</volume> <fpage>775</fpage> <lpage>787</lpage> </element-citation></ref>
<ref id="pone.0010685-Horwitz1"><label>87</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Horwitz</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Zheng</surname><given-names>SG</given-names></name>
<name name-style="western"><surname>Gray</surname><given-names>JD</given-names></name>
</person-group> <year>2008</year> <article-title>Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.</article-title> <source>Trends Immunol</source> <volume>29</volume> <fpage>429</fpage> <lpage>435</lpage> </element-citation></ref>
<ref id="pone.0010685-Mahnke1"><label>88</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mahnke</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Bedke</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Enk</surname><given-names>AH</given-names></name>
</person-group> <year>2007</year> <article-title>Regulatory conversation between antigen presenting cells and regulatory T cells enhance immune suppression.</article-title> <source>Cell Immunol</source> <volume>250</volume> <fpage>1</fpage> <lpage>13</lpage> </element-citation></ref>
<ref id="pone.0010685-Zhao1"><label>89</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Zhao</surname><given-names>DM</given-names></name>
<name name-style="western"><surname>Thornton</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>DiPaolo</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Shevach</surname><given-names>EM</given-names></name>
</person-group> <year>2006</year> <article-title>Activated CD4+CD25+ T cells selectively kill B lymphocytes.</article-title> <source>Blood</source> <volume>107</volume> <fpage>3925</fpage> <lpage>3932</lpage> </element-citation></ref>
<ref id="pone.0010685-LudwigPortugall1"><label>90</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Ludwig-Portugall</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Hamilton-Williams</surname><given-names>EE</given-names></name>
<name name-style="western"><surname>Gottschalk</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Kurts</surname><given-names>C</given-names></name>
</person-group> <year>2008</year> <article-title>Cutting edge: CD25+ regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens.</article-title> <source>J Immunol</source> <volume>181</volume> <fpage>4447</fpage> <lpage>4451</lpage> </element-citation></ref>
<ref id="pone.0010685-CurottodeLafaille1"><label>91</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Curotto de Lafaille</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Kutchukhidze</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Shen</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Yee</surname><given-names>H</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation.</article-title> <source>Immunity</source> <volume>29</volume> <fpage>114</fpage> <lpage>126</lpage> </element-citation></ref>
<ref id="pone.0010685-Lim1"><label>92</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Lim</surname><given-names>HW</given-names></name>
<name name-style="western"><surname>Hillsamer</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Banham</surname><given-names>AH</given-names></name>
<name name-style="western"><surname>Kim</surname><given-names>CH</given-names></name>
</person-group> <year>2005</year> <article-title>Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells.</article-title> <source>J Immunol</source> <volume>175</volume> <fpage>4180</fpage> <lpage>4183</lpage> </element-citation></ref>
<ref id="pone.0010685-Tang1"><label>93</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Tang</surname><given-names>Q</given-names></name>
<name name-style="western"><surname>Bluestone</surname><given-names>JA</given-names></name>
</person-group> <year>2008</year> <article-title>The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.</article-title> <source>Nat Immunol</source> <volume>9</volume> <fpage>239</fpage> <lpage>244</lpage> </element-citation></ref>
<ref id="pone.0010685-Murphy1"><label>94</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Murphy</surname><given-names>TJ</given-names></name>
<name name-style="western"><surname>Ni Choileain</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Zang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Mannick</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Lederer</surname><given-names>JA</given-names></name>
</person-group> <year>2005</year> <article-title>CD4+CD25+ regulatory T cells control innate immune reactivity after injury.</article-title> <source>J Immunol</source> <volume>174</volume> <fpage>2957</fpage> <lpage>2963</lpage> </element-citation></ref>
<ref id="pone.0010685-Zhang1"><label>95</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Zhang</surname><given-names>ZX</given-names></name>
<name name-style="western"><surname>Yang</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Young</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>DuTemple</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>
</person-group> <year>2000</year> <article-title>Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression.</article-title> <source>Nat Med</source> <volume>6</volume> <fpage>782</fpage> <lpage>789</lpage> </element-citation></ref>
<ref id="pone.0010685-Gondek1"><label>96</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Gondek</surname><given-names>DC</given-names></name>
<name name-style="western"><surname>Devries</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Nowak</surname><given-names>EC</given-names></name>
<name name-style="western"><surname>Lu</surname><given-names>LF</given-names></name>
<name name-style="western"><surname>Bennett</surname><given-names>KA</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells.</article-title> <source>J Immunol</source> <volume>181</volume> <fpage>4752</fpage> <lpage>4760</lpage> </element-citation></ref>
<ref id="pone.0010685-CarvalhoGaspar1"><label>97</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Carvalho-Gaspar</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Jones</surname><given-names>ND</given-names></name>
<name name-style="western"><surname>Luo</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Martin</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Brook</surname><given-names>MO</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells.</article-title> <source>J Immunol</source> <volume>180</volume> <fpage>6640</fpage> <lpage>6648</lpage> </element-citation></ref>
<ref id="pone.0010685-Mills1"><label>98</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name>
</person-group> <year>2004</year> <article-title>Regulatory T cells: friend or foe in immunity to infection?</article-title> <source>Nat Rev Immunol</source> <volume>4</volume> <fpage>841</fpage> <lpage>855</lpage> </element-citation></ref>
<ref id="pone.0010685-Belkaid1"><label>99</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Belkaid</surname><given-names>Y</given-names></name>
</person-group> <year>2007</year> <article-title>Regulatory T cells and infection: a dangerous necessity.</article-title> <source>Nat Rev Immunol</source> <volume>7</volume> <fpage>875</fpage> <lpage>888</lpage> </element-citation></ref>
<ref id="pone.0010685-Mellor1"><label>100</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mellor</surname><given-names>AL</given-names></name>
<name name-style="western"><surname>Munn</surname><given-names>DH</given-names></name>
</person-group> <year>2008</year> <article-title>Creating immune privilege: active local suppression that benefits friends, but protects foes.</article-title> <source>Nat Rev Immunol</source> <volume>8</volume> <fpage>74</fpage> <lpage>80</lpage> </element-citation></ref>
<ref id="pone.0010685-Clark1"><label>101</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Clark</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Chong</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Mirchandani</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Brinster</surname><given-names>NK</given-names></name>
<name name-style="western"><surname>Yamanaka</surname><given-names>K</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>The vast majority of CLA+ T cells are resident in normal skin.</article-title> <source>J Immunol</source> <volume>176</volume> <fpage>4431</fpage> <lpage>4439</lpage> </element-citation></ref>
<ref id="pone.0010685-Clark2"><label>102</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Clark</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Kupper</surname><given-names>TS</given-names></name>
</person-group> <year>2007</year> <article-title>IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin.</article-title> <source>Blood</source> <volume>109</volume> <fpage>194</fpage> <lpage>202</lpage> </element-citation></ref>
<ref id="pone.0010685-Boyd1"><label>103</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Boyd</surname><given-names>MF</given-names></name>
<name name-style="western"><surname>Kitchen</surname><given-names>SF</given-names></name>
</person-group> <year>1939</year> <article-title>The demonstration of sporozoites in human tissue.</article-title> <source>Am J Trop Med Hyg</source> <volume>19</volume> <fpage>27</fpage> <lpage>31</lpage> </element-citation></ref>
<ref id="pone.0010685-Griffiths1"><label>104</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Griffiths</surname><given-names>RB</given-names></name>
<name name-style="western"><surname>Gordon</surname><given-names>RM</given-names></name>
</person-group> <year>1952</year> <article-title>An apparatus which enables the process of feeding by mosquitoes to be observed in the tissues of a live rodent; together with an account of the ejection of saliva and its significance in Malaria.</article-title> <source>Ann Trop Med Parasitol</source> <volume>46</volume> <fpage>311</fpage> <lpage>319</lpage> </element-citation></ref>
<ref id="pone.0010685-Sidjanski1"><label>105</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sidjanski</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
</person-group> <year>1997</year> <article-title>Delayed migration of Plasmodium sporozoites from the mosquito bite site to the blood.</article-title> <source>Am J Trop Med Hyg</source> <volume>57</volume> <fpage>426</fpage> <lpage>429</lpage> </element-citation></ref>
<ref id="pone.0010685-Vanderberg1"><label>106</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Frevert</surname><given-names>U</given-names></name>
</person-group> <year>2004</year> <article-title>Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes.</article-title> <source>Int J Parasitol</source> <volume>34</volume> <fpage>991</fpage> <lpage>996</lpage> </element-citation></ref>
<ref id="pone.0010685-Amino1"><label>107</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Amino</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Thiberge</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Martin</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Celli</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Shorte</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Quantitative imaging of Plasmodium transmission from mosquito to mammal.</article-title> <source>Nat Med</source> <volume>12</volume> <fpage>220</fpage> <lpage>224</lpage> </element-citation></ref>
<ref id="pone.0010685-Vanderberg2"><label>108</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
</person-group> <year>1974</year> <article-title>Studies on the motility of <italic>Plasmodium</italic> sporozoites.</article-title> <source>J Protozool</source> <volume>21</volume> <fpage>527</fpage> <lpage>537</lpage> </element-citation></ref>
<ref id="pone.0010685-Yamauchi1"><label>109</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Yamauchi</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Coppi</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Snounou</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Sinnis</surname><given-names>P</given-names></name>
</person-group> <year>2007</year> <article-title>Plasmodium sporozoites trickle out of the injection site.</article-title> <source>Cell Microbiol</source> <volume>9</volume> <fpage>1215</fpage> <lpage>1222</lpage> </element-citation></ref>
<ref id="pone.0010685-Jin1"><label>110</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kebaier</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>J</given-names></name>
</person-group> <year>2007</year> <article-title>Direct microscopic quantification of dynamics of Plasmodium berghei sporozoite transmission from mosquitoes to mice.</article-title> <source>Infect Immun</source> <volume>75</volume> <fpage>5532</fpage> <lpage>5539</lpage> </element-citation></ref>
<ref id="pone.0010685-Chakravarty1"><label>111</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chakravarty</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Cockburn</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Kuk</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Overstreet</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>Sacci</surname><given-names>JB</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes.</article-title> <source>Nat Med</source> <volume>13</volume> <fpage>1035</fpage> <lpage>1041</lpage> </element-citation></ref>
<ref id="pone.0010685-Shortt1"><label>112</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Shortt</surname><given-names>HE</given-names></name>
<name name-style="western"><surname>Bray</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Cooper</surname><given-names>W</given-names></name>
</person-group> <year>1954</year> <article-title>Further note on the tissue stages of P. cynomolgi.</article-title> <source>Trans R Soc Trop Med Hyg</source> <volume>48</volume> <fpage>122</fpage> <lpage>131</lpage> </element-citation></ref>
<ref id="pone.0010685-Laveran1"><label>113</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Laveran</surname><given-names>A</given-names></name>
</person-group> <year>1880</year> <article-title>Un nouveau parasite trouve dans le sang des malades atteintes de fievre palustre origine parisitaire des accidents de impaludisme.</article-title> <source>Bulletins et memoires de la Societe Medicale des Hopitaux de Paris</source> <volume>17</volume> <fpage>158</fpage> <lpage>164</lpage> </element-citation></ref>
<ref id="pone.0010685-Sturm1"><label>114</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sturm</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Amino</surname><given-names>R</given-names></name>
<name name-style="western"><surname>van de Sand</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Regen</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Retzlaff</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids.</article-title> <source>Science</source> <volume>313</volume> <fpage>1287</fpage> <lpage>1290</lpage> </element-citation></ref>
<ref id="pone.0010685-Clark3"><label>115</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Clark</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Alleva</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Mills</surname><given-names>AC</given-names></name>
<name name-style="western"><surname>Cowden</surname><given-names>WB</given-names></name>
</person-group> <year>2004</year> <article-title>Pathogenesis of malaria and clinically similar conditions.</article-title> <source>Clin Microbiol Rev</source> <volume>17</volume> <fpage>509</fpage> <lpage>539</lpage> </element-citation></ref>
<ref id="pone.0010685-Liberati1"><label>116</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Liberati</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name>
<name name-style="western"><surname>Tetzlaff</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Mulrow</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Gotzsche</surname><given-names>PC</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.</article-title> <source>PLoS Med</source> <volume>6</volume> <fpage>e1000100</fpage> </element-citation></ref>
<ref id="pone.0010685-Hoffman2"><label>117</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Goh</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Luke</surname><given-names>TC</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Le</surname><given-names>TP</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>(Table 1: subject 10)</article-title> <source>J Infect Dis</source> <volume>185</volume> <fpage>1155</fpage> <lpage>1164</lpage> </element-citation></ref>
<ref id="pone.0010685-Clyde1"><label>118</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Clyde</surname><given-names>DF</given-names></name>
<name name-style="western"><surname>Most</surname><given-names>H</given-names></name>
<name name-style="western"><surname>McCarthy</surname><given-names>VC</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
</person-group> <year>1973</year> <article-title>Immunization of man against sporozite-induced falciparum malaria.</article-title> <source>Am J Med Sci</source> <volume>266</volume> <fpage>169</fpage> <lpage>177</lpage> </element-citation></ref>
<ref id="pone.0010685-Clyde2"><label>119</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Clyde</surname><given-names>DF</given-names></name>
</person-group> <year>1975</year> <article-title>Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.</article-title> <source>Am J Trop Med Hyg</source> <volume>24</volume> <fpage>397</fpage> <lpage>401</lpage> </element-citation></ref>
<ref id="pone.0010685-Clyde3"><label>120</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Clyde</surname><given-names>DF</given-names></name>
<name name-style="western"><surname>McCarthy</surname><given-names>VC</given-names></name>
<name name-style="western"><surname>Miller</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Hornick</surname><given-names>RB</given-names></name>
</person-group> <year>1973</year> <article-title>Specificity of protection of man immunized against sporozoite-induced falciparum malaria.</article-title> <source>Am J Med Sci</source> <volume>266</volume> <fpage>398</fpage> <lpage>403</lpage> </element-citation></ref>
<ref id="pone.0010685-Rieckmann1"><label>121</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Rieckmann</surname><given-names>KH</given-names></name>
<name name-style="western"><surname>Carson</surname><given-names>PE</given-names></name>
<name name-style="western"><surname>Beaudoin</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Cassells</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>Sell</surname><given-names>KW</given-names></name>
</person-group> <year>1974</year> <article-title>Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum.</article-title> <source>Trans R Soc Trop Med Hyg</source> <volume>68</volume> <fpage>258</fpage> <lpage>259</lpage> </element-citation></ref>
<ref id="pone.0010685-Rieckmann2"><label>122</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Rieckmann</surname><given-names>KH</given-names></name>
<name name-style="western"><surname>Beaudoin</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Cassells</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>Sell</surname><given-names>KW</given-names></name>
</person-group> <year>1979</year> <article-title>Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria.</article-title> <source>Bull World Health Organ</source> <volume>57</volume> <supplement>Suppl 1</supplement> <fpage>261</fpage> <lpage>265</lpage> </element-citation></ref>
<ref id="pone.0010685-Rieckmann3"><label>123</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Rieckmann</surname><given-names>KH</given-names></name>
</person-group> <year>1990</year> <article-title>Human immunization with attenuated sporozoites.</article-title> <source>Bull World Health Organ</source> <volume>68</volume> <supplement>Suppl</supplement> <fpage>13</fpage> <lpage>16</lpage> </element-citation></ref>
<ref id="pone.0010685-Vaughan1"><label>124</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Vaughan</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Scheller</surname><given-names>LF</given-names></name>
<name name-style="western"><surname>Wirtz</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Azad</surname><given-names>AF</given-names></name>
</person-group> <year>1999</year> <article-title>Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials.</article-title> <source>Infect Immun</source> <volume>67</volume> <fpage>4285</fpage> <lpage>4289</lpage> </element-citation></ref>
<ref id="pone.0010685-Spitalny2"><label>125</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Spitalny</surname><given-names>GL</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
</person-group> <year>1972</year> <article-title>Effect of various routes of immunization and methods of parasite attenuation on the development of protection against sporozoite-induced rodent malaria.</article-title> <source>Proc Helm Soc Wash</source> <volume>39</volume> <fpage>506</fpage> <lpage>514</lpage> </element-citation></ref>
<ref id="pone.0010685-Kramer1"><label>126</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kramer</surname><given-names>LD</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
</person-group> <year>1975</year> <article-title>Intramuscular immunization of mice with irradiated Plasmodium berghei sporozoites. Enhancement of protection with albumin.</article-title> <source>Am J Trop Med Hyg</source> <volume>24</volume> <fpage>913</fpage> <lpage>916</lpage> </element-citation></ref>
<ref id="pone.0010685-Sina1"><label>127</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sina</surname><given-names>BJ</given-names></name>
<name name-style="western"><surname>do Rosario</surname><given-names>VE</given-names></name>
<name name-style="western"><surname>Woollett</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Sakhuja</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Hollingdale</surname><given-names>MR</given-names></name>
</person-group> <year>1993</year> <article-title>Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.</article-title> <source>Exp Parasitol</source> <volume>77</volume> <fpage>129</fpage> <lpage>135</lpage> </element-citation></ref>
<ref id="pone.0010685-Douradinha1"><label>128</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Douradinha</surname><given-names>B</given-names></name>
<name name-style="western"><surname>van Dijk</surname><given-names>MR</given-names></name>
<name name-style="western"><surname>Ataide</surname><given-names>R</given-names></name>
<name name-style="western"><surname>van Gemert</surname><given-names>GJ</given-names></name>
<name name-style="western"><surname>Thompson</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.</article-title> <source>Int J Parasitol</source> <volume>37</volume> <fpage>1511</fpage> <lpage>1519</lpage> </element-citation></ref>
<ref id="pone.0010685-Putrianti1"><label>129</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Putrianti</surname><given-names>ED</given-names></name>
<name name-style="western"><surname>Silvie</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Kordes</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Borrmann</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Matuschewski</surname><given-names>K</given-names></name>
</person-group> <year>2009</year> <article-title>Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites.</article-title> <source>J Infect Dis</source> <volume>199</volume> <fpage>899</fpage> <lpage>903</lpage> </element-citation></ref>
<ref id="pone.0010685-Sedagah1"><label>130</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sedagah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Weiss</surname><given-names>WR</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
</person-group> <year>2007</year> <article-title>Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites.</article-title> <source>Parasite Immunology</source> <volume>29</volume> <fpage>559</fpage> <lpage>565</lpage> </element-citation></ref>
<ref id="pone.0010685-Frischknecht1"><label>131</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Frischknecht</surname><given-names>F</given-names></name>
</person-group> <year>2007</year> <article-title>The skin as interface in the transmission of arthropod-borne pathogens.</article-title> <source>Cell Microbiol</source> <volume>9</volume> <fpage>1630</fpage> <lpage>1640</lpage> </element-citation></ref>
<ref id="pone.0010685-Wong1"><label>132</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wong</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>Zhou</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Rodriguez</surname><given-names>A</given-names></name>
</person-group> <year>2008</year> <article-title>Protective immunity induced by daily bites from irradiated mosquitoes infected with Parasite Immunol</article-title> <volume>30</volume> <fpage>482</fpage> <lpage>486</lpage> </element-citation></ref>
<ref id="pone.0010685-Collins1"><label>133</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Collins</surname><given-names>WE</given-names></name>
<name name-style="western"><surname>Skinner</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Millet</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Broderson</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Filipski</surname><given-names>VK</given-names></name>
<etal/></person-group> <year>1992</year> <article-title>Reinforcement of immunity in Saimiri monkeys following immunization with irradiated sporozoites of Plasmodium vivax.</article-title> <source>Am J Trop Med Hyg</source> <volume>46</volume> <fpage>327</fpage> <lpage>334</lpage> </element-citation></ref>
<ref id="pone.0010685-Hoffman3"><label>134</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Goh</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Luke</surname><given-names>TC</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Le</surname><given-names>TP</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.</article-title> <source>J Infect Dis</source> <volume>185</volume> <fpage>1155</fpage> <lpage>1164</lpage> </element-citation></ref>
<ref id="pone.0010685-McCarthy1"><label>135</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>McCarthy</surname><given-names>VC</given-names></name>
<name name-style="western"><surname>Clyde</surname><given-names>DF</given-names></name>
</person-group> <year>1977</year> <article-title>Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man.</article-title> <source>Exp Parasitol</source> <volume>41</volume> <fpage>167</fpage> <lpage>171</lpage> </element-citation></ref>
<ref id="pone.0010685-Edelman1"><label>136</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Edelman</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Davis</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Beier</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Sztein</surname><given-names>MB</given-names></name>
<etal/></person-group> <year>1993</year> <article-title>Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporo-zoites.</article-title> <source>J Infect Dis</source> <volume>168</volume> <fpage>1066</fpage> <lpage>1070</lpage> </element-citation></ref>
<ref id="pone.0010685-Fandeur1"><label>137</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Fandeur</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Gysin</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Mercereau-Puijalon</surname><given-names>O</given-names></name>
</person-group> <year>1992</year> <article-title>Protection of squirrel monkeys against virulent Plasmodium falciparum infections by use of attenuated parasites.</article-title> <source>Infect Immun</source> <volume>60</volume> <fpage>1390</fpage> <lpage>1396</lpage> </element-citation></ref>
<ref id="pone.0010685-Ting1"><label>138</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Ting</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Gissot</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Coppi</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Sinnis</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Kim</surname><given-names>K</given-names></name>
</person-group> <year>2008</year> <article-title>Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity.</article-title> <source>Nat Med</source> <volume>14</volume> <fpage>954</fpage> <lpage>958</lpage> </element-citation></ref>
<ref id="pone.0010685-Hirunpetcharat1"><label>139</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hirunpetcharat</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Tian</surname><given-names>JH</given-names></name>
<name name-style="western"><surname>Kaslow</surname><given-names>DC</given-names></name>
<name name-style="western"><surname>van Rooijen</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name>
<etal/></person-group> <year>1997</year> <article-title>Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.</article-title> <source>J Immunol</source> <volume>159</volume> <fpage>3400</fpage> <lpage>3411</lpage> </element-citation></ref>
<ref id="pone.0010685-Stowers1"><label>140</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Stowers</surname><given-names>AW</given-names></name>
<name name-style="western"><surname>Kennedy</surname><given-names>MC</given-names></name>
<name name-style="western"><surname>Keegan</surname><given-names>BP</given-names></name>
<name name-style="western"><surname>Saul</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Long</surname><given-names>CA</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.</article-title> <source>Infect Immun</source> <volume>70</volume> <fpage>6961</fpage> <lpage>6967</lpage> </element-citation></ref>
<ref id="pone.0010685-Thera1"><label>141</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Thera</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Doumbo</surname><given-names>OK</given-names></name>
<name name-style="western"><surname>Coulibaly</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Diallo</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Sagara</surname><given-names>I</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.</article-title> <source>PLoS Clin Trials</source> <volume>1</volume> <fpage>e34</fpage> </element-citation></ref>
<ref id="pone.0010685-Sagara1"><label>142</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sagara</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Dicko</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Ellis</surname><given-names>RD</given-names></name>
<name name-style="western"><surname>Fay</surname><given-names>MP</given-names></name>
<name name-style="western"><surname>Diawara</surname><given-names>SI</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali.</article-title> <source>Vaccine</source> <volume>27</volume> <fpage>3090</fpage> <lpage>3098</lpage> </element-citation></ref>
<ref id="pone.0010685-Stanisic1"><label>143</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Stanisic</surname><given-names>DI</given-names></name>
<name name-style="western"><surname>Richards</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>McCallum</surname><given-names>FJ</given-names></name>
<name name-style="western"><surname>Michon</surname><given-names>P</given-names></name>
<name name-style="western"><surname>King</surname><given-names>CL</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.</article-title> <source>Infect Immun</source> <volume>77</volume> <fpage>1165</fpage> <lpage>1174</lpage> </element-citation></ref>
<ref id="pone.0010685-Fowkes1"><label>144</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Fowkes</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Richards</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Simpson</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Beeson</surname><given-names>J</given-names></name>
</person-group> <year>2010</year> <article-title>The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.</article-title> <source>PLoS Med</source> <volume>7</volume> <fpage>e1000218</fpage> </element-citation></ref>
<ref id="pone.0010685-Graves3"><label>145</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Graves</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Gelband</surname><given-names>H</given-names></name>
</person-group> <year>2006</year> <article-title>Vaccines for preventing malaria (blood-stage).</article-title> <source>Cochrane Database Syst Rev:</source> <fpage>CD006199</fpage> </element-citation></ref>
<ref id="pone.0010685-Thompson1"><label>146</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Thompson</surname><given-names>FM</given-names></name>
<name name-style="western"><surname>Porter</surname><given-names>DW</given-names></name>
<name name-style="western"><surname>Okitsu</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Westerfeld</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Vogel</surname><given-names>D</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.</article-title> <source>PLoS One</source> <volume>3</volume> <fpage>e1493</fpage> </element-citation></ref>
<ref id="pone.0010685-Spring1"><label>147</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Spring</surname><given-names>MD</given-names></name>
<name name-style="western"><surname>Cummings</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Ockenhouse</surname><given-names>CF</given-names></name>
<name name-style="western"><surname>Dutta</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Reidler</surname><given-names>R</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.</article-title> <source>PLoS One</source> <volume>4</volume> <fpage>e5254</fpage> </element-citation></ref>
<ref id="pone.0010685-Luke1"><label>148</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Luke</surname><given-names>TC</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
</person-group> <year>2003</year> <article-title>Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine.</article-title> <source>J Exp Biol</source> <volume>206</volume> <fpage>3803</fpage> <lpage>3808</lpage> </element-citation></ref>
<ref id="pone.0010685-Vanderberg3"><label>149</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Most</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Orton</surname><given-names>CG</given-names></name>
</person-group> <year>1968</year> <article-title>Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. II. Effects of radiation on sporozoites.</article-title> <source>J Parasitol</source> <volume>54</volume> <fpage>1175</fpage> <lpage>1180</lpage> </element-citation></ref>
<ref id="pone.0010685-Puri1"><label>150</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Puri</surname><given-names>SK</given-names></name>
<name name-style="western"><surname>Maheshwari</surname><given-names>RK</given-names></name>
<name name-style="western"><surname>Dutta</surname><given-names>GP</given-names></name>
<name name-style="western"><surname>Friedman</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Dhar</surname><given-names>MM</given-names></name>
</person-group> <year>1988</year> <article-title>Human interferon-gamma protects rhesus monkeys against sporozoite-induced Plasmodium cynomolgi malaria infection.</article-title> <source>J Interferon Res</source> <volume>8</volume> <fpage>201</fpage> <lpage>206</lpage> </element-citation></ref>
<ref id="pone.0010685-Romero2"><label>151</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Romero</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Ibrahim</surname><given-names>GH</given-names></name>
<name name-style="western"><surname>Renggli</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Himmelrich</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Graber</surname><given-names>P</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.</article-title> <source>Parasite Immunol</source> <volume>29</volume> <fpage>541</fpage> <lpage>548</lpage> </element-citation></ref>
<ref id="pone.0010685-Donovan1"><label>152</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Donovan</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Messmore</surname><given-names>AS</given-names></name>
<name name-style="western"><surname>Scrafford</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Sacks</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Kamhawi</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Uninfected mosquito bites confer protection against infection with malaria parasites.</article-title> <source>Infect Immun</source> <volume>75</volume> <fpage>2523</fpage> <lpage>2530</lpage> </element-citation></ref>
<ref id="pone.0010685-Luty1"><label>153</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Luty</surname><given-names>AJ</given-names></name>
<name name-style="western"><surname>Lell</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Schmidt-Ott</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Lehman</surname><given-names>LG</given-names></name>
<name name-style="western"><surname>Luckner</surname><given-names>D</given-names></name>
<etal/></person-group> <year>1999</year> <article-title>Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children.</article-title> <source>J Infect Dis</source> <volume>179</volume> <fpage>980</fpage> <lpage>988</lpage> </element-citation></ref>
<ref id="pone.0010685-Farouk1"><label>154</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Farouk</surname><given-names>SE</given-names></name>
<name name-style="western"><surname>Dolo</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Bereczky</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Kouriba</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Maiga</surname><given-names>B</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Different antibody- and cytokine-mediated responses to Plasmodium falciparum parasite in two sympatric ethnic tribes living in Mali.</article-title> <source>Microbes Infect</source> <volume>7</volume> <fpage>110</fpage> <lpage>117</lpage> </element-citation></ref>
<ref id="pone.0010685-Torcia1"><label>155</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Torcia</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>Santarlasci</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Cosmi</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Clemente</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Maggi</surname><given-names>L</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>105</volume> <fpage>646</fpage> <lpage>651</lpage> </element-citation></ref>
<ref id="pone.0010685-Bergqvist1"><label>156</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bergqvist</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Domeij-Nyberg</surname><given-names>B</given-names></name>
</person-group> <year>1983</year> <article-title>Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma.</article-title> <source>J Chromatogr</source> <volume>272</volume> <fpage>137</fpage> <lpage>148</lpage> </element-citation></ref>
<ref id="pone.0010685-Kalia1"><label>157</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kalia</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Dutz</surname><given-names>JP</given-names></name>
</person-group> <year>2007</year> <article-title>New concepts in antimalarial use and mode of action in dermatology.</article-title> <source>Dermatol Ther</source> <volume>20</volume> <fpage>160</fpage> <lpage>174</lpage> </element-citation></ref>
<ref id="pone.0010685-Lee2"><label>158</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></name>
<name name-style="western"><surname>McGready</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Fernandez</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Stepniewska</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Paw</surname><given-names>MK</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria.</article-title> <source>Eur J Clin Pharmacol</source> <volume>64</volume> <fpage>987</fpage> <lpage>992</lpage> </element-citation></ref>
<ref id="pone.0010685-Reid1"><label>159</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Reid</surname><given-names>PA</given-names></name>
<name name-style="western"><surname>Watts</surname><given-names>C</given-names></name>
</person-group> <year>1989</year> <article-title>Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments.</article-title> <source>Nature</source> <volume>346</volume> <fpage>655</fpage> <lpage>657</lpage> </element-citation></ref>
<ref id="pone.0010685-DiPucchio1"><label>160</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Di Pucchio</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Chatterjee</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Smed-Sorensen</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Clayton</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Palazzo</surname><given-names>A</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.</article-title> <source>Nat Immunol</source> <volume>9</volume> <fpage>551</fpage> <lpage>557</lpage> </element-citation></ref>
<ref id="pone.0010685-Burgdorf1"><label>161</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Burgdorf</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Scholz</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Kautz</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Tampe</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Kurts</surname><given-names>C</given-names></name>
</person-group> <year>2008</year> <article-title>Spatial and mechanistic separation of crosspresentation and endogenous antigen presentation.</article-title> <source>Nat Immunol</source> <volume>9</volume> <fpage>558</fpage> <lpage>566</lpage> </element-citation></ref>
<ref id="pone.0010685-Verhage1"><label>162</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Verhage</surname><given-names>DF</given-names></name>
<name name-style="western"><surname>Telgt</surname><given-names>DS</given-names></name>
<name name-style="western"><surname>Bousema</surname><given-names>JT</given-names></name>
<name name-style="western"><surname>Hermsen</surname><given-names>CC</given-names></name>
<name name-style="western"><surname>van Gemert</surname><given-names>GJ</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes.</article-title> <source>Neth J Med</source> <volume>63</volume> <fpage>52</fpage> <lpage>58</lpage> </element-citation></ref>
<ref id="pone.0010685-Roestenberg1"><label>163</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Roestenberg</surname><given-names>M</given-names></name>
<name name-style="western"><surname>McCall</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hopman</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Wiersma</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Luty</surname><given-names>AJ</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Protection against a malaria challenge by sporozoite inoculation.</article-title> <source>N Engl J Med</source> <volume>361</volume> <fpage>468</fpage> <lpage>477</lpage> </element-citation></ref>
<ref id="pone.0010685-Sauerwein1"><label>164</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sauerwein</surname><given-names>RW</given-names></name>
</person-group> <year>2009</year> <article-title>Clinical malaria vaccine development.</article-title> <source>Immunol Lett</source> <volume>122</volume> <fpage>115</fpage> <lpage>117</lpage> </element-citation></ref>
<ref id="pone.0010685-Scheller1"><label>165</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Scheller</surname><given-names>LF</given-names></name>
<name name-style="western"><surname>Azad</surname><given-names>AF</given-names></name>
</person-group> <year>1995</year> <article-title>Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>92</volume> <fpage>4066</fpage> <lpage>4068</lpage> </element-citation></ref>
<ref id="pone.0010685-Mueller2"><label>166</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mueller</surname><given-names>AK</given-names></name>
<name name-style="western"><surname>Deckert</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Heiss</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Goetz</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Matuschewski</surname><given-names>K</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.</article-title> <source>Am J Pathol</source> <volume>171</volume> <fpage>107</fpage> <lpage>115</lpage> </element-citation></ref>
<ref id="pone.0010685-Suhrbier1"><label>167</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Suhrbier</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Winger</surname><given-names>LA</given-names></name>
<name name-style="western"><surname>Castellano</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Sinden</surname><given-names>RE</given-names></name>
</person-group> <year>1990</year> <article-title>Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells.</article-title> <source>Infect Immun</source> <volume>58</volume> <fpage>2834</fpage> <lpage>2839</lpage> </element-citation></ref>
<ref id="pone.0010685-Sigler1"><label>168</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sigler</surname><given-names>CI</given-names></name>
<name name-style="western"><surname>Leland</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Hollingdale</surname><given-names>MR</given-names></name>
</person-group> <year>1984</year> <article-title>In vitro infectivity of irradiated Plasmodium berghei sporozoites to cultured hepatoma cells.</article-title> <source>Am J Trop Med Hyg</source> <volume>33</volume> <fpage>544</fpage> <lpage>547</lpage> </element-citation></ref>
<ref id="pone.0010685-Mellouk1"><label>169</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mellouk</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Lunel</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Beaudoin</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Druilhe</surname><given-names>P</given-names></name>
</person-group> <year>1990</year> <article-title>Protection against malaria induced by irradiated sporozoites.</article-title> <source>Lancet</source> <volume>335</volume> <fpage>721</fpage> </element-citation></ref>
<ref id="pone.0010685-Silvie1"><label>170</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Silvie</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Semblat</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Franetich</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Hannoun</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Eling</surname><given-names>W</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>Effects of irradiation on Plasmodium falciparum sporozoite hepatic development: implications for the design of pre-erythrocytic malaria vaccines.</article-title> <source>Parasite Immunol</source> <volume>24</volume> <fpage>221</fpage> <lpage>223</lpage> </element-citation></ref>
<ref id="pone.0010685-Labaied1"><label>171</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Labaied</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Harupa</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Dumpit</surname><given-names>RF</given-names></name>
<name name-style="western"><surname>Coppens</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Mikolajczak</surname><given-names>SA</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.</article-title> <source>Infect Immun</source> <volume>75</volume> <fpage>3758</fpage> <lpage>3768</lpage> </element-citation></ref>
<ref id="pone.0010685-Palmer1"><label>172</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Palmer</surname><given-names>DR</given-names></name>
<name name-style="western"><surname>Krzych</surname><given-names>U</given-names></name>
</person-group> <year>2002</year> <article-title>Cellular and molecular requirements for the recall of IL-4-producing memory CD4(+)CD45RO(+)CD27(-) T cells during protection induced by attenuated Plasmodium falciparum sporozoites.</article-title> <source>Eur J Immunol</source> <volume>32</volume> <fpage>652</fpage> <lpage>661</lpage> </element-citation></ref>
<ref id="pone.0010685-Orjih2"><label>173</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Orjih</surname><given-names>AU</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
</person-group> <year>1979</year> <article-title>Plasmodium berghei: suppression of antibody response to sporozoite stage by acute blood stage infection.</article-title> <source>Clin Exp Immunol</source> <volume>38</volume> <fpage>1</fpage> <lpage>8</lpage> </element-citation></ref>
<ref id="pone.0010685-Bejon3"><label>174</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bejon</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Mwacharo</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kai</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Todryk</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Keating</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum.</article-title> <source>J Immunol</source> <volume>179</volume> <fpage>4193</fpage> <lpage>4201</lpage> </element-citation></ref>
<ref id="pone.0010685-Ziegler1"><label>175</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Ziegler</surname><given-names>HK</given-names></name>
<name name-style="western"><surname>Unanue</surname><given-names>ER</given-names></name>
</person-group> <year>1982</year> <article-title>Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>79</volume> <fpage>175</fpage> <lpage>178</lpage> </element-citation></ref>
<ref id="pone.0010685-Nowell1"><label>176</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Nowell</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Quaranta</surname><given-names>V</given-names></name>
</person-group> <year>1985</year> <article-title>Chloroquine affects biosynthesis of ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells.</article-title> <source>J Exp Med</source> <volume>162</volume> <fpage>1371</fpage> <lpage>1376</lpage> </element-citation></ref>
<ref id="pone.0010685-Stoitzner1"><label>177</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Stoitzner</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Tripp</surname><given-names>CH</given-names></name>
<name name-style="western"><surname>Eberhart</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Price</surname><given-names>KM</given-names></name>
<name name-style="western"><surname>Jung</surname><given-names>JY</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Langerhans cells cross-present antigen derived from skin.</article-title> <source>Proc Natl Acad Sci USA</source> <volume>103</volume> <fpage>7783</fpage> <lpage>7788</lpage> </element-citation></ref>
<ref id="pone.0010685-Klechevsky1"><label>178</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Klechevsky</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Morita</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Coquery</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic Cells.</article-title> <source>Immunity</source> <volume>29</volume> <fpage>497</fpage> <lpage>510</lpage> </element-citation></ref>
<ref id="pone.0010685-Flacher1"><label>179</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Flacher</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Sparber</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Tripp</surname><given-names>CH</given-names></name>
<name name-style="western"><surname>Romani</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Stoitzner</surname><given-names>P</given-names></name>
</person-group> <year>2009</year> <article-title>Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.</article-title> <source>Cancer Immunol Immunother</source> <volume>58</volume> <fpage>1137</fpage> <lpage>1147</lpage> </element-citation></ref>
<ref id="pone.0010685-Dzierszinski1"><label>180</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Dzierszinski</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Pepper</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Stumhofer</surname><given-names>JS</given-names></name>
<name name-style="western"><surname>LaRosa</surname><given-names>DF</given-names></name>
<name name-style="western"><surname>Wilson</surname><given-names>EH</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.</article-title> <source>Infect Immun</source> <volume>75</volume> <fpage>5200</fpage> <lpage>5209</lpage> </element-citation></ref>
<ref id="pone.0010685-Bongfen2"><label>181</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bongfen</surname><given-names>SE</given-names></name>
<name name-style="western"><surname>Balam</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Torgler</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Romero</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Corradin</surname><given-names>G</given-names></name>
</person-group> <year>2008</year> <article-title>Processing of the circumsporozoite protein in infected hepatocytes is not dependent on aspartic proteases.</article-title> <source>Parasite Immunol</source> <volume>30</volume> <fpage>375</fpage> <lpage>378</lpage> </element-citation></ref>
<ref id="pone.0010685-Bongfen3"><label>182</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bongfen</surname><given-names>SE</given-names></name>
<name name-style="western"><surname>Torgler</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Romero</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Renia</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Corradin</surname><given-names>G</given-names></name>
</person-group> <year>2007</year> <article-title>Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro.</article-title> <source>J Immunol</source> <volume>178</volume> <fpage>7054</fpage> <lpage>7063</lpage> </element-citation></ref>
<ref id="pone.0010685-Doolan5"><label>183</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Southwood</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Chesnut</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Appella</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Gomez</surname><given-names>E</given-names></name>
<etal/></person-group> <year>2000</year> <article-title>HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.</article-title> <source>J Immunol</source> <volume>165</volume> <fpage>1123</fpage> <lpage>1137</lpage> </element-citation></ref>
<ref id="pone.0010685-Doolan6"><label>184</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Southwood</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Freilich</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Sidney</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Graber</surname><given-names>NL</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>100</volume> <fpage>9952</fpage> <lpage>9957</lpage> </element-citation></ref>
<ref id="pone.0010685-White1"><label>185</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>White</surname><given-names>KL</given-names></name>
<name name-style="western"><surname>Snyder</surname><given-names>HL</given-names></name>
<name name-style="western"><surname>Krzych</surname><given-names>U</given-names></name>
</person-group> <year>1996</year> <article-title>MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.</article-title> <source>J Immunol</source> <volume>156</volume> <fpage>3374</fpage> <lpage>3381</lpage> </element-citation></ref>
<ref id="pone.0010685-Accapezzato1"><label>186</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Accapezzato</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Visco</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Francavilla</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Molette</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Donato</surname><given-names>T</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo.</article-title> <source>J Exp Med</source> <volume>202</volume> <fpage>817</fpage> <lpage>828</lpage> </element-citation></ref>
<ref id="pone.0010685-Peng1"><label>187</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Peng</surname><given-names>Z</given-names></name>
<name name-style="western"><surname>Simons</surname><given-names>FE</given-names></name>
</person-group> <year>2004</year> <article-title>Mosquito allergy: immune mechanisms and recombinant salivary allergens.</article-title> <source>Int Arch Allergy Immunol</source> <volume>133</volume> <fpage>198</fpage> <lpage>209</lpage> </element-citation></ref>
<ref id="pone.0010685-Iellem1"><label>188</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Iellem</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Colantonio</surname><given-names>L</given-names></name>
<name name-style="western"><surname>D'Ambrosio</surname><given-names>D</given-names></name>
</person-group> <year>2003</year> <article-title>Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.</article-title> <source>Eur J Immunol</source> <volume>33</volume> <fpage>1488</fpage> <lpage>1496</lpage> </element-citation></ref>
<ref id="pone.0010685-Hirahara1"><label>189</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hirahara</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Clark</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Yamanaka</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Fuhlbrigge</surname><given-names>RC</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors oming Receptors.</article-title> <source>J Immunol</source> <volume>177</volume> <fpage>4488</fpage> <lpage>4494</lpage> </element-citation></ref>
<ref id="pone.0010685-Demeure1"><label>190</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Demeure</surname><given-names>CE</given-names></name>
<name name-style="western"><surname>Brahimi</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Hacini</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Marchand</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Peronet</surname><given-names>R</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia.</article-title> <source>J Immunol</source> <volume>174</volume> <fpage>3932</fpage> <lpage>3940</lpage> </element-citation></ref>
<ref id="pone.0010685-Iellem2"><label>191</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Iellem</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Mariani</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Lang</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Recalde</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Panina-Bordignon</surname><given-names>P</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.</article-title> <source>J Exp Med</source> <volume>194</volume> <fpage>847</fpage> <lpage>853</lpage> </element-citation></ref>
<ref id="pone.0010685-Selvaraj1"><label>192</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Selvaraj</surname><given-names>RK</given-names></name>
<name name-style="western"><surname>Geiger</surname><given-names>TL</given-names></name>
</person-group> <year>2008</year> <article-title>Mitigation of experimental allergic encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance.</article-title> <source>J Immunol</source> <volume>180</volume> <fpage>2830</fpage> <lpage>2838</lpage> </element-citation></ref>
<ref id="pone.0010685-Huehn1"><label>193</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Huehn</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Hamann</surname><given-names>A</given-names></name>
</person-group> <year>2005</year> <article-title>Homing to suppress: address codes for Treg migration.</article-title> <source>Trends Immunol</source> <volume>26</volume> <fpage>632</fpage> <lpage>636</lpage> </element-citation></ref>
<ref id="pone.0010685-Campanelli1"><label>194</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Campanelli</surname><given-names>AP</given-names></name>
<name name-style="western"><surname>Roselino</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Cavassani</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>Pereira</surname><given-names>MS</given-names></name>
<name name-style="western"><surname>Mortara</surname><given-names>RA</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells.</article-title> <source>J Infect Dis</source> <volume>193</volume> <fpage>1313</fpage> <lpage>1322</lpage> </element-citation></ref>
<ref id="pone.0010685-Loser1"><label>195</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Loser</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Mehling</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Loeser</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Apelt</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kuhn</surname><given-names>A</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells.</article-title> <source>Nat Med</source> <volume>12</volume> <fpage>1372</fpage> <lpage>1379</lpage> </element-citation></ref>
<ref id="pone.0010685-Romani1"><label>196</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Romani</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Holzmann</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Tripp</surname><given-names>CH</given-names></name>
<name name-style="western"><surname>Koch</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Stoitzner</surname><given-names>P</given-names></name>
</person-group> <year>2003</year> <article-title>Langerhans cells – dendritic cells of the epidermis.</article-title> <source>APMIS</source> <volume>111</volume> <fpage>725</fpage> <lpage>740</lpage> </element-citation></ref>
<ref id="pone.0010685-Hudson1"><label>197</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hudson</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Bowman</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Orr</surname><given-names>CW</given-names></name>
</person-group> <year>1960</year> <article-title>Effects of absence of saliva on blood feeding by mosquitoes.</article-title> <source>Science</source> <volume>131</volume> <fpage>1730</fpage> <lpage>1731</lpage> </element-citation></ref>
<ref id="pone.0010685-Peng2"><label>198</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Peng</surname><given-names>Z</given-names></name>
<name name-style="western"><surname>Yang</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Simons</surname><given-names>FE</given-names></name>
</person-group> <year>1996</year> <article-title>Immunologic mechanisms in mosquito allergy: correlation of skin reactions with specific IgE and IgG antibodies and lymphocyte proliferation response to mosquito antigens.</article-title> <source>Ann Allergy Asthma Immunol</source> <volume>77</volume> <fpage>238</fpage> <lpage>244</lpage> </element-citation></ref>
<ref id="pone.0010685-Jawdat1"><label>199</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Jawdat</surname><given-names>DM</given-names></name>
<name name-style="western"><surname>Albert</surname><given-names>EJ</given-names></name>
<name name-style="western"><surname>Rowden</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Haidl</surname><given-names>ID</given-names></name>
<name name-style="western"><surname>Marshall</surname><given-names>JS</given-names></name>
</person-group> <year>2004</year> <article-title>IgE-mediated mast cell activation induces Langerhans cell migration in vivo.</article-title> <source>J Immunol</source> <volume>173</volume> <fpage>5275</fpage> <lpage>5282</lpage> </element-citation></ref>
<ref id="pone.0010685-LeBorgne1"><label>200</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Le Borgne</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Etchart</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Goubier</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lira</surname><given-names>SA</given-names></name>
<name name-style="western"><surname>Sirard</surname><given-names>JC</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.</article-title> <source>Immunity</source> <volume>24</volume> <fpage>191</fpage> <lpage>201</lpage> </element-citation></ref>
<ref id="pone.0010685-Williams1"><label>201</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Williams</surname><given-names>IR</given-names></name>
</person-group> <year>2006</year> <article-title>CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis.</article-title> <source>Ann N Y Acad Sci</source> <volume>1072</volume> <fpage>52</fpage> <lpage>61</lpage> </element-citation></ref>
<ref id="pone.0010685-Urosevic1"><label>202</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Urosevic</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Dummer</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Conrad</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Beyeler</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Laine</surname><given-names>E</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.</article-title> <source>J Natl Cancer Inst</source> <volume>97</volume> <fpage>1143</fpage> <lpage>1153</lpage> </element-citation></ref>
<ref id="pone.0010685-Ueno1"><label>203</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Ueno</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Klechevsky</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Morita</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Aspord</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Cao</surname><given-names>T</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Dendritic cell subsets in health and disease.</article-title> <source>Immunol Rev</source> <volume>219</volume> <fpage>118</fpage> <lpage>142</lpage> </element-citation></ref>
<ref id="pone.0010685-Randolph1"><label>204</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Randolph</surname><given-names>GJ</given-names></name>
<name name-style="western"><surname>Inaba</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Robbiani</surname><given-names>DF</given-names></name>
<name name-style="western"><surname>Steinman</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Muller</surname><given-names>WA</given-names></name>
</person-group> <year>1999</year> <article-title>Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo.</article-title> <source>Immunity</source> <volume>11</volume> <fpage>753</fpage> <lpage>761</lpage> </element-citation></ref>
<ref id="pone.0010685-Wollenberg1"><label>205</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wollenberg</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Wagner</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Gunther</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Towarowski</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Tuma</surname><given-names>E</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases.</article-title> <source>J Invest Dermatol</source> <volume>119</volume> <fpage>1096</fpage> <lpage>1102</lpage> </element-citation></ref>
<ref id="pone.0010685-Vermi1"><label>206</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Vermi</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Riboldi</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Wittamer</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Gentili</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Luini</surname><given-names>W</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin.</article-title> <source>J Exp Med</source> <volume>201</volume> <fpage>509</fpage> <lpage>515</lpage> </element-citation></ref>
<ref id="pone.0010685-Albanesi1"><label>207</label><element-citation publication-type="other" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Albanesi</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Scarponi</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Bosisio</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Sozzani</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Girolomoni</surname><given-names>G</given-names></name>
</person-group> <year>2010</year> <article-title>Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis.</article-title> <source>Autoimmunity</source> </element-citation></ref>
<ref id="pone.0010685-Hawiger1"><label>208</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hawiger</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Inaba</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Dorsett</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Guo</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Mahnke</surname><given-names>K</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo.</article-title> <source>J Exp Med</source> <volume>194</volume> <fpage>769</fpage> <lpage>779</lpage> </element-citation></ref>
<ref id="pone.0010685-Steinman1"><label>209</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Steinman</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Hawiger</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></name>
</person-group> <year>2003</year> <article-title>Tolerogenic dendritic cells.</article-title> <source>Annu Rev Immunol</source> <volume>21</volume> <fpage>685</fpage> <lpage>711</lpage> </element-citation></ref>
<ref id="pone.0010685-Kaplan1"><label>210</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kaplan</surname><given-names>DH</given-names></name>
<name name-style="western"><surname>Jenison</surname><given-names>MC</given-names></name>
<name name-style="western"><surname>Saeland</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Shlomchik</surname><given-names>WD</given-names></name>
<name name-style="western"><surname>Shlomchik</surname><given-names>MJ</given-names></name>
</person-group> <year>2005</year> <article-title>Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity.</article-title> <source>Immunity</source> <volume>23</volume> <fpage>611</fpage> <lpage>620</lpage> </element-citation></ref>
<ref id="pone.0010685-Morelli1"><label>211</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Morelli</surname><given-names>AE</given-names></name>
<name name-style="western"><surname>Rubin</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Erdos</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Tkacheva</surname><given-names>OA</given-names></name>
<name name-style="western"><surname>Mathers</surname><given-names>AR</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells.</article-title> <source>J Immunol</source> <volume>175</volume> <fpage>7905</fpage> <lpage>7915</lpage> </element-citation></ref>
<ref id="pone.0010685-Li1"><label>212</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Li</surname><given-names>MO</given-names></name>
<name name-style="western"><surname>Wan</surname><given-names>YY</given-names></name>
<name name-style="western"><surname>Sanjabi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Robertson</surname><given-names>AK</given-names></name>
<name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name>
</person-group> <year>2006</year> <article-title>Transforming growth factor-beta regulation of immune responses.</article-title> <source>Annu Rev Immunol</source> <volume>24</volume> <fpage>99</fpage> <lpage>146</lpage> </element-citation></ref>
<ref id="pone.0010685-Lindstedt1"><label>213</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Lindstedt</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Shiota</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Saarinen</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Hyytiainen</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase.</article-title> <source>FASEB J</source> <volume>15</volume> <fpage>1377</fpage> <lpage>1388</lpage> </element-citation></ref>
<ref id="pone.0010685-Geissmann1"><label>214</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Geissmann</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Revy</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Regnault</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lepelletier</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Dy</surname><given-names>M</given-names></name>
<etal/></person-group> <year>1999</year> <article-title>TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.</article-title> <source>J Immunol</source> <volume>162</volume> <fpage>4567</fpage> <lpage>4575</lpage> </element-citation></ref>
<ref id="pone.0010685-Kitani1"><label>215</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kitani</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Fuss</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Kumaki</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Usui</surname><given-names>T</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis.</article-title> <source>J Exp Med</source> <volume>198</volume> <fpage>1179</fpage> <lpage>1188</lpage> </element-citation></ref>
<ref id="pone.0010685-Levings1"><label>216</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Levings</surname><given-names>MK</given-names></name>
<name name-style="western"><surname>Gregori</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Tresoldi</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Cazzaniga</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Bonini</surname><given-names>C</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells.</article-title> <source>Blood</source> <volume>105</volume> <fpage>1162</fpage> <lpage>1169</lpage> </element-citation></ref>
<ref id="pone.0010685-Ginhoux1"><label>217</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Ginhoux</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Tacke</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Angeli</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Bogunovic</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Loubeau</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Langerhans cells arise from monocytes in vivo.</article-title> <source>Nat Immunol</source> <volume>7</volume> <fpage>265</fpage> <lpage>273</lpage> </element-citation></ref>
<ref id="pone.0010685-Jonuleit1"><label>218</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Jonuleit</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Schmitt</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Schuler</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Knop</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Enk</surname><given-names>AH</given-names></name>
</person-group> <year>2000</year> <article-title>Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.</article-title> <source>J Exp Med</source> <volume>192</volume> <fpage>1213</fpage> <lpage>1222</lpage> </element-citation></ref>
<ref id="pone.0010685-Dhodapkar1"><label>219</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Dhodapkar</surname><given-names>MV</given-names></name>
<name name-style="western"><surname>Steinman</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Krasovsky</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Munz</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Bhardwaj</surname><given-names>N</given-names></name>
</person-group> <year>2001</year> <article-title>Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.</article-title> <source>J Exp Med</source> <volume>193</volume> <fpage>233</fpage> <lpage>238</lpage> </element-citation></ref>
<ref id="pone.0010685-Mahnke2"><label>220</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mahnke</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Qian</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Knop</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Enk</surname><given-names>AH</given-names></name>
</person-group> <year>2003</year> <article-title>Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells.</article-title> <source>Blood</source> <volume>101</volume> <fpage>4862</fpage> <lpage>4869</lpage> </element-citation></ref>
<ref id="pone.0010685-Roncarolo1"><label>221</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Roncarolo</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>Gregori</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Battaglia</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Bacchetta</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Fleischhauer</surname><given-names>K</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.</article-title> <source>Immunol Rev</source> <volume>212</volume> <fpage>28</fpage> <lpage>50</lpage> </element-citation></ref>
<ref id="pone.0010685-Cools1"><label>222</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Cools</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Van Tendeloo</surname><given-names>VF</given-names></name>
<name name-style="western"><surname>Smits</surname><given-names>EL</given-names></name>
<name name-style="western"><surname>Lenjou</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Nijs</surname><given-names>G</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+ regulatory T cells.</article-title> <source>J Cell Mol Med</source> <volume>12</volume> <fpage>690</fpage> <lpage>700</lpage> </element-citation></ref>
<ref id="pone.0010685-Gilliet1"><label>223</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Gilliet</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>YJ</given-names></name>
</person-group> <year>2002</year> <article-title>Generation of human CD8+ T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells.</article-title> <source>J Exp Med</source> <volume>195</volume> <fpage>695</fpage> <lpage>704</lpage> </element-citation></ref>
<ref id="pone.0010685-Ito1"><label>224</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Ito</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Yang</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>YH</given-names></name>
<name name-style="western"><surname>Lande</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Gregorio</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.</article-title> <source>J Exp Med</source> <volume>204</volume> <fpage>105</fpage> <lpage>115</lpage> </element-citation></ref>
<ref id="pone.0010685-Kretschmer1"><label>225</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kretschmer</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Apostolou</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Hawiger</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Khazaie</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Inducing and expanding regulatory T cell populations by foreign antigen.</article-title> <source>Nat Immunol</source> <volume>6</volume> <fpage>1219</fpage> <lpage>1227</lpage> </element-citation></ref>
<ref id="pone.0010685-Roncarolo2"><label>226</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Roncarolo</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>Levings</surname><given-names>MK</given-names></name>
<name name-style="western"><surname>Traversari</surname><given-names>C</given-names></name>
</person-group> <year>2001</year> <article-title>Differentiation of T regulatory cells by immature dendritic cells.</article-title> <source>J Exp Med</source> <volume>193</volume> <fpage>F5</fpage> <lpage>9</lpage> </element-citation></ref>
<ref id="pone.0010685-George1"><label>227</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>George</surname><given-names>TC</given-names></name>
<name name-style="western"><surname>Bilsborough</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Viney</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Norment</surname><given-names>AM</given-names></name>
</person-group> <year>2003</year> <article-title>High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell mediated suppression in vitro.</article-title> <source>Eur J Immunol</source> <volume>33</volume> <fpage>502</fpage> <lpage>511</lpage> </element-citation></ref>
<ref id="pone.0010685-Sarris1"><label>228</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sarris</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Andersen</surname><given-names>KG</given-names></name>
<name name-style="western"><surname>Randow</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Mayr</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Betz</surname><given-names>AG</given-names></name>
</person-group> <year>2008</year> <article-title>Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition.</article-title> <source>Immunity</source> <volume>28</volume> <fpage>402</fpage> <lpage>413</lpage> </element-citation></ref>
<ref id="pone.0010685-Tang2"><label>229</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Tang</surname><given-names>Q</given-names></name>
<name name-style="western"><surname>Adams</surname><given-names>JY</given-names></name>
<name name-style="western"><surname>Tooley</surname><given-names>AJ</given-names></name>
<name name-style="western"><surname>Bi</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Fife</surname><given-names>BT</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice.</article-title> <source>Nat Immunol</source> <volume>7</volume> <fpage>83</fpage> <lpage>92</lpage> </element-citation></ref>
<ref id="pone.0010685-Dieckmann1"><label>230</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Dieckmann</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Bruett</surname><given-names>CH</given-names></name>
<name name-style="western"><surname>Ploettner</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Lutz</surname><given-names>MB</given-names></name>
<name name-style="western"><surname>Schuler</surname><given-names>G</given-names></name>
</person-group> <year>2002</year> <article-title>Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].</article-title> <source>J Exp Med</source> <volume>196</volume> <fpage>247</fpage> <lpage>253</lpage> </element-citation></ref>
<ref id="pone.0010685-vonBoehmer1"><label>231</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>von Boehmer</surname><given-names>H</given-names></name>
</person-group> <year>2005</year> <article-title>Mechanisms of suppression by suppressor T cells.</article-title> <source>Nat Immunol</source> <volume>6</volume> <fpage>338</fpage> <lpage>344</lpage> </element-citation></ref>
<ref id="pone.0010685-Belkaid2"><label>232</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Belkaid</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Rouse</surname><given-names>B</given-names></name>
</person-group> <year>2005</year> <article-title>Natural regulatory T cells in infectious disease.</article-title> <source>Nat Immunol</source> <volume>6</volume> <fpage>353</fpage> <lpage>360</lpage> </element-citation></ref>
<ref id="pone.0010685-Robson1"><label>233</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Robson</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Hall</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Jennings</surname><given-names>MW</given-names></name>
<name name-style="western"><surname>Harris</surname><given-names>TJ</given-names></name>
<name name-style="western"><surname>Marsh</surname><given-names>K</given-names></name>
<etal/></person-group> <year>1988</year> <article-title>A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite.</article-title> <source>Nature</source> <volume>335</volume> <fpage>79</fpage> <lpage>82</lpage> </element-citation></ref>
<ref id="pone.0010685-Okitsu1"><label>234</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Okitsu</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Silvie</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Westerfeld</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Curcic</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kammer</surname><given-names>AR</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.</article-title> <source>PLoS One</source> <volume>2</volume> <fpage>e1278</fpage> </element-citation></ref>
<ref id="pone.0010685-Miller1"><label>235</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Miller</surname><given-names>A</given-names></name>
<name name-style="western"><surname>al-Sabbagh</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Santos</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Das</surname><given-names>MP</given-names></name>
<name name-style="western"><surname>Weiner</surname><given-names>HL</given-names></name>
</person-group> <year>1993</year> <article-title>Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.</article-title> <source>J Immunol</source> <volume>151</volume> <fpage>7307</fpage> <lpage>7315</lpage> </element-citation></ref>
<ref id="pone.0010685-Zheng1"><label>236</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Zheng</surname><given-names>SG</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>JH</given-names></name>
<name name-style="western"><surname>Gray</surname><given-names>JD</given-names></name>
<name name-style="western"><surname>Soucier</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Horwitz</surname><given-names>DA</given-names></name>
</person-group> <year>2004</year> <article-title>Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.</article-title> <source>J Immunol</source> <volume>172</volume> <fpage>5213</fpage> <lpage>5221</lpage> </element-citation></ref>
<ref id="pone.0010685-Li2"><label>237</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Li</surname><given-names>MO</given-names></name>
<name name-style="western"><surname>Sanjabi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name>
</person-group> <year>2006</year> <article-title>Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms.</article-title> <source>Immunity</source> <volume>25</volume> <fpage>455</fpage> <lpage>471</lpage> </element-citation></ref>
<ref id="pone.0010685-Groux1"><label>238</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Groux</surname><given-names>H</given-names></name>
<name name-style="western"><surname>O'Garra</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Bigler</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Rouleau</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Antonenko</surname><given-names>S</given-names></name>
<etal/></person-group> <year>1997</year> <article-title>A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.</article-title> <source>Nature</source> <volume>389</volume> <fpage>737</fpage> <lpage>742</lpage> </element-citation></ref>
<ref id="pone.0010685-Maynard1"><label>239</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Maynard</surname><given-names>CL</given-names></name>
<name name-style="western"><surname>Harrington</surname><given-names>LE</given-names></name>
<name name-style="western"><surname>Janowski</surname><given-names>KM</given-names></name>
<name name-style="western"><surname>Oliver</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Zindl</surname><given-names>CL</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3– precursor cells in the absence of interleukin 10.</article-title> <source>Nat Immunol</source> <volume>8</volume> <fpage>931</fpage> <lpage>941</lpage> </element-citation></ref>
<ref id="pone.0010685-Cottrez1"><label>240</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Cottrez</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Groux</surname><given-names>H</given-names></name>
</person-group> <year>2001</year> <article-title>Regulation of TGF-beta response during T cell activation is modulated by IL-10.</article-title> <source>J Immunol</source> <volume>167</volume> <fpage>773</fpage> <lpage>778</lpage> </element-citation></ref>
<ref id="pone.0010685-Chen2"><label>241</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chen</surname><given-names>ZM</given-names></name>
<name name-style="western"><surname>O'Shaughnessy</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Gramaglia</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Panoskaltsis-Mortari</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Murphy</surname><given-names>WJ</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function.</article-title> <source>Blood</source> <volume>101</volume> <fpage>5076</fpage> <lpage>5083</lpage> </element-citation></ref>
<ref id="pone.0010685-Chen3"><label>242</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chen</surname><given-names>ML</given-names></name>
<name name-style="western"><surname>Pittet</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Gorelik</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Weissleder</surname><given-names>R</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>102</volume> <fpage>419</fpage> <lpage>424</lpage> </element-citation></ref>
<ref id="pone.0010685-Fahlen1"><label>243</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Fahlen</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Read</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Gorelik</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Hurst</surname><given-names>SD</given-names></name>
<name name-style="western"><surname>Coffman</surname><given-names>RL</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells.</article-title> <source>J Exp Med</source> <volume>201</volume> <fpage>737</fpage> <lpage>746</lpage> </element-citation></ref>
<ref id="pone.0010685-Chen4"><label>244</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chen</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Jin</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Hardegen</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Lei</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>L</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.</article-title> <source>J Exp Med</source> <volume>198</volume> <fpage>1875</fpage> <lpage>1886</lpage> </element-citation></ref>
<ref id="pone.0010685-Horwitz2"><label>245</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Horwitz</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Zheng</surname><given-names>SG</given-names></name>
<name name-style="western"><surname>Gray</surname><given-names>JD</given-names></name>
</person-group> <year>2003</year> <article-title>The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets.</article-title> <source>J Leukoc Biol</source> <volume>74</volume> <fpage>471</fpage> <lpage>478</lpage> </element-citation></ref>
<ref id="pone.0010685-Apostolou1"><label>246</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Apostolou</surname><given-names>I</given-names></name>
<name name-style="western"><surname>von Boehmer</surname><given-names>H</given-names></name>
</person-group> <year>2004</year> <article-title>In vivo instruction of suppressor commitment in naive T cells.</article-title> <source>J Exp Med</source> <volume>199</volume> <fpage>1401</fpage> <lpage>1408</lpage> </element-citation></ref>
<ref id="pone.0010685-Andersson1"><label>247</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Andersson</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Tran</surname><given-names>DQ</given-names></name>
<name name-style="western"><surname>Pesu</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Davidson</surname><given-names>TS</given-names></name>
<name name-style="western"><surname>Ramsey</surname><given-names>H</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner.</article-title> <source>J Exp Med</source> <volume>205</volume> <fpage>1975</fpage> <lpage>1981</lpage> </element-citation></ref>
<ref id="pone.0010685-Jonuleit2"><label>248</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Jonuleit</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Schmitt</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Kakirman</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Stassen</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Knop</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells.</article-title> <source>J Exp Med</source> <volume>196</volume> <fpage>255</fpage> <lpage>260</lpage> </element-citation></ref>
<ref id="pone.0010685-Filaci1"><label>249</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Filaci</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Fravega</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Negrini</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Procopio</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Fenoglio</surname><given-names>D</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.</article-title> <source>Hum Immunol</source> <volume>65</volume> <fpage>142</fpage> <lpage>156</lpage> </element-citation></ref>
<ref id="pone.0010685-Lau1"><label>250</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Lau</surname><given-names>AW</given-names></name>
<name name-style="western"><surname>Biester</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Cornall</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Forrester</surname><given-names>JV</given-names></name>
</person-group> <year>2008</year> <article-title>Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells.</article-title> <source>J Immunol</source> <volume>180</volume> <fpage>3889</fpage> <lpage>3899</lpage> </element-citation></ref>
<ref id="pone.0010685-Zhang2"><label>251</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Zhang</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Schroppel</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Lal</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Jakubzick</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Mao</surname><given-names>X</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.</article-title> <source>Immunity</source> <volume>30</volume> <fpage>458</fpage> <lpage>469</lpage> </element-citation></ref>
<ref id="pone.0010685-Haribhai1"><label>252</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Haribhai</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Lin</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Relland</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Truong</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Williams</surname><given-names>CB</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Regulatory T cells dynamically control the primary immune response to foreign antigen.</article-title> <source>J Immunol</source> <volume>178</volume> <fpage>2961</fpage> <lpage>2972</lpage> </element-citation></ref>
<ref id="pone.0010685-Tadokoro1"><label>253</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Tadokoro</surname><given-names>CE</given-names></name>
<name name-style="western"><surname>Shakhar</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Shen</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Ding</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Lino</surname><given-names>AC</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo.</article-title> <source>J Exp Med</source> <volume>203</volume> <fpage>505</fpage> <lpage>511</lpage> </element-citation></ref>
<ref id="pone.0010685-Veldhoen1"><label>254</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Veldhoen</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Moncrieffe</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Hocking</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Atkins</surname><given-names>CJ</given-names></name>
<name name-style="western"><surname>Stockinger</surname><given-names>B</given-names></name>
</person-group> <year>2006</year> <article-title>Modulation of dendritic cell function by naive and regulatory CD4+ T cells.</article-title> <source>J Immunol</source> <volume>176</volume> <fpage>6202</fpage> <lpage>6210</lpage> </element-citation></ref>
<ref id="pone.0010685-Steinbrink1"><label>255</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Steinbrink</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Graulich</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Kubsch</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Knop</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Enk</surname><given-names>AH</given-names></name>
</person-group> <year>2002</year> <article-title>CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.</article-title> <source>Blood</source> <volume>99</volume> <fpage>2468</fpage> <lpage>2476</lpage> </element-citation></ref>
<ref id="pone.0010685-Bellinghausen1"><label>256</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bellinghausen</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Konig</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Bottcher</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Knop</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Saloga</surname><given-names>J</given-names></name>
</person-group> <year>2006</year> <article-title>Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.</article-title> <source>Clin Exp Allergy</source> <volume>36</volume> <fpage>1546</fpage> <lpage>1555</lpage> </element-citation></ref>
<ref id="pone.0010685-Depinay1"><label>257</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Depinay</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Hacini</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Beghdadi</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Peronet</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Mecheri</surname><given-names>S</given-names></name>
</person-group> <year>2006</year> <article-title>Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites.</article-title> <source>J Immunol</source> <volume>176</volume> <fpage>4141</fpage> <lpage>4146</lpage> </element-citation></ref>
<ref id="pone.0010685-Mbs1"><label>258</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Möbs</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Slotosch</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Loffler</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Pfutzner</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Hertl</surname><given-names>M</given-names></name>
</person-group> <year>2008</year> <article-title>Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy.</article-title> <source>Int Arch Allergy Immunol</source> <volume>147</volume> <fpage>171</fpage> <lpage>178</lpage> </element-citation></ref>
<ref id="pone.0010685-Suffia1"><label>259</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Suffia</surname><given-names>IJ</given-names></name>
<name name-style="western"><surname>Reckling</surname><given-names>SK</given-names></name>
<name name-style="western"><surname>Piccirillo</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Goldszmid</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Belkaid</surname><given-names>Y</given-names></name>
</person-group> <year>2006</year> <article-title>Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigen.</article-title> <source>J Exp Med</source> <volume>203</volume> <fpage>777</fpage> <lpage>788</lpage> </element-citation></ref>
<ref id="pone.0010685-Anderson1"><label>260</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Anderson</surname><given-names>CF</given-names></name>
<name name-style="western"><surname>Mendez</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sacks</surname><given-names>DL</given-names></name>
</person-group> <year>2005</year> <article-title>Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.</article-title> <source>J Immunol</source> <volume>174</volume> <fpage>2934</fpage> <lpage>2941</lpage> </element-citation></ref>
<ref id="pone.0010685-Bowen1"><label>261</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bowen</surname><given-names>DG</given-names></name>
<name name-style="western"><surname>Zen</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Holz</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Davis</surname><given-names>T</given-names></name>
<name name-style="western"><surname>McCaughan</surname><given-names>GW</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity.</article-title> <source>J Clin Invest</source> <volume>114</volume> <fpage>701</fpage> <lpage>712</lpage> </element-citation></ref>
<ref id="pone.0010685-Wei1"><label>262</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wei</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Duramad</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Perng</surname><given-names>OA</given-names></name>
<name name-style="western"><surname>Reiner</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>YJ</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>104</volume> <fpage>18169</fpage> <lpage>18174</lpage> </element-citation></ref>
<ref id="pone.0010685-Kapp1"><label>263</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kapp</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Honjo</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Kapp</surname><given-names>LM</given-names></name>
<name name-style="western"><surname>Goldsmith</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Bucy</surname><given-names>RP</given-names></name>
</person-group> <year>2007</year> <article-title>Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.</article-title> <source>J Immunol</source> <volume>179</volume> <fpage>2105</fpage> <lpage>2114</lpage> </element-citation></ref>
<ref id="pone.0010685-Oldenhove1"><label>264</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Oldenhove</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Bouladoux</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Wohlfert</surname><given-names>EA</given-names></name>
<name name-style="western"><surname>Hall</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Chou</surname><given-names>D</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection.</article-title> <source>Immunity</source> <volume>31</volume> <fpage>772</fpage> <lpage>786</lpage> </element-citation></ref>
<ref id="pone.0010685-Littman1"><label>265</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Littman</surname><given-names>DR</given-names></name>
<name name-style="western"><surname>Rudensky</surname><given-names>AY</given-names></name>
</person-group> <year>2010</year> <article-title>Th17 and regulatory T cells in mediating and restraining inflammation.</article-title> <source>Cell</source> <volume>140</volume> <fpage>845</fpage> <lpage>858</lpage> </element-citation></ref>
<ref id="pone.0010685-Hafalla3"><label>266</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hafalla</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Morrot</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Sano</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Milon</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Lafaille</surname><given-names>JJ</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria.</article-title> <source>J Immunol</source> <volume>171</volume> <fpage>964</fpage> <lpage>970</lpage> </element-citation></ref>
<ref id="pone.0010685-Tarun1"><label>267</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Tarun</surname><given-names>AS</given-names></name>
<name name-style="western"><surname>Dumpit</surname><given-names>RF</given-names></name>
<name name-style="western"><surname>Camargo</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Labaied</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>P</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.</article-title> <source>J Infect Dis</source> <volume>196</volume> <fpage>608</fpage> <lpage>616</lpage> </element-citation></ref>
<ref id="pone.0010685-Weiss3"><label>268</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Weiss</surname><given-names>WR</given-names></name>
<name name-style="western"><surname>Mellouk</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Houghten</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name>
<etal/></person-group> <year>1990</year> <article-title>Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.</article-title> <source>J Exp Med</source> <volume>171</volume> <fpage>763</fpage> <lpage>773</lpage> </element-citation></ref>
<ref id="pone.0010685-Saute1"><label>269</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Saute</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Aponte</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Almeda</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ascaso</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Vaz</surname><given-names>N</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>Malaria in southern Mozambique: incidence of clinical malaria in children living in a rural community in Manhica district.</article-title> <source>Trans R Soc Trop Med Hyg</source> <volume>97</volume> <fpage>655</fpage> <lpage>660</lpage> </element-citation></ref>
<ref id="pone.0010685-Guerra1"><label>270</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Guerra</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Gikandi</surname><given-names>PW</given-names></name>
<name name-style="western"><surname>Tatem</surname><given-names>AJ</given-names></name>
<name name-style="western"><surname>Noor</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide.</article-title> <source>PLoS Med</source> <volume>5</volume> <fpage>e38</fpage> </element-citation></ref>
<ref id="pone.0010685-Hay1"><label>271</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hay</surname><given-names>SI</given-names></name>
<name name-style="western"><surname>Guerra</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Tatem</surname><given-names>AJ</given-names></name>
<name name-style="western"><surname>Atkinson</surname><given-names>PM</given-names></name>
<name name-style="western"><surname>Snow</surname><given-names>RW</given-names></name>
</person-group> <year>2005</year> <article-title>Urbanization, malaria transmission and disease burden in Africa.</article-title> <source>Nat Rev Microbiol</source> <volume>3</volume> <fpage>81</fpage> <lpage>90</lpage> </element-citation></ref>
<ref id="pone.0010685-Hay2"><label>272</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hay</surname><given-names>SI</given-names></name>
<name name-style="western"><surname>Smith</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Snow</surname><given-names>RW</given-names></name>
</person-group> <year>2008</year> <article-title>Measuring malaria endemicity from intense to interrupted transmission.</article-title> <source>Lancet Infect Dis</source> <volume>8</volume> <fpage>369</fpage> <lpage>378</lpage> </element-citation></ref>
<ref id="pone.0010685-Beier1"><label>273</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Beier</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Killeen</surname><given-names>GF</given-names></name>
<name name-style="western"><surname>Githure</surname><given-names>JI</given-names></name>
</person-group> <year>1999</year> <article-title>Short report: Entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa.</article-title> <source>Am J Trop Med Hyg</source> <volume>61</volume> <fpage>109</fpage> <lpage>113</lpage> </element-citation></ref>
<ref id="pone.0010685-Reyburn1"><label>274</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Reyburn</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Mbatia</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Drakeley</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Bruce</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Carneiro</surname><given-names>I</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria.</article-title> <source>JAMA</source> <volume>293</volume> <fpage>1461</fpage> <lpage>1470</lpage> </element-citation></ref>
<ref id="pone.0010685-Wyler1"><label>275</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wyler</surname><given-names>DJ</given-names></name>
<name name-style="western"><surname>Brown</surname><given-names>J</given-names></name>
</person-group> <year>1977</year> <article-title>Malaria antigen-specific T-cell responsiveness during infection with Plasmodium falciparum.</article-title> <source>Clin Exp Immunol</source> <volume>29</volume> <fpage>401</fpage> <lpage>407</lpage> </element-citation></ref>
<ref id="pone.0010685-Greenwood2"><label>276</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Greenwood</surname><given-names>BM</given-names></name>
<name name-style="western"><surname>Bradley-Moore</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Bryceson</surname><given-names>AD</given-names></name>
<name name-style="western"><surname>Palit</surname><given-names>A</given-names></name>
</person-group> <year>1972</year> <article-title>Immunosuppression in children with malaria.</article-title> <source>Lancet</source> <volume>1</volume> <fpage>169</fpage> <lpage>172</lpage> </element-citation></ref>
<ref id="pone.0010685-Whittle1"><label>277</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Whittle</surname><given-names>HC</given-names></name>
<name name-style="western"><surname>Brown</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Marsh</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Greenwood</surname><given-names>BM</given-names></name>
<name name-style="western"><surname>Seidelin</surname><given-names>P</given-names></name>
<etal/></person-group> <year>1984</year> <article-title>T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria.</article-title> <source>Nature</source> <volume>312</volume> <fpage>449</fpage> <lpage>450</lpage> </element-citation></ref>
<ref id="pone.0010685-Cook1"><label>278</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Cook</surname><given-names>IF</given-names></name>
</person-group> <year>1985</year> <article-title>Herpes zoster in children following malaria.</article-title> <source>J Trop Med Hyg</source> <volume>88</volume> <fpage>261</fpage> <lpage>264</lpage> </element-citation></ref>
<ref id="pone.0010685-Williamson1"><label>279</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Williamson</surname><given-names>WA</given-names></name>
<name name-style="western"><surname>Greenwood</surname><given-names>BM</given-names></name>
</person-group> <year>1978</year> <article-title>Impairment of the immune response to vaccination after acute malaria.</article-title> <source>Lancet</source> <volume>1</volume> <fpage>1328</fpage> <lpage>1329</lpage> </element-citation></ref>
<ref id="pone.0010685-BradleyMoore1"><label>280</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bradley-Moore</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Greenwood</surname><given-names>BM</given-names></name>
<name name-style="western"><surname>Bradley</surname><given-names>AK</given-names></name>
<name name-style="western"><surname>Bartlett</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Bidwell</surname><given-names>DE</given-names></name>
<etal/></person-group> <year>1985</year> <article-title>Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination.</article-title> <source>Ann Trop Med Parasitol</source> <volume>79</volume> <fpage>563</fpage> <lpage>573</lpage> </element-citation></ref>
<ref id="pone.0010685-Riley1"><label>281</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Riley</surname><given-names>EM</given-names></name>
<name name-style="western"><surname>Andersson</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Otoo</surname><given-names>LN</given-names></name>
<name name-style="western"><surname>Jepsen</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Greenwood</surname><given-names>BM</given-names></name>
</person-group> <year>1988</year> <article-title>Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria.</article-title> <source>Clin Exp Immunol</source> <volume>73</volume> <fpage>17</fpage> <lpage>22</lpage> </element-citation></ref>
<ref id="pone.0010685-Sacci1"><label>282</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sacci</surname><given-names>JB</given-names><suffix>Jr</suffix></name>
<name name-style="western"><surname>Ribeiro</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Huang</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Alam</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Russell</surname><given-names>JA</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression.</article-title> <source>Mol Biochem Parasitol</source> <volume>142</volume> <fpage>177</fpage> <lpage>183</lpage> </element-citation></ref>
<ref id="pone.0010685-Mikolajczak1"><label>283</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mikolajczak</surname><given-names>SA</given-names></name>
<name name-style="western"><surname>Silva-Rivera</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Peng</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Tarun</surname><given-names>AS</given-names></name>
<name name-style="western"><surname>Camargo</surname><given-names>N</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host.</article-title> <source>Mol Cell Biol</source> <volume>29</volume> <fpage>6196</fpage> <lpage>6207</lpage> </element-citation></ref>
<ref id="pone.0010685-Siau1"><label>284</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Siau</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Silvie</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Franetich</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Yalaoui</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Marinach</surname><given-names>C</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection.</article-title> <source>PLoS Pathog</source> <volume>4</volume> <fpage>e1000121</fpage> </element-citation></ref>
<ref id="pone.0010685-Senti1"><label>285</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Senti</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Prinz Vavricka</surname><given-names>BM</given-names></name>
<name name-style="western"><surname>Erdmann</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Diaz</surname><given-names>MI</given-names></name>
<name name-style="western"><surname>Markus</surname><given-names>R</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>105</volume> <fpage>17908</fpage> <lpage>17912</lpage> </element-citation></ref>
<ref id="pone.0010685-Houot1"><label>286</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Houot</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Perrot</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Garcia</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Durand</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Lebecque</surname><given-names>S</given-names></name>
</person-group> <year>2006</year> <article-title>Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation.</article-title> <source>J Immunol</source> <volume>176</volume> <fpage>5293</fpage> <lpage>5298</lpage> </element-citation></ref>
<ref id="pone.0010685-Bayry1"><label>287</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bayry</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Triebel</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Kaveri</surname><given-names>SV</given-names></name>
<name name-style="western"><surname>Tough</surname><given-names>DF</given-names></name>
</person-group> <year>2007</year> <article-title>Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells.</article-title> <source>J Immunol</source> <volume>178</volume> <fpage>4184</fpage> <lpage>4193</lpage> </element-citation></ref>
<ref id="pone.0010685-Anderson2"><label>288</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Anderson</surname><given-names>AE</given-names></name>
<name name-style="western"><surname>Sayers</surname><given-names>BL</given-names></name>
<name name-style="western"><surname>Haniffa</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Swan</surname><given-names>DJ</given-names></name>
<name name-style="western"><surname>Diboll</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells.</article-title> <source>J Leukoc Biol</source> <volume>84</volume> <fpage>124</fpage> <lpage>133</lpage> </element-citation></ref>
<ref id="pone.0010685-Krishnegowda1"><label>289</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Krishnegowda</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Hajjar</surname><given-names>AM</given-names></name>
<name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Douglass</surname><given-names>EJ</given-names></name>
<name name-style="western"><surname>Uematsu</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity.</article-title> <source>J Biol Chem</source> <volume>280</volume> <fpage>8606</fpage> <lpage>8616</lpage> </element-citation></ref>
<ref id="pone.0010685-Allan1"><label>290</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Allan</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Waithman</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Bedoui</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Jones</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Villadangos</surname><given-names>JA</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming.</article-title> <source>Immunity</source> <volume>25</volume> <fpage>153</fpage> <lpage>162</lpage> </element-citation></ref>
<ref id="pone.0010685-Lammermann1"><label>291</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Lammermann</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Sixt</surname><given-names>M</given-names></name>
</person-group> <year>2008</year> <article-title>The microanatomy of T-cell responses.</article-title> <source>Immunol Rev</source> <volume>221</volume> <fpage>26</fpage> <lpage>43</lpage> </element-citation></ref>
<ref id="pone.0010685-Rothenfusser1"><label>292</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Rothenfusser</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Tuma</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Endres</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Hartmann</surname><given-names>G</given-names></name>
</person-group> <year>2002</year> <article-title>Plasmacytoid dendritic cells: the key to CpG.</article-title> <source>Hum Immunol</source> <volume>63</volume> <fpage>1111</fpage> <lpage>1119</lpage> </element-citation></ref>
<ref id="pone.0010685-Kissenpfennig1"><label>293</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kissenpfennig</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Henri</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Dubois</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Laplace-Builhe</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Perrin</surname><given-names>P</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells.</article-title> <source>Immunity</source> <volume>22</volume> <fpage>643</fpage> <lpage>654</lpage> </element-citation></ref>
<ref id="pone.0010685-Macatonia1"><label>294</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Macatonia</surname><given-names>SE</given-names></name>
<name name-style="western"><surname>Knight</surname><given-names>SC</given-names></name>
<name name-style="western"><surname>Edwards</surname><given-names>AJ</given-names></name>
<name name-style="western"><surname>Griffiths</surname><given-names>SF</given-names></name>
<name name-style="western"><surname>Fryer</surname><given-names>P</given-names></name>
</person-group> <year>1987</year> <article-title>Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies.</article-title> <source>J Exp Med</source> <volume>166</volume> <fpage>1654</fpage> <lpage>1667</lpage> </element-citation></ref>
<ref id="pone.0010685-Randolph2"><label>295</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Randolph</surname><given-names>GJ</given-names></name>
<name name-style="western"><surname>Ochando</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Partida-Sanchez</surname><given-names>S</given-names></name>
</person-group> <year>2008</year> <article-title>Migration of dendritic cell subsets and their precursors.</article-title> <source>Annu Rev Immunol</source> <volume>26</volume> <fpage>293</fpage> <lpage>316</lpage> </element-citation></ref>
<ref id="pone.0010685-Geissmann2"><label>296</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Geissmann</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Dieu-Nosjean</surname><given-names>MC</given-names></name>
<name name-style="western"><surname>Dezutter</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Valladeau</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kayal</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin.</article-title> <source>J Exp Med</source> <volume>196</volume> <fpage>417</fpage> <lpage>430</lpage> </element-citation></ref>
<ref id="pone.0010685-Stewart1"><label>297</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Stewart</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
</person-group> <year>1988</year> <article-title>Malaria sporozoites leave behind trails of circumsporozoite protein during gliding.</article-title> <source>J Protozool</source> <volume>35</volume> <fpage>389</fpage> <lpage>393</lpage> </element-citation></ref>
<ref id="pone.0010685-Mota1"><label>298</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mota</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Pradel</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Hafalla</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Frevert</surname><given-names>U</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Migration of Plasmodium sporozoites through cells before infection.</article-title> <source>Science</source> <volume>291</volume> <fpage>141</fpage> <lpage>144</lpage> </element-citation></ref>
<ref id="pone.0010685-Amino2"><label>299</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Amino</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Giovanni</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Thiberge</surname><given-names>S</given-names></name>
<name name-style="western"><surname>e</surname><given-names>al</given-names></name>
</person-group> <year>2008</year> <article-title>Host cell traversal is important for progression of the malaria parasite through the dermis to the liver.</article-title> <source>Cell Host Microbe</source> <volume>3</volume> <fpage>88</fpage> <lpage>96</lpage> </element-citation></ref>
<ref id="pone.0010685-Stewart2"><label>300</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Stewart</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
</person-group> <year>1992</year> <article-title>Electron microscopic analysis of circumsporozoite protein trail formation by gliding malaria sporozoites.</article-title> <source>J Protozool</source> <volume>39</volume> <fpage>663</fpage> <lpage>671</lpage> </element-citation></ref>
<ref id="pone.0010685-Singh1"><label>301</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Singh</surname><given-names>AP</given-names></name>
<name name-style="western"><surname>Buscaglia</surname><given-names>CA</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name>
<name name-style="western"><surname>Levay</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>DR</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite.</article-title> <source>Cell</source> <volume>131</volume> <fpage>492</fpage> <lpage>504</lpage> </element-citation></ref>
<ref id="pone.0010685-Doolan7"><label>302</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hedstrom</surname><given-names>RC</given-names></name>
<name name-style="western"><surname>Hobart</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Charoenvit</surname><given-names>Y</given-names></name>
<etal/></person-group> <year>1996</year> <article-title>Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.</article-title> <source>J Exp Med</source> <volume>183</volume> <fpage>1739</fpage> <lpage>1746</lpage> </element-citation></ref>
<ref id="pone.0010685-Veldhoen2"><label>303</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Veldhoen</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hocking</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Atkins</surname><given-names>CJ</given-names></name>
<name name-style="western"><surname>Locksley</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Stockinger</surname><given-names>B</given-names></name>
</person-group> <year>2006</year> <article-title>TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.</article-title> <source>Immunity</source> <volume>24</volume> <fpage>179</fpage> <lpage>189</lpage> </element-citation></ref>
<ref id="pone.0010685-Bettelli1"><label>304</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bettelli</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Korn</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Oukka</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Kuchroo</surname><given-names>VK</given-names></name>
</person-group> <year>2008</year> <article-title>Induction and effector functions of T(H)17 cells.</article-title> <source>Nature</source> <volume>453</volume> <fpage>1051</fpage> <lpage>1057</lpage> </element-citation></ref>
<ref id="pone.0010685-Chen5"><label>305</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Das</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Komorowski</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Beres</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Hessner</surname><given-names>MJ</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.</article-title> <source>Blood</source> <volume>114</volume> <fpage>891</fpage> <lpage>900</lpage> </element-citation></ref>
<ref id="pone.0010685-Piconese1"><label>306</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Piconese</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Gri</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Tripodo</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Musio</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Gorzanelli</surname><given-names>A</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Mast cells counteract regulatory T cell suppression through interleukin-6 and OX40/OX40L axis toward Th17 cell differentiation.</article-title> <source>Blood</source> <volume>114</volume> <fpage>2639</fpage> <lpage>2648</lpage> </element-citation></ref>
<ref id="pone.0010685-Pasare1"><label>307</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Pasare</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Medzhitov</surname><given-names>R</given-names></name>
</person-group> <year>2003</year> <article-title>Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.</article-title> <source>Science</source> <volume>299</volume> <fpage>1033</fpage> <lpage>1036</lpage> </element-citation></ref>
<ref id="pone.0010685-Longhi1"><label>308</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Longhi</surname><given-names>MP</given-names></name>
<name name-style="western"><surname>Wright</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Lauder</surname><given-names>SN</given-names></name>
<name name-style="western"><surname>Nowell</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Jones</surname><given-names>GW</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells.</article-title> <source>PLoS Pathog</source> <volume>4</volume> <fpage>e1000006</fpage> </element-citation></ref>
<ref id="pone.0010685-Heit1"><label>309</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Heit</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Gebhardt</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Lahl</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Neuenhahn</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Schmitz</surname><given-names>F</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Circumvention of regulatory CD4+ T cell activity during cross-priming strongly enhances T cell-mediated immunity.</article-title> <source>Eur J Immunol</source> <volume>38</volume> <fpage>1585</fpage> <lpage>1597</lpage> </element-citation></ref>
<ref id="pone.0010685-Tan1"><label>310</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Tan</surname><given-names>PH</given-names></name>
<name name-style="western"><surname>Sagoo</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Chan</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Yates</surname><given-names>JB</given-names></name>
<name name-style="western"><surname>Campbell</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells.</article-title> <source>J Immunol</source> <volume>174</volume> <fpage>7633</fpage> <lpage>7644</lpage> </element-citation></ref>
<ref id="pone.0010685-Cong1"><label>311</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Cong</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Konrad</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Iqbal</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Hatton</surname><given-names>RD</given-names></name>
<name name-style="western"><surname>Weaver</surname><given-names>CT</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function.</article-title> <source>J Immunol</source> <volume>174</volume> <fpage>2787</fpage> <lpage>2795</lpage> </element-citation></ref>
<ref id="pone.0010685-Cockburn1"><label>312</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Cockburn</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Chakravarty</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Overstreet</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>Garcia-Sastre</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Zavala</surname><given-names>F</given-names></name>
</person-group> <year>2008</year> <article-title>Memory CD8+ T cell responses expand when antigen presentation overcomes T cell self-regulation.</article-title> <source>J Immunol</source> <volume>180</volume> <fpage>64</fpage> <lpage>71</lpage> </element-citation></ref>
<ref id="pone.0010685-Cowan1"><label>313</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Cowan</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Krishna</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Crisanti</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Robson</surname><given-names>KJ</given-names></name>
</person-group> <year>1992</year> <article-title>Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites.</article-title> <source>Lancet</source> <volume>339</volume> <fpage>1412</fpage> <lpage>1413</lpage> </element-citation></ref>
<ref id="pone.0010685-Omer1"><label>314</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Omer</surname><given-names>FM</given-names></name>
<name name-style="western"><surname>de Souza</surname><given-names>JB</given-names></name>
<name name-style="western"><surname>Corran</surname><given-names>PH</given-names></name>
<name name-style="western"><surname>Sultan</surname><given-names>AA</given-names></name>
<name name-style="western"><surname>Riley</surname><given-names>EM</given-names></name>
</person-group> <year>2003</year> <article-title>Activation of transforming growth factor β by malaria parasite-derived metalloproteinases and a thrombospondin-like molecule.</article-title> <source>J Exp Med</source> <volume>198</volume> <fpage>1817</fpage> <lpage>1827</lpage> </element-citation></ref>
<ref id="pone.0010685-Lawler1"><label>315</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Lawler</surname><given-names>J</given-names></name>
</person-group> <year>2000</year> <article-title>The functions of thrombospondin-1 and-2.</article-title> <source>Curr Opin Cell Biol</source> <volume>12</volume> <fpage>634</fpage> <lpage>640</lpage> </element-citation></ref>
<ref id="pone.0010685-Futagami1"><label>316</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Futagami</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Sugita</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Vega</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ishida</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Takase</surname><given-names>H</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells.</article-title> <source>J Immunol</source> <volume>178</volume> <fpage>6994</fpage> <lpage>7005</lpage> </element-citation></ref>
<ref id="pone.0010685-Walther1"><label>317</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Walther</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Tongren</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Andrews</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Korbel</surname><given-names>D</given-names></name>
<name name-style="western"><surname>King</surname><given-names>E</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection.</article-title> <source>Immunity</source> <volume>23</volume> <fpage>287</fpage> <lpage>296</lpage> </element-citation></ref>
<ref id="pone.0010685-Omer2"><label>318</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Omer</surname><given-names>FM</given-names></name>
<name name-style="western"><surname>de Souza</surname><given-names>JB</given-names></name>
<name name-style="western"><surname>Riley</surname><given-names>EM</given-names></name>
</person-group> <year>2003</year> <article-title>Differential induction of TGF-beta regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections.</article-title> <source>J Immunol</source> <volume>171</volume> <fpage>5430</fpage> <lpage>5436</lpage> </element-citation></ref>
<ref id="pone.0010685-Hisaeda1"><label>319</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hisaeda</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Maekawa</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Iwakawa</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Okada</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Himeno</surname><given-names>K</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells.</article-title> <source>Nat Med</source> <volume>10</volume> <fpage>29</fpage> <lpage>30</lpage> </element-citation></ref>
<ref id="pone.0010685-Birch1"><label>320</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Birch</surname><given-names>KE</given-names></name>
<name name-style="western"><surname>Vukmanovic-Stejic</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Reed</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Akbar</surname><given-names>AN</given-names></name>
<name name-style="western"><surname>Rustin</surname><given-names>MH</given-names></name>
</person-group> <year>2005</year> <article-title>The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin.</article-title> <source>Br J Dermatol</source> <volume>152</volume> <fpage>409</fpage> <lpage>417</lpage> </element-citation></ref>
<ref id="pone.0010685-VukmanovicStejic1"><label>321</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Vukmanovic-Stejic</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Agius</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Booth</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Dunne</surname><given-names>PJ</given-names></name>
<name name-style="western"><surname>Lacy</surname><given-names>KE</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo.</article-title> <source>J Clin Invest</source> <volume>118</volume> <fpage>3639</fpage> <lpage>3650</lpage> </element-citation></ref>
<ref id="pone.0010685-Akbar1"><label>322</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Akbar</surname><given-names>AN</given-names></name>
<name name-style="western"><surname>Vukmanovic-Stejic</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Taams</surname><given-names>LS</given-names></name>
<name name-style="western"><surname>Macallan</surname><given-names>DC</given-names></name>
</person-group> <year>2007</year> <article-title>The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery.</article-title> <source>Nat Rev Immunol</source> <volume>7</volume> <fpage>231</fpage> <lpage>237</lpage> </element-citation></ref>
<ref id="pone.0010685-VukmanovicStejic2"><label>323</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Vukmanovic-Stejic</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Cook</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Fletcher</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>McQuaid</surname><given-names>A</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo.</article-title> <source>J Clin Invest</source> <volume>116</volume> <fpage>2423</fpage> <lpage>2433</lpage> </element-citation></ref>
<ref id="pone.0010685-Janssens1"><label>324</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Janssens</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Carlier</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Wu</surname><given-names>B</given-names></name>
<name name-style="western"><surname>VanderElst</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Jacquemin</surname><given-names>MG</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner.</article-title> <source>J Immunol</source> <volume>171</volume> <fpage>4604</fpage> <lpage>4612</lpage> </element-citation></ref>
<ref id="pone.0010685-Florens1"><label>325</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Florens</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Washburn</surname><given-names>MP</given-names></name>
<name name-style="western"><surname>Raine</surname><given-names>JD</given-names></name>
<name name-style="western"><surname>Anthony</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Grainger</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>A proteomic view of the Plasmodium falciparum life cycle.</article-title> <source>Nature</source> <volume>419</volume> <fpage>520</fpage> <lpage>526</lpage> </element-citation></ref>
<ref id="pone.0010685-Hope1"><label>326</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hope</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Hall</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Simmons</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Hyde</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Scaife</surname><given-names>JG</given-names></name>
</person-group> <year>1984</year> <article-title>Evidence for immunological cross-reaction between sporozoites and blood stages of a human malaria parasite.</article-title> <source>Nature</source> <volume>308</volume> <fpage>191</fpage> <lpage>194</lpage> </element-citation></ref>
<ref id="pone.0010685-Meraldi1"><label>327</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Meraldi</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Nebie</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Tiono</surname><given-names>AB</given-names></name>
<name name-style="western"><surname>Diallo</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Sanogo</surname><given-names>E</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection.</article-title> <source>Parasite Immunol</source> <volume>26</volume> <fpage>265</fpage> <lpage>272</lpage> </element-citation></ref>
<ref id="pone.0010685-Couper1"><label>328</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Couper</surname><given-names>KN</given-names></name>
<name name-style="western"><surname>Blount</surname><given-names>DG</given-names></name>
<name name-style="western"><surname>Wilson</surname><given-names>MS</given-names></name>
<name name-style="western"><surname>Hafalla</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Belkaid</surname><given-names>Y</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>IL-10 from CD4<sup>+</sup> CD25<sup>−</sup> Foxp3<sup>−</sup> CD127<sup>−</sup> adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection.</article-title> <source>PLoS Pathog</source> <volume>4</volume> <fpage>e1000004</fpage> </element-citation></ref>
<ref id="pone.0010685-Scholzen1"><label>329</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Scholzen</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Mittag</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Rogerson</surname><given-names>SJ</given-names></name>
<name name-style="western"><surname>Cooke</surname><given-names>BM</given-names></name>
<name name-style="western"><surname>Plebanski</surname><given-names>M</given-names></name>
</person-group> <year>2009</year> <article-title>Plasmodium falciparum-mediated induction of human CD25<sup>hi</sup> Foxp3<sup>hi</sup> CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFβ.</article-title> <source>PLoS Pathog</source> <volume>5</volume> <fpage>e1000543</fpage> </element-citation></ref>
<ref id="pone.0010685-Urban1"><label>330</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Urban</surname><given-names>BC</given-names></name>
<name name-style="western"><surname>Ferguson</surname><given-names>DJP</given-names></name>
<name name-style="western"><surname>Pain</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Willcox</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Plebanski</surname><given-names>M</given-names></name>
<etal/></person-group> <year>1999</year> <article-title>Plasmodium falciparum infected erythrocytes modulate the maturation of dendritic cells.</article-title> <source>Nature</source> <volume>400</volume> <fpage>73</fpage> <lpage>77</lpage> </element-citation></ref>
<ref id="pone.0010685-OcaaMorgner1"><label>331</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Ocaña-Morgner</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Mota</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Rodriguez</surname><given-names>A</given-names></name>
</person-group> <year>2003</year> <article-title>Malaria blood stage suppression of liver stage immunity by dendritic cells.</article-title> <source>J Exp Med</source> <volume>197</volume> <fpage>143</fpage> <lpage>151</lpage> </element-citation></ref>
<ref id="pone.0010685-Wilson1"><label>332</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wilson</surname><given-names>NS</given-names></name>
<name name-style="western"><surname>Behrens</surname><given-names>GM</given-names></name>
<name name-style="western"><surname>Lundie</surname><given-names>RJ</given-names></name>
<name name-style="western"><surname>Smith</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Waithman</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity.</article-title> <source>Nat Immunol</source> <volume>7</volume> <fpage>165</fpage> <lpage>172</lpage> </element-citation></ref>
<ref id="pone.0010685-Belkaid3"><label>333</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Belkaid</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Blank</surname><given-names>RB</given-names></name>
<name name-style="western"><surname>Suffia</surname><given-names>I</given-names></name>
</person-group> <year>2006</year> <article-title>Natural regulatory T cells and parasites: a common quest for host homeostasis.</article-title> <source>Immunol Rev</source> <volume>212</volume> <fpage>287</fpage> <lpage>300</lpage> </element-citation></ref>
<ref id="pone.0010685-Todryk1"><label>334</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Todryk</surname><given-names>SM</given-names></name>
<name name-style="western"><surname>Bejon</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Mwangi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Plebanski</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Urban</surname><given-names>B</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.</article-title> <source>PLoS One</source> <volume>3</volume> <fpage>e2027</fpage> </element-citation></ref>
<ref id="pone.0010685-Kumar1"><label>335</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kumar</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>Sano</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Boscardin</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></name>
<etal/></person-group> <year>2006</year> <article-title>The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.</article-title> <source>Nature</source> <volume>444</volume> <fpage>937</fpage> <lpage>940</lpage> </element-citation></ref>
<ref id="pone.0010685-Khusmith1"><label>336</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Khusmith</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Charoenvit</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Beaudoin</surname><given-names>RL</given-names></name>
<etal/></person-group> <year>1991</year> <article-title>Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.</article-title> <source>Science</source> <volume>252</volume> <fpage>715</fpage> <lpage>718</lpage> </element-citation></ref>
<ref id="pone.0010685-Kumar2"><label>337</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kumar</surname><given-names>KA</given-names></name>
<name name-style="western"><surname>Baxter</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Tarun</surname><given-names>AS</given-names></name>
<name name-style="western"><surname>Kappe</surname><given-names>SH</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>V</given-names></name>
</person-group> <year>2009</year> <article-title>Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoites.</article-title> <source>PLoS One</source> <volume>4</volume> <fpage>e4480</fpage> </element-citation></ref>
<ref id="pone.0010685-Overstreet1"><label>338</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Overstreet</surname><given-names>MG</given-names></name>
<name name-style="western"><surname>Cockburn</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Chen</surname><given-names>YC</given-names></name>
<name name-style="western"><surname>Zavala</surname><given-names>F</given-names></name>
</person-group> <year>2008</year> <article-title>Protective CD8 T cells against Plasmodium liver stages: immunobiology of an ‘unnatural’ immune response.</article-title> <source>Immunol Rev</source> <volume>225</volume> <fpage>272</fpage> <lpage>283</lpage> </element-citation></ref>
<ref id="pone.0010685-Klein1"><label>339</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Klein</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Khazaie</surname><given-names>K</given-names></name>
<name name-style="western"><surname>von Boehmer</surname><given-names>H</given-names></name>
</person-group> <year>2003</year> <article-title>In vivo dynamics of antigen specific regulatory T cells not predicted from behavior in vitro.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>100</volume> <fpage>8886</fpage> <lpage>8891</lpage> </element-citation></ref>
<ref id="pone.0010685-Moorthy4"><label>340</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Moorthy</surname><given-names>VS</given-names></name>
<name name-style="western"><surname>Pinder</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Reece</surname><given-names>WH</given-names></name>
<name name-style="western"><surname>Watkins</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Atabani</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.</article-title> <source>J Infect Dis</source> <volume>188</volume> <fpage>1239</fpage> <lpage>1244</lpage> </element-citation></ref>
<ref id="pone.0010685-Hill2"><label>341</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hill</surname><given-names>AV</given-names></name>
<name name-style="western"><surname>Reece</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Gothard</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Moorthy</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Roberts</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2000</year> <article-title>DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.</article-title> <source>Dev Biol (Basel)</source> <volume>104</volume> <fpage>171</fpage> <lpage>179</lpage> </element-citation></ref>
<ref id="pone.0010685-Macete1"><label>342</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Macete</surname><given-names>EV</given-names></name>
<name name-style="western"><surname>Sacarlal</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Aponte</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Leach</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Navia</surname><given-names>MM</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial.</article-title> <source>Trials</source> <volume>8</volume> <fpage>11</fpage> </element-citation></ref>
<ref id="pone.0010685-Kester2"><label>343</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kester</surname><given-names>KE</given-names></name>
<name name-style="western"><surname>Cummings</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Ockenhouse</surname><given-names>CF</given-names></name>
<name name-style="western"><surname>Nielsen</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Hall</surname><given-names>BT</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research.</article-title> <source>Vaccine</source> <volume>26</volume> <fpage>2191</fpage> <lpage>2202</lpage> </element-citation></ref>
<ref id="pone.0010685-Kester3"><label>344</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kester</surname><given-names>KE</given-names></name>
<name name-style="western"><surname>McKinney</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Tornieporth</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Ockenhouse</surname><given-names>CF</given-names></name>
<name name-style="western"><surname>Heppner</surname><given-names>DG</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.</article-title> <source>J Infect Dis</source> <volume>183</volume> <fpage>640</fpage> <lpage>647</lpage> </element-citation></ref>
<ref id="pone.0010685-Kester4"><label>345</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kester</surname><given-names>KE</given-names></name>
<name name-style="western"><surname>McKinney</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Tornieporth</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Ockenhouse</surname><given-names>CF</given-names></name>
<name name-style="western"><surname>Heppner</surname><given-names>DG</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults.</article-title> <source>Vaccine</source> <volume>25</volume> <fpage>5359</fpage> <lpage>5366</lpage> </element-citation></ref>
<ref id="pone.0010685-Daubersies2"><label>346</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Daubersies</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Thomas</surname><given-names>AW</given-names></name>
<name name-style="western"><surname>Millet</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Brahimi</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Langermans</surname><given-names>JA</given-names></name>
<etal/></person-group> <year>2000</year> <article-title>Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved preerythrocytic liver-stage antigen 3.</article-title> <source>Nat Med</source> <volume>6</volume> <fpage>1258</fpage> <lpage>1263</lpage> </element-citation></ref>
<ref id="pone.0010685-ToureBalde1"><label>347</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Toure-Balde</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Perlaza</surname><given-names>BL</given-names></name>
<name name-style="western"><surname>Sauzet</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Ndiaye</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Aribot</surname><given-names>G</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.</article-title> <source>Infect Immun</source> <volume>77</volume> <fpage>1189</fpage> <lpage>1196</lpage> </element-citation></ref>
<ref id="pone.0010685-McCallum1"><label>348</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>McCallum</surname><given-names>FJ</given-names></name>
<name name-style="western"><surname>Persson</surname><given-names>KE</given-names></name>
<name name-style="western"><surname>Mugyenyi</surname><given-names>CK</given-names></name>
<name name-style="western"><surname>Fowkes</surname><given-names>FJ</given-names></name>
<name name-style="western"><surname>Simpson</surname><given-names>JA</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.</article-title> <source>PLoS One</source> <volume>3</volume> <fpage>e3571</fpage> </element-citation></ref>
<ref id="pone.0010685-Guinovart1"><label>349</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Guinovart</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Aponte</surname><given-names>JJ</given-names></name>
<name name-style="western"><surname>Sacarlal</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Aide</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Leach</surname><given-names>A</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children.</article-title> <source>PLoS One</source> <volume>4</volume> <fpage>e5165</fpage> </element-citation></ref>
<ref id="pone.0010685-Whalen1"><label>350</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Whalen</surname><given-names>J</given-names></name>
</person-group> <year>2009</year> <article-title>Patent rescindication/release (Glaxo-Smith and Kline).</article-title> <source>Wall Street Journal</source> </element-citation></ref>
<ref id="pone.0010685-Law1"><label>351</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Law</surname><given-names>I</given-names></name>
<name name-style="western"><surname>Ilett</surname><given-names>KF</given-names></name>
<name name-style="western"><surname>Hackett</surname><given-names>LP</given-names></name>
<name name-style="western"><surname>Page-Sharp</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Baiwog</surname><given-names>F</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers.</article-title> <source>Br J Clin Pharmacol</source> <volume>65</volume> <fpage>674</fpage> <lpage>679</lpage> </element-citation></ref>
<ref id="pone.0010685-Okiro1"><label>352</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Okiro</surname><given-names>EA</given-names></name>
<name name-style="western"><surname>Hay</surname><given-names>SI</given-names></name>
<name name-style="western"><surname>Gikandi</surname><given-names>PW</given-names></name>
<name name-style="western"><surname>Sharif</surname><given-names>SK</given-names></name>
<name name-style="western"><surname>Noor</surname><given-names>AM</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>The decline in paediatric malaria admissions on the coast of Kenya.</article-title> <source>Malar J</source> <volume>6</volume> <fpage>151</fpage> </element-citation></ref>
<ref id="pone.0010685-OMeara1"><label>353</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>O'Meara</surname><given-names>WP</given-names></name>
<name name-style="western"><surname>Bejon</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Mwangi</surname><given-names>TW</given-names></name>
<name name-style="western"><surname>Okiro</surname><given-names>EA</given-names></name>
<name name-style="western"><surname>Peshu</surname><given-names>N</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya.</article-title> <source>Lancet</source> <volume>372</volume> <fpage>1555</fpage> <lpage>1562</lpage> </element-citation></ref>
<ref id="pone.0010685-Penny1"><label>354</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Penny</surname><given-names>MA</given-names></name>
<name name-style="western"><surname>Maire</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Studer</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Schapira</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Smith</surname><given-names>TA</given-names></name>
</person-group> <year>2008</year> <article-title>What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines.</article-title> <source>PLoS One</source> <volume>3</volume> <fpage>e3193</fpage> </element-citation></ref>
<ref id="pone.0010685-Martinez1"><label>355</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Martinez</surname><given-names>PA</given-names></name>
<name name-style="western"><surname>Yandar</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Lesmes</surname><given-names>LP</given-names></name>
<name name-style="western"><surname>Forero</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Perez-Leal</surname><given-names>O</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Passive transfer of Plasmodium falciparum MSP-2 pseudopeptide-induced antibodies efficiently controlled parasitemia in Plasmodium berghei-infected mice.</article-title> <source>Peptides</source> <volume>30</volume> <fpage>330</fpage> <lpage>342</lpage> </element-citation></ref>
<ref id="pone.0010685-Amante1"><label>356</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Amante</surname><given-names>FH</given-names></name>
<name name-style="western"><surname>Good</surname><given-names>MF</given-names></name>
</person-group> <year>1997</year> <article-title>Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice.</article-title> <source>Parasite Immunol</source> <volume>19</volume> <fpage>111</fpage> <lpage>126</lpage> </element-citation></ref>
<ref id="pone.0010685-Brahimi1"><label>357</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Brahimi</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Badell</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Sauzet</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>BenMohamed</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Daubersies</surname><given-names>P</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.</article-title> <source>Infect Immun</source> <volume>69</volume> <fpage>3845</fpage> <lpage>3852</lpage> </element-citation></ref>
<ref id="pone.0010685-BrunaRomero1"><label>358</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Bruna-Romero</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Gonzalez-Aseguinolaza</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Hafalla</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Tsuji</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
</person-group> <year>2001</year> <article-title>Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>98</volume> <fpage>11491</fpage> <lpage>11496</lpage> </element-citation></ref>
<ref id="pone.0010685-Burns1"><label>359</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Burns</surname><given-names>JM</given-names><suffix>Jr</suffix></name>
<name name-style="western"><surname>Flaherty</surname><given-names>PR</given-names></name>
<name name-style="western"><surname>Nanavati</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Weidanz</surname><given-names>WP</given-names></name>
</person-group> <year>2004</year> <article-title>Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.</article-title> <source>Infect Immun</source> <volume>72</volume> <fpage>5605</fpage> <lpage>5612</lpage> </element-citation></ref>
<ref id="pone.0010685-Cabrera1"><label>360</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Cabrera</surname><given-names>EJ</given-names></name>
<name name-style="western"><surname>Barr</surname><given-names>ML</given-names></name>
<name name-style="western"><surname>Silverman</surname><given-names>PH</given-names></name>
</person-group> <year>1977</year> <article-title>Long-term studies on rhesus monkeys (Macaca mulatta) immunized against Plasmodium knowlesi.</article-title> <source>Infect Immun</source> <volume>15</volume> <fpage>461</fpage> <lpage>465</lpage> </element-citation></ref>
<ref id="pone.0010685-Cao1"><label>361</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Pan</surname><given-names>W</given-names></name>
</person-group> <year>2009</year> <article-title>Construction of transgenic Plasmodium berghei as a model for evaluation of blood-stage vaccine candidate of Plasmodium falciparum chimeric protein 2.9.</article-title> <source>PLoS One</source> <volume>4</volume> <fpage>e6894</fpage> </element-citation></ref>
<ref id="pone.0010685-Charoenvit1"><label>362</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Charoenvit</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Brice</surname><given-names>GT</given-names></name>
<name name-style="western"><surname>Bacon</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Majam</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Williams</surname><given-names>J</given-names></name>
<etal/></person-group> <year>2004</year> <article-title>A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner.</article-title> <source>Antimicrob Agents Chemother</source> <volume>48</volume> <fpage>2455</fpage> <lpage>2463</lpage> </element-citation></ref>
<ref id="pone.0010685-Charoenvit2"><label>363</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Charoenvit</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Collins</surname><given-names>WE</given-names></name>
<name name-style="western"><surname>Jones</surname><given-names>TR</given-names></name>
<name name-style="western"><surname>Millet</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Yuan</surname><given-names>L</given-names></name>
<etal/></person-group> <year>1991</year> <article-title>Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.</article-title> <source>Science</source> <volume>251</volume> <fpage>668</fpage> <lpage>671</lpage> </element-citation></ref>
<ref id="pone.0010685-Charoenvit3"><label>364</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Charoenvit</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Majam</surname><given-names>VF</given-names></name>
<name name-style="western"><surname>Corradin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Sacci</surname><given-names>JB</given-names><suffix>Jr</suffix></name>
<name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>
<etal/></person-group> <year>1999</year> <article-title>CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.</article-title> <source>Infect Immun</source> <volume>67</volume> <fpage>5604</fpage> <lpage>5614</lpage> </element-citation></ref>
<ref id="pone.0010685-Charoenvit4"><label>365</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Charoenvit</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Yuan</surname><given-names>LF</given-names></name>
<name name-style="western"><surname>Gross</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Cole</surname><given-names>C</given-names></name>
<etal/></person-group> <year>1990</year> <article-title>Active and passive immunization against Plasmodium yoelii sporozoites.</article-title> <source>Bull World Health Organ</source> <volume>68</volume> <supplement>Suppl</supplement> <fpage>26</fpage> <lpage>32</lpage> </element-citation></ref>
<ref id="pone.0010685-Chatterjee1"><label>366</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chatterjee</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Druilhe</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Wery</surname><given-names>M</given-names></name>
</person-group> <year>1999</year> <article-title>Irradiated sporozoites prime mice to produce high antibody titres upon viable Plasmodium berghei sporozoite challenge, which act upon liver-stage development.</article-title> <source>Parasitology</source> <volume>118</volume> <fpage>219</fpage> <lpage>225</lpage> </element-citation></ref>
<ref id="pone.0010685-Chatterjee2"><label>367</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chatterjee</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Francois</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Druilhe</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Timperman</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Wery</surname><given-names>M</given-names></name>
</person-group> <year>1996</year> <article-title>Immunity to Plasmodium berghei exoerythrocytic forms derived from irradiated sporozoites.</article-title> <source>Parasitol Res</source> <volume>82</volume> <fpage>297</fpage> <lpage>303</lpage> </element-citation></ref>
<ref id="pone.0010685-Chatterjee3"><label>368</label><element-citation publication-type="other" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chatterjee</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Ngonseu</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Van Overmeir</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Correwyn</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Druilhe</surname><given-names>P</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Rodent malaria in the natural host–irradiated sporozoites of Plasmodium berghei induce liver-stage specific immune responses in the natural host Grammomys surdaster and protect immunized Grammomys against P. berghei sporozoite challenge.</article-title> <source>Afr J Med Med Sci</source> <volume>30</volume> <supplement>Suppl</supplement> <fpage>25</fpage> <lpage>33</lpage> </element-citation></ref>
<ref id="pone.0010685-Chattopadhyay1"><label>369</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Chattopadhyay</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Conteh</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>M</given-names></name>
<name name-style="western"><surname>James</surname><given-names>ER</given-names></name>
<name name-style="western"><surname>Epstein</surname><given-names>JE</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine.</article-title> <source>Vaccine</source> <volume>27</volume> <fpage>3675</fpage> <lpage>3680</lpage> </element-citation></ref>
<ref id="pone.0010685-Clark4"><label>370</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Clark</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Allison</surname><given-names>AC</given-names></name>
<name name-style="western"><surname>Cox</surname><given-names>FE</given-names></name>
</person-group> <year>1976</year> <article-title>Protection of mice against Babesia and Plasmodium with BCG.</article-title> <source>Nature</source> <volume>259</volume> <fpage>309</fpage> <lpage>311</lpage> </element-citation></ref>
<ref id="pone.0010685-Clark5"><label>371</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Clark</surname><given-names>IA</given-names></name>
<name name-style="western"><surname>Cox</surname><given-names>FE</given-names></name>
<name name-style="western"><surname>Allison</surname><given-names>AC</given-names></name>
</person-group> <year>1977</year> <article-title>Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum.</article-title> <source>Parasitology</source> <volume>74</volume> <fpage>9</fpage> <lpage>18</lpage> </element-citation></ref>
<ref id="pone.0010685-Daly1"><label>372</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Daly</surname><given-names>TM</given-names></name>
<name name-style="western"><surname>Long</surname><given-names>CA</given-names></name>
</person-group> <year>1995</year> <article-title>Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.</article-title> <source>J Immunol</source> <volume>155</volume> <fpage>236</fpage> <lpage>243</lpage> </element-citation></ref>
<ref id="pone.0010685-Degano1"><label>373</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Degano</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Hannan</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name>
<name name-style="western"><surname>Hill</surname><given-names>AV</given-names></name>
</person-group> <year>1999</year> <article-title>Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.</article-title> <source>Vaccine</source> <volume>18</volume> <fpage>623</fpage> <lpage>632</lpage> </element-citation></ref>
<ref id="pone.0010685-Doolan8"><label>374</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
</person-group> <year>1999</year> <article-title>IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.</article-title> <source>J Immunol</source> <volume>163</volume> <fpage>884</fpage> <lpage>892</lpage> </element-citation></ref>
<ref id="pone.0010685-Egan1"><label>375</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Egan</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Weber</surname><given-names>JL</given-names></name>
<name name-style="western"><surname>Ballou</surname><given-names>WR</given-names></name>
<name name-style="western"><surname>Hollingdale</surname><given-names>MR</given-names></name>
<name name-style="western"><surname>Majarian</surname><given-names>WR</given-names></name>
<etal/></person-group> <year>1987</year> <article-title>Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.</article-title> <source>Science</source> <volume>236</volume> <fpage>453</fpage> <lpage>456</lpage> </element-citation></ref>
<ref id="pone.0010685-Gilbert1"><label>376</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Plebanski</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hannan</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Blanchard</surname><given-names>TJ</given-names></name>
<etal/></person-group> <year>1999</year> <article-title>Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.</article-title> <source>Biol Chem</source> <volume>380</volume> <fpage>299</fpage> <lpage>303</lpage> </element-citation></ref>
<ref id="pone.0010685-Gramzinski1"><label>377</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Gramzinski</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Davis</surname><given-names>HL</given-names></name>
<name name-style="western"><surname>Krieg</surname><given-names>AM</given-names></name>
<etal/></person-group> <year>2001</year> <article-title>Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.</article-title> <source>Infect Immun</source> <volume>69</volume> <fpage>1643</fpage> <lpage>1649</lpage> </element-citation></ref>
<ref id="pone.0010685-Gruner1"><label>378</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Gruner</surname><given-names>AC</given-names></name>
<name name-style="western"><surname>Mauduit</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Tewari</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Romero</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Depinay</surname><given-names>N</given-names></name>
<etal/></person-group> <year>2007</year> <article-title>Sterile protection against malaria is independent of immune responses to the circumsporozoite protein.</article-title> <source>PLoS One</source> <volume>2</volume> <fpage>e1371</fpage> </element-citation></ref>
<ref id="pone.0010685-GuebreXabier1"><label>379</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Guebre-Xabier</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Schwenk</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Krzych</surname><given-names>U</given-names></name>
</person-group> <year>1999</year> <article-title>Memory phenotype CD8(+) T cells persist in livers of mice protected against malaria by immunization with attenuated Plasmodium berghei sporozoites.</article-title> <source>Eur J Immunol</source> <volume>29</volume> <fpage>3978</fpage> <lpage>3986</lpage> </element-citation></ref>
<ref id="pone.0010685-Hirunpetcharat2"><label>380</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hirunpetcharat</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Vukovic</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>XQ</given-names></name>
<name name-style="western"><surname>Kaslow</surname><given-names>DC</given-names></name>
<name name-style="western"><surname>Miller</surname><given-names>LH</given-names></name>
<etal/></person-group> <year>1999</year> <article-title>Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carboxyl-terminal fragment of merozoite surface protein-1.</article-title> <source>J Immunol</source> <volume>162</volume> <fpage>7309</fpage> <lpage>7314</lpage> </element-citation></ref>
<ref id="pone.0010685-Hirunpetcharat3"><label>381</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hirunpetcharat</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Wipasa</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Sakkhachornphop</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Nitkumhan</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Zheng</surname><given-names>YZ</given-names></name>
<etal/></person-group> <year>2003</year> <article-title>CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based Montanides.</article-title> <source>Vaccine</source> <volume>21</volume> <fpage>2923</fpage> <lpage>2932</lpage> </element-citation></ref>
<ref id="pone.0010685-Hoffman4"><label>382</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Berzofsky</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Isenbarger</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Zeltser</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Majarian</surname><given-names>WR</given-names></name>
<etal/></person-group> <year>1989</year> <article-title>Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite protein vaccines. Overcoming genetic restriction with whole organism and subunit vaccines.</article-title> <source>J Immunol</source> <volume>142</volume> <fpage>3581</fpage> <lpage>3584</lpage> </element-citation></ref>
<ref id="pone.0010685-Hoffman5"><label>383</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Crutcher</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Puri</surname><given-names>SK</given-names></name>
<name name-style="western"><surname>Ansari</surname><given-names>AA</given-names></name>
<name name-style="western"><surname>Villinger</surname><given-names>F</given-names></name>
<etal/></person-group> <year>1997</year> <article-title>Sterile protection of monkeys against malaria after administration of interleukin-12.</article-title> <source>Nat Med</source> <volume>3</volume> <fpage>80</fpage> <lpage>83</lpage> </element-citation></ref>
<ref id="pone.0010685-Hunter1"><label>384</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hunter</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Kidd</surname><given-names>MR</given-names></name>
<name name-style="western"><surname>Olsen</surname><given-names>MR</given-names></name>
<name name-style="western"><surname>Patterson</surname><given-names>PS</given-names></name>
<name name-style="western"><surname>Lal</surname><given-names>AA</given-names></name>
</person-group> <year>1995</year> <article-title>Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.</article-title> <source>J Immunol</source> <volume>154</volume> <fpage>1762</fpage> <lpage>1769</lpage> </element-citation></ref>
<ref id="pone.0010685-Imai1"><label>385</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Imai</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Shen</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Chou</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Duan</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Tu</surname><given-names>L</given-names></name>
<etal/></person-group> <year>2010</year> <article-title>Involvement of CD8(+) T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.</article-title> <source>Eur J Immunol</source> </element-citation></ref>
<ref id="pone.0010685-Jaffe1"><label>386</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Jaffe</surname><given-names>RI</given-names></name>
<name name-style="western"><surname>Lowell</surname><given-names>GH</given-names></name>
<name name-style="western"><surname>Gordon</surname><given-names>DM</given-names></name>
</person-group> <year>1990</year> <article-title>Differences in susceptibility among mouse strains to infection with Plasmodium berghei (ANKA clone) sporozoites and its relationship to protection by gamma-irradiated sporozoites.</article-title> <source>Am J Trop Med Hyg</source> <volume>42</volume> <fpage>309</fpage> <lpage>313</lpage> </element-citation></ref>
<ref id="pone.0010685-Aly1"><label>387</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Aly</surname><given-names>AS</given-names></name>
<name name-style="western"><surname>Mikolajczak</surname><given-names>SA</given-names></name>
<name name-style="western"><surname>Rivera</surname><given-names>HS</given-names></name>
<name name-style="western"><surname>Camargo</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Jacobs-Lorena</surname><given-names>V</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection.</article-title> <source>Mol Microbiol</source> <volume>69</volume> <fpage>152</fpage> <lpage>163</lpage> </element-citation></ref>
<ref id="pone.0010685-Aly2"><label>388</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Aly</surname><given-names>AS</given-names></name>
<name name-style="western"><surname>Downie</surname><given-names>MJ</given-names></name>
<name name-style="western"><surname>Mamoun</surname><given-names>CB</given-names></name>
<name name-style="western"><surname>Kappe</surname><given-names>SH</given-names></name>
</person-group> <year>2010</year> <article-title>Subpatent infection with Nucleoside Transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.</article-title> <source>Cell Microbiol</source> </element-citation></ref>
<ref id="pone.0010685-Draper1"><label>389</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Draper</surname><given-names>SJ</given-names></name>
<name name-style="western"><surname>Goodman</surname><given-names>AL</given-names></name>
<name name-style="western"><surname>Biswas</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Forbes</surname><given-names>EK</given-names></name>
<name name-style="western"><surname>Moore</surname><given-names>AC</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria.</article-title> <source>Cell Host Microbe</source> <volume>5</volume> <fpage>95</fpage> <lpage>105</lpage> </element-citation></ref>
<ref id="pone.0010685-Jobe2"><label>390</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Jobe</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Donofrio</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Sun</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Liepinsh</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Schwenk</surname><given-names>R</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Immunization with radiation-attenuated Plasmodium berghei sporozoites induces liver cCD8alpha+DC that activate CD8+T cells against liver-stage malaria.</article-title> <source>PLoS One</source> <volume>4</volume> <fpage>e5075</fpage> </element-citation></ref>
<ref id="pone.0010685-Jones1"><label>391</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Jones</surname><given-names>TR</given-names></name>
<name name-style="western"><surname>Obaldia</surname><given-names>Nr</given-names></name>
<name name-style="western"><surname>Gramzinski</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
</person-group> <year>2000</year> <article-title>Repeated infection of Aotus monkeys with Plasmodium falciparum induces protection against subsequent challenge with homologous and heterologous strains of parasite.</article-title> <source>Am J Trop Med Hyg</source> <volume>62</volume> <fpage>675</fpage> <lpage>680</lpage> </element-citation></ref>
<ref id="pone.0010685-Kaba1"><label>392</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kaba</surname><given-names>SA</given-names></name>
<name name-style="western"><surname>Brando</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Guo</surname><given-names>Q</given-names></name>
<name name-style="western"><surname>Mittelholzer</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Raman</surname><given-names>S</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.</article-title> <source>J Immunol</source> <volume>183</volume> <fpage>7268</fpage> <lpage>7277</lpage> </element-citation></ref>
<ref id="pone.0010685-Kaur1"><label>393</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kaur</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Kinhikar</surname><given-names>AG</given-names></name>
<name name-style="western"><surname>Singh</surname><given-names>PP</given-names></name>
</person-group> <year>2004</year> <article-title>Bioimmunotherapy of rodent malaria: co-treatment with recombinant mouse granulocyte-macrophage colony-stimulating factor and an enkephalin fragment peptide Tyr-Gly-Gly.</article-title> <source>Acta Trop</source> <volume>91</volume> <fpage>27</fpage> <lpage>41</lpage> </element-citation></ref>
<ref id="pone.0010685-Khan1"><label>394</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Khan</surname><given-names>ZM</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
</person-group> <year>1992</year> <article-title>Specific inflammatory cell infiltration of hepatic schizonts in BALB/c mice immunized with attenuated Plasmodium yoelii sporozoites.</article-title> <source>Int Immunol</source> <volume>4</volume> <fpage>711</fpage> <lpage>718</lpage> </element-citation></ref>
<ref id="pone.0010685-Khullar1"><label>395</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Khullar</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Sehgal</surname><given-names>S</given-names></name>
</person-group> <year>1990</year> <article-title>Use of adjuvants in modulating the behaviour of Plasmodium berghei.</article-title> <source>Indian J Exp Biol</source> <volume>28</volume> <fpage>1112</fpage> <lpage>1117</lpage> </element-citation></ref>
<ref id="pone.0010685-Khusmith2"><label>396</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Khusmith</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
</person-group> <year>1994</year> <article-title>Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.</article-title> <source>Infect Immun</source> <volume>62</volume> <fpage>2979</fpage> <lpage>2983</lpage> </element-citation></ref>
<ref id="pone.0010685-Kumar3"><label>397</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Good</surname><given-names>MF</given-names></name>
<name name-style="western"><surname>Dontfraid</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Vinetz</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Miller</surname><given-names>LH</given-names></name>
</person-group> <year>1989</year> <article-title>Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development.</article-title> <source>J Immunol</source> <volume>143</volume> <fpage>2017</fpage> <lpage>2023</lpage> </element-citation></ref>
<ref id="pone.0010685-Lanar1"><label>398</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Lanar</surname><given-names>DE</given-names></name>
<name name-style="western"><surname>Tine</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>de Taisne</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Seguin</surname><given-names>MC</given-names></name>
<name name-style="western"><surname>Cox</surname><given-names>WI</given-names></name>
<etal/></person-group> <year>1996</year> <article-title>Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria.</article-title> <source>Infect Immun</source> <volume>64</volume> <fpage>1666</fpage> <lpage>1671</lpage> </element-citation></ref>
<ref id="pone.0010685-Li3"><label>399</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Li</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Rodrigues</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Rodriguez</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Rodriguez</surname><given-names>JR</given-names></name>
<name name-style="western"><surname>Esteban</surname><given-names>M</given-names></name>
<etal/></person-group> <year>1993</year> <article-title>Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>90</volume> <fpage>5214</fpage> <lpage>5218</lpage> </element-citation></ref>
<ref id="pone.0010685-Ling1"><label>400</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Ling</surname><given-names>IT</given-names></name>
<name name-style="western"><surname>Ogun</surname><given-names>SA</given-names></name>
<name name-style="western"><surname>Holder</surname><given-names>AA</given-names></name>
</person-group> <year>1994</year> <article-title>Immunization against malaria with a recombinant protein.</article-title> <source>Parasite Immunol</source> <volume>16</volume> <fpage>63</fpage> <lpage>67</lpage> </element-citation></ref>
<ref id="pone.0010685-Marussig1"><label>401</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Marussig</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Renia</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Motard</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Miltgen</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Petour</surname><given-names>P</given-names></name>
<etal/></person-group> <year>1997</year> <article-title>Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.</article-title> <source>Int Immunol</source> <volume>9</volume> <fpage>1817</fpage> <lpage>1824</lpage> </element-citation></ref>
<ref id="pone.0010685-Mauduit1"><label>402</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mauduit</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Gruner</surname><given-names>AC</given-names></name>
<name name-style="western"><surname>Tewari</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Depinay</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Kayibanda</surname><given-names>M</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites.</article-title> <source>PLoS One</source> <volume>4</volume> <fpage>e7717</fpage> </element-citation></ref>
<ref id="pone.0010685-McColm1"><label>403</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>McColm</surname><given-names>AA</given-names></name>
<name name-style="western"><surname>Bomford</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Dalton</surname><given-names>L</given-names></name>
</person-group> <year>1982</year> <article-title>A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelii vaccine in the mouse.</article-title> <source>Parasite Immunol</source> <volume>4</volume> <fpage>337</fpage> <lpage>347</lpage> </element-citation></ref>
<ref id="pone.0010685-McColm2"><label>404</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>McColm</surname><given-names>AA</given-names></name>
<name name-style="western"><surname>Dalton</surname><given-names>L</given-names></name>
</person-group> <year>1983</year> <article-title>Heterologous immunity in rodent malaria: comparison of the degree of cross-immunity generated by vaccination with that produced by exposure to live infection.</article-title> <source>Ann Trop Med Parasitol</source> <volume>77</volume> <fpage>355</fpage> <lpage>377</lpage> </element-citation></ref>
<ref id="pone.0010685-Mueller3"><label>405</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Mueller</surname><given-names>AK</given-names></name>
<name name-style="western"><surname>Camargo</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Kaiser</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Andorfer</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Frevert</surname><given-names>U</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Plasmodium liver stage developmental arrest by depletion of a protein at the parasite– host interface.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>102</volume> <fpage>3022</fpage> <lpage>3027</lpage> </element-citation></ref>
<ref id="pone.0010685-Orjih3"><label>406</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Orjih</surname><given-names>AU</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
</person-group> <year>1980</year> <article-title>Immunization against rodent malaria with cryopreserved irradiated sporozoites of Plasmodium berghei.</article-title> <source>Am J Trop Med Hyg</source> <volume>29</volume> <fpage>343</fpage> <lpage>347</lpage> </element-citation></ref>
<ref id="pone.0010685-Patterson1"><label>407</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Patterson</surname><given-names>PS</given-names></name>
<name name-style="western"><surname>Bosshardt</surname><given-names>SC</given-names></name>
<name name-style="western"><surname>Udhayukumar</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Xiao</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Kidd</surname><given-names>M</given-names></name>
<etal/></person-group> <year>1999</year> <article-title>Prolonged expression of IFNgamma induced by protective blood-stage immunization against Plasmodium yoelii malaria.</article-title> <source>Vaccine</source> <volume>18</volume> <fpage>173</fpage> <lpage>180</lpage> </element-citation></ref>
<ref id="pone.0010685-Perlaza2"><label>408</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Perlaza</surname><given-names>BL</given-names></name>
<name name-style="western"><surname>Valencia</surname><given-names>AZ</given-names></name>
<name name-style="western"><surname>Zapata</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Castellanos</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Sauzet</surname><given-names>JP</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.</article-title> <source>Eur J Immunol</source> <volume>38</volume> <fpage>2610</fpage> <lpage>2615</lpage> </element-citation></ref>
<ref id="pone.0010685-Roberts1"><label>409</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Roberts</surname><given-names>DW</given-names></name>
<name name-style="western"><surname>Rank</surname><given-names>RG</given-names></name>
<name name-style="western"><surname>Weidanz</surname><given-names>WP</given-names></name>
<name name-style="western"><surname>Finerty</surname><given-names>JF</given-names></name>
</person-group> <year>1977</year> <article-title>Prevention of recrudescent malaria in nude mice by thymic grafting or by treatment with hyperimmune serum.</article-title> <source>Infect Immun</source> <volume>16</volume> <fpage>821</fpage> <lpage>826</lpage> </element-citation></ref>
<ref id="pone.0010685-Playfair1"><label>410</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Playfair</surname><given-names>JH</given-names></name>
<name name-style="western"><surname>De Souza</surname><given-names>JB</given-names></name>
</person-group> <year>1979</year> <article-title>Antibody responses in mice protected against malaria by vaccination.</article-title> <source>Parasite Immunol</source> <volume>1</volume> <fpage>197</fpage> <lpage>208</lpage> </element-citation></ref>
<ref id="pone.0010685-Playfair2"><label>411</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Playfair</surname><given-names>JH</given-names></name>
<name name-style="western"><surname>De Souza</surname><given-names>JB</given-names></name>
<name name-style="western"><surname>Cottrell</surname><given-names>BJ</given-names></name>
</person-group> <year>1977</year> <article-title>Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei.</article-title> <source>Immunology</source> <volume>33</volume> <fpage>507</fpage> <lpage>515</lpage> </element-citation></ref>
<ref id="pone.0010685-Potocnjak1"><label>412</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Potocnjak</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Yoshida</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>V</given-names></name>
</person-group> <year>1980</year> <article-title>Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection.</article-title> <source>J Exp Med</source> <volume>151</volume> <fpage>1504</fpage> <lpage>1513</lpage> </element-citation></ref>
<ref id="pone.0010685-Puri2"><label>413</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Puri</surname><given-names>SK</given-names></name>
<name name-style="western"><surname>Dutta</surname><given-names>GP</given-names></name>
<name name-style="western"><surname>Levy</surname><given-names>HB</given-names></name>
<name name-style="western"><surname>Maheshwari</surname><given-names>RK</given-names></name>
</person-group> <year>1996</year> <article-title>Poly ICLC inhibits Plasmodium cynomolgi B malaria infection in rhesus monkeys.</article-title> <source>J Interferon Cytokine Res</source> <volume>16</volume> <fpage>49</fpage> <lpage>52</lpage> </element-citation></ref>
<ref id="pone.0010685-Pye1"><label>414</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Pye</surname><given-names>D</given-names></name>
<name name-style="western"><surname>O'Brien</surname><given-names>CM</given-names></name>
<name name-style="western"><surname>Franchina</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Monger</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Anders</surname><given-names>RF</given-names></name>
</person-group> <year>1994</year> <article-title>Plasmodium falciparum infection of splenectomized and intact Guyanan Saimiri monkeys.</article-title> <source>J Parasitol</source> <volume>80</volume> <fpage>558</fpage> <lpage>562</lpage> </element-citation></ref>
<ref id="pone.0010685-Reed1"><label>415</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Reed</surname><given-names>RC</given-names></name>
<name name-style="western"><surname>Louis-Wileman</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Wells</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Verheul</surname><given-names>AF</given-names></name>
<name name-style="western"><surname>Hunter</surname><given-names>RL</given-names></name>
<etal/></person-group> <year>1996</year> <article-title>Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection.</article-title> <source>Vaccine</source> <volume>14</volume> <fpage>828</fpage> <lpage>836</lpage> </element-citation></ref>
<ref id="pone.0010685-Reed2"><label>416</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Reed</surname><given-names>RC</given-names></name>
<name name-style="western"><surname>Louis-Wileman</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Cosmai</surname><given-names>EV</given-names></name>
<name name-style="western"><surname>Fang</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Jue</surname><given-names>DL</given-names></name>
<etal/></person-group> <year>1997</year> <article-title>Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.</article-title> <source>Vaccine</source> <volume>15</volume> <fpage>482</fpage> <lpage>488</lpage> </element-citation></ref>
<ref id="pone.0010685-Renia1"><label>417</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Renia</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Grillot</surname><given-names>D</given-names></name>
<name name-style="western"><surname>Marussig</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Corradin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Miltgen</surname><given-names>F</given-names></name>
<etal/></person-group> <year>1993</year> <article-title>Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages.</article-title> <source>J Immunol</source> <volume>150</volume> <fpage>1471</fpage> <lpage>1478</lpage> </element-citation></ref>
<ref id="pone.0010685-ReyesSandoval1"><label>418</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Reyes-Sandoval</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Berthoud</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Alder</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Siani</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name>
<etal/></person-group> <year>2010</year> <article-title>Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses.</article-title> <source>Infect Immun</source> <volume>78</volume> <fpage>145</fpage> <lpage>153</lpage> </element-citation></ref>
<ref id="pone.0010685-Rodrigues2"><label>419</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Rodrigues</surname><given-names>EG</given-names></name>
<name name-style="western"><surname>Claassen</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Wilson</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<etal/></person-group> <year>2000</year> <article-title>Interferon-gamma-independent CD8+ T cell-mediated protective anti-malaria immunity elicited by recombinant adenovirus.</article-title> <source>Parasite Immunol</source> <volume>22</volume> <fpage>157</fpage> <lpage>160</lpage> </element-citation></ref>
<ref id="pone.0010685-Rodrigues3"><label>420</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Rodrigues</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Cordey</surname><given-names>AS</given-names></name>
<name name-style="western"><surname>Arreaza</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Corradin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Romero</surname><given-names>P</given-names></name>
<etal/></person-group> <year>1991</year> <article-title>CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.</article-title> <source>Int Immunol</source> <volume>3</volume> <fpage>579</fpage> <lpage>585</lpage> </element-citation></ref>
<ref id="pone.0010685-Romero3"><label>421</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Romero</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Ciabattini</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Guillaume</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Frank</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Ruggiero</surname><given-names>P</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge.</article-title> <source>Vaccine</source> <volume>27</volume> <fpage>1266</fpage> <lpage>1271</lpage> </element-citation></ref>
<ref id="pone.0010685-Romero4"><label>422</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Romero</surname><given-names>JF</given-names></name>
<name name-style="western"><surname>Eberl</surname><given-names>G</given-names></name>
<name name-style="western"><surname>MacDonald</surname><given-names>HR</given-names></name>
<name name-style="western"><surname>Corradin</surname><given-names>G</given-names></name>
</person-group> <year>2001</year> <article-title>CD1d-restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice.</article-title> <source>Parasite Immunol</source> <volume>23</volume> <fpage>267</fpage> <lpage>269</lpage> </element-citation></ref>
<ref id="pone.0010685-Sadoff1"><label>423</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sadoff</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Ballou</surname><given-names>WR</given-names></name>
<name name-style="western"><surname>Baron</surname><given-names>LS</given-names></name>
<name name-style="western"><surname>Majarian</surname><given-names>WR</given-names></name>
<name name-style="western"><surname>Brey</surname><given-names>RN</given-names></name>
<etal/></person-group> <year>1988</year> <article-title>Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.</article-title> <source>Science</source> <volume>240</volume> <fpage>336</fpage> <lpage>338</lpage> </element-citation></ref>
<ref id="pone.0010685-Schmidt1"><label>424</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Schmidt</surname><given-names>LH</given-names></name>
<name name-style="western"><surname>Rossan</surname><given-names>RN</given-names></name>
<name name-style="western"><surname>Fradkin</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Sullivan</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Schulemann</surname><given-names>W</given-names></name>
<etal/></person-group> <year>1985</year> <article-title>Antimalarial activities and subacute toxicity of RC-12, a 4-amino-substituted pyrocatechol.</article-title> <source>Antimicrob Agents Chemother</source> <volume>28</volume> <fpage>612</fpage> <lpage>625</lpage> </element-citation></ref>
<ref id="pone.0010685-Schmidt2"><label>425</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Schmidt</surname><given-names>NW</given-names></name>
<name name-style="western"><surname>Podyminogin</surname><given-names>RL</given-names></name>
<name name-style="western"><surname>Butler</surname><given-names>NS</given-names></name>
<name name-style="western"><surname>Badovinac</surname><given-names>VP</given-names></name>
<name name-style="western"><surname>Tucker</surname><given-names>BJ</given-names></name>
<etal/></person-group> <year>2008</year> <article-title>Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>105</volume> <fpage>14017</fpage> <lpage>14022</lpage> </element-citation></ref>
<ref id="pone.0010685-Schneider2"><label>426</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Schneider</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Gilbert</surname><given-names>SC</given-names></name>
<name name-style="western"><surname>Blanchard</surname><given-names>TJ</given-names></name>
<name name-style="western"><surname>Hanke</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Robson</surname><given-names>KJ</given-names></name>
<etal/></person-group> <year>1998</year> <article-title>Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.</article-title> <source>Nat Med</source> <volume>4</volume> <fpage>397</fpage> <lpage>402</lpage> </element-citation></ref>
<ref id="pone.0010685-Sedegah1"><label>427</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Brice</surname><given-names>GT</given-names></name>
<name name-style="western"><surname>Rogers</surname><given-names>WO</given-names></name>
<name name-style="western"><surname>Doolan</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Charoenvit</surname><given-names>Y</given-names></name>
<etal/></person-group> <year>2002</year> <article-title>Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.</article-title> <source>Infect Immun</source> <volume>70</volume> <fpage>3493</fpage> <lpage>3499</lpage> </element-citation></ref>
<ref id="pone.0010685-Sedegah2"><label>428</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Finkelman</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
</person-group> <year>1994</year> <article-title>Interleukin 12 induction of interferon gamma-dependent protection against malaria.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>91</volume> <fpage>10700</fpage> <lpage>10702</lpage> </element-citation></ref>
<ref id="pone.0010685-Siddiqui1"><label>429</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Siddiqui</surname><given-names>WA</given-names></name>
<name name-style="western"><surname>Tam</surname><given-names>LQ</given-names></name>
<name name-style="western"><surname>Kan</surname><given-names>SC</given-names></name>
<name name-style="western"><surname>Kramer</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Case</surname><given-names>SE</given-names></name>
<etal/></person-group> <year>1986</year> <article-title>Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys.</article-title> <source>Infect Immun</source> <volume>52</volume> <fpage>314</fpage> <lpage>318</lpage> </element-citation></ref>
<ref id="pone.0010685-Spitalny3"><label>430</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Spitalny</surname><given-names>GL</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
</person-group> <year>1973</year> <article-title>Plasmodium berghei: relationship between protective immunity and anti-sporozoite (CSP) antibody in mice.</article-title> <source>Exp Parasitol</source> <volume>33</volume> <fpage>168</fpage> <lpage>178</lpage> </element-citation></ref>
<ref id="pone.0010685-TaylorRobinson1"><label>431</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Taylor-Robinson</surname><given-names>AW</given-names></name>
<name name-style="western"><surname>Phillips</surname><given-names>RS</given-names></name>
</person-group> <year>1994</year> <article-title>Th1 and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection.</article-title> <source>Eur J Immunol</source> <volume>24</volume> <fpage>158</fpage> <lpage>164</lpage> </element-citation></ref>
<ref id="pone.0010685-TaylorRobinson2"><label>432</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Taylor-Robinson</surname><given-names>AW</given-names></name>
<name name-style="western"><surname>Phillips</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Severn</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Moncada</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Liew</surname><given-names>FY</given-names></name>
</person-group> <year>1993</year> <article-title>The role of TH1 and TH2 cells in a rodent malaria infection.</article-title> <source>Science</source> <volume>260</volume> <fpage>1931</fpage> <lpage>1934</lpage> </element-citation></ref>
<ref id="pone.0010685-Tsuji2"><label>433</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Tsuji</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Miyahira</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Aguet</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Reichel</surname><given-names>M</given-names></name>
<etal/></person-group> <year>1995</year> <article-title>Development of antimalaria immunity in mice lacking IFN-gamma receptor.</article-title> <source>J Immunol</source> <volume>154</volume> <fpage>5338</fpage> <lpage>5344</lpage> </element-citation></ref>
<ref id="pone.0010685-Trimnell1"><label>434</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Trimnell</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Takagi</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Gupta</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Richie</surname><given-names>TL</given-names></name>
<name name-style="western"><surname>Kappe</surname><given-names>SH</given-names></name>
<etal/></person-group> <year>2009</year> <article-title>Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.</article-title> <source>J Immunol</source> <volume>183</volume> <fpage>5870</fpage> <lpage>5878</lpage> </element-citation></ref>
<ref id="pone.0010685-vanDijk1"><label>435</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>van Dijk</surname><given-names>MR</given-names></name>
<name name-style="western"><surname>Douradinha</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Franke-Fayard</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Heussler</surname><given-names>V</given-names></name>
<name name-style="western"><surname>van Dooren</surname><given-names>MW</given-names></name>
<etal/></person-group> <year>2005</year> <article-title>Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.</article-title> <source>Proc Natl Acad Sci U S A</source> <volume>102</volume> <fpage>12194</fpage> <lpage>12199</lpage> </element-citation></ref>
<ref id="pone.0010685-Vinetz1"><label>436</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Vinetz</surname><given-names>JM</given-names></name>
<name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Good</surname><given-names>MF</given-names></name>
<name name-style="western"><surname>Fowlkes</surname><given-names>BJ</given-names></name>
<name name-style="western"><surname>Berzofsky</surname><given-names>JA</given-names></name>
<etal/></person-group> <year>1990</year> <article-title>Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria.</article-title> <source>J Immunol</source> <volume>144</volume> <fpage>1069</fpage> <lpage>1074</lpage> </element-citation></ref>
<ref id="pone.0010685-Waki1"><label>437</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Waki</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Takagi</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Suzuki</surname><given-names>M</given-names></name>
</person-group> <year>1989</year> <article-title>Acquirement of protective immunity in mice through infection with an attenuated isolate and its failure in parent virulent Plasmodium berghei.</article-title> <source>Parasitol Res</source> <volume>75</volume> <fpage>614</fpage> <lpage>618</lpage> </element-citation></ref>
<ref id="pone.0010685-Wang2"><label>438</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Charoenvit</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Corradin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>De La Vega</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Franke</surname><given-names>ED</given-names></name>
<etal/></person-group> <year>1996</year> <article-title>Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T-cell and IFN-dependent elimination of infected hepatocytes.</article-title> <source>J Immunol</source> <volume>157</volume> <fpage>4061</fpage> <lpage>4067</lpage> </element-citation></ref>
<ref id="pone.0010685-Wang3"><label>439</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wang</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Charoenvit</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Corradin</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Porrozzi</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Hunter</surname><given-names>RL</given-names></name>
<etal/></person-group> <year>1995</year> <article-title>Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.</article-title> <source>J Immunol</source> <volume>154</volume> <fpage>2784</fpage> <lpage>2793</lpage> </element-citation></ref>
<ref id="pone.0010685-Weiss4"><label>440</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Weiss</surname><given-names>WR</given-names></name>
<name name-style="western"><surname>Berzofsky</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Houghten</surname><given-names>RA</given-names></name>
<name name-style="western"><surname>Sedegah</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Hollindale</surname><given-names>M</given-names></name>
<etal/></person-group> <year>1992</year> <article-title>A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.</article-title> <source>J Immunol</source> <volume>149</volume> <fpage>2103</fpage> <lpage>2109</lpage> </element-citation></ref>
<ref id="pone.0010685-White2"><label>441</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>White</surname><given-names>KL</given-names></name>
<name name-style="western"><surname>Jarboe</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Krzych</surname><given-names>U</given-names></name>
</person-group> <year>1994</year> <article-title>Immunization with irradiated Plasmodium berghei sporozoites induces IL-2 and IFN gamma but not IL-4.</article-title> <source>Parasite Immunol</source> <volume>16</volume> <fpage>479</fpage> <lpage>491</lpage> </element-citation></ref>
<ref id="pone.0010685-Wykes1"><label>442</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Wykes</surname><given-names>MN</given-names></name>
<name name-style="western"><surname>Zhou</surname><given-names>YH</given-names></name>
<name name-style="western"><surname>Liu</surname><given-names>XQ</given-names></name>
<name name-style="western"><surname>Good</surname><given-names>MF</given-names></name>
</person-group> <year>2005</year> <article-title>Plasmodium yoelii can ablate vaccine-induced long-term protection in mice.</article-title> <source>J Immunol</source> <volume>175</volume> <fpage>2510</fpage> <lpage>2516</lpage> </element-citation></ref>
<ref id="pone.0010685-Pacheco1"><label>443</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Pacheco</surname><given-names>ND</given-names></name>
<name name-style="western"><surname>McConnell</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Beaudoin</surname><given-names>RL</given-names></name>
</person-group> <year>1979</year> <article-title>Duration of immunity following a single vaccination with irradiated sporozoites of Plasmodium berghei.</article-title> <source>Bull World Health Organ</source> <volume>57</volume> <supplement>Suppl 1</supplement> <fpage>159</fpage> <lpage>163</lpage> </element-citation></ref>
<ref id="pone.0010685-Nussenzweig1"><label>444</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>JP</given-names></name>
<name name-style="western"><surname>Most</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Orton</surname><given-names>C</given-names></name>
</person-group> <year>1969</year> <article-title>Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites.</article-title> <source>Nature</source> <volume>222</volume> <fpage>488</fpage> <lpage>489</lpage> </element-citation></ref>
<ref id="pone.0010685-Nussenzweig2"><label>445</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Nussenzweig</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Vanderberg</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Most</surname><given-names>H</given-names></name>
</person-group> <year>1969</year> <article-title>Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity.</article-title> <source>Mil Med</source> <volume>134</volume> <fpage>1176</fpage> <lpage>1182</lpage> </element-citation></ref>
<ref id="pone.0010685-Orjih4"><label>446</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Orjih</surname><given-names>AU</given-names></name>
<name name-style="western"><surname>Cochrane</surname><given-names>AH</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>RS</given-names></name>
</person-group> <year>1982</year> <article-title>Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei.</article-title> <source>Trans R Soc Trop Med Hyg</source> <volume>76</volume> <fpage>57</fpage> <lpage>61</lpage> </element-citation></ref>
<ref id="pone.0010685-Renia2"><label>447</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Renia</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Rodrigues</surname><given-names>MM</given-names></name>
<name name-style="western"><surname>Nussenzweig</surname><given-names>V</given-names></name>
</person-group> <year>1994</year> <article-title>Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage.</article-title> <source>Immunology</source> <volume>82</volume> <fpage>164</fpage> <lpage>168</lpage> </element-citation></ref>
<ref id="pone.0010685-FavilaCastillo1"><label>448</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Favila-Castillo</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Monroy-Ostria</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Kobayashi</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Hirunpetcharat</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Kamada</surname><given-names>N</given-names></name>
<etal/></person-group> <year>1996</year> <article-title>Protection of rats against malaria by a transplanted immune spleen.</article-title> <source>Parasite Immunol</source> <volume>18</volume> <fpage>325</fpage> <lpage>331</lpage> </element-citation></ref>
<ref id="pone.0010685-Butler1"><label>449</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Butler</surname><given-names>NS</given-names></name>
<name name-style="western"><surname>Schmidt</surname><given-names>NW</given-names></name>
<name name-style="western"><surname>Harty</surname><given-names>JT</given-names></name>
</person-group> <year>2010</year> <article-title>Differential Effector Pathways Regulate Memory CD8 T Cell Immunity against Plasmodium berghei versus P. yoelii Sporozoites.</article-title> <source>J Immunol</source> <volume>184</volume> <fpage>2528</fpage> <lpage>2538</lpage> </element-citation></ref>
<ref id="pone.0010685-Yoshida1"><label>450</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Yoshida</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Araki</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Yokomine</surname><given-names>T</given-names></name>
</person-group> <year>2010</year> <article-title>Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice.</article-title> <source>Infect Immun</source> <volume>78</volume> <fpage>595</fpage> <lpage>602</lpage> </element-citation></ref>
<ref id="pone.0010685-Falae1"><label>451</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Falae</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Combe</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Amaladoss</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Carvalho</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Menard</surname><given-names>R</given-names></name>
<etal/></person-group> <year>2010</year> <article-title>Role of Plasmodium berghei cGMP-dependent protein kinase in late liver stage development.</article-title> <source>J Biol Chem</source> <volume>285</volume> <fpage>3282</fpage> <lpage>3288</lpage> </element-citation></ref>
<ref id="pone.0010685-Sina2"><label>452</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sina</surname><given-names>BJ</given-names></name>
<name name-style="western"><surname>Wright</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Atkinson</surname><given-names>CT</given-names></name>
<name name-style="western"><surname>Ballou</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Aikawa</surname><given-names>M</given-names></name>
<etal/></person-group> <year>1995</year> <article-title>Characterization of a sporozoite antigen common to <italic>Plasmodium falciparum</italic> and <italic>Plasmodium berghei</italic>.</article-title> <source>Mol Biochem Parasitol</source> <volume>69</volume> <fpage>239</fpage> <lpage>246</lpage> </element-citation></ref>
<ref id="pone.0010685-Sina3"><label>453</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Sina</surname><given-names>BJ</given-names></name>
<name name-style="western"><surname>Wright</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Ballou</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Hollingdale</surname><given-names>M</given-names></name>
</person-group> <year>1992</year> <article-title>A protective monoclonal antibody with dual specificity for Plasmodium falciparum and Plasmodium berghei circumsporozoite proteins.</article-title> <source>Exp Parasitol</source> <volume>74</volume> <fpage>431</fpage> <lpage>440</lpage> </element-citation></ref>
<ref id="pone.0010685-Clyde4"><label>454</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Clyde</surname><given-names>DF</given-names></name>
</person-group> <year>1990</year> <article-title>Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75.</article-title> <source>Bull World Health Organ</source> <volume>68</volume> <supplement>Suppl</supplement> <fpage>9</fpage> <lpage>12</lpage> </element-citation></ref>
<ref id="pone.0010685-Egan2"><label>455</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Egan</surname><given-names>JE</given-names></name>
<name name-style="western"><surname>Hoffman</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Haynes</surname><given-names>JD</given-names></name>
<name name-style="western"><surname>Sadoff</surname><given-names>JC</given-names></name>
<name name-style="western"><surname>Schneider</surname><given-names>I</given-names></name>
<etal/></person-group> <year>1993</year> <article-title>Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.</article-title> <source>Am J Trop Med Hyg</source> <volume>49</volume> <fpage>166</fpage> <lpage>173</lpage> </element-citation></ref>
<ref id="pone.0010685-Herrington3"><label>456</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Herrington</surname><given-names>DA</given-names></name>
<name name-style="western"><surname>Nardin</surname><given-names>EH</given-names></name>
<name name-style="western"><surname>Losonsky</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Bathurst</surname><given-names>IC</given-names></name>
<name name-style="western"><surname>Barr</surname><given-names>PJ</given-names></name>
<etal/></person-group> <year>1991</year> <article-title>Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax.</article-title> <source>Am J Trop Med Hyg</source> <volume>45</volume> <fpage>695</fpage> <lpage>701</lpage> </element-citation></ref>
<ref id="pone.0010685-Schmidt3"><label>457</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Schmidt</surname><given-names>NW</given-names></name>
<name name-style="western"><surname>Butler</surname><given-names>NS</given-names></name>
<name name-style="western"><surname>Harty</surname><given-names>JT</given-names></name>
</person-group> <year>2009</year> <article-title>CD8 T cell immunity to Plasmodium permits generation of protective antibodies after repeated sporozoite challenge.</article-title> <source>Vaccine</source> <volume>27</volume> <fpage>6103</fpage> <lpage>6106</lpage> </element-citation></ref>
<ref id="pone.0010685-Butcher1"><label>458</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Butcher</surname><given-names>GA</given-names></name>
<name name-style="western"><surname>Mitchell</surname><given-names>GH</given-names></name>
<name name-style="western"><surname>Cohen</surname><given-names>S</given-names></name>
</person-group> <year>1978</year> <article-title>Antibody mediated mechanisms of immunity to malaria induced by vaccination with Plasmodium knowlesi merozoites.</article-title> <source>Immunology</source> <volume>34</volume> <fpage>77</fpage> <lpage>86</lpage> </element-citation></ref>
<ref id="pone.0010685-Hommel1"><label>459</label><element-citation publication-type="journal" xlink:type="simple"> <person-group person-group-type="author">
<name name-style="western"><surname>Hommel</surname><given-names>M</given-names></name>
<name name-style="western"><surname>David</surname><given-names>PH</given-names></name>
<name name-style="western"><surname>Guillotte</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Pereira da Silva</surname><given-names>L</given-names></name>
</person-group> <year>1982</year> <article-title>Protection against Plasmodium chabaudi malaria. I.–Vaccination of mice with merozoites and Freund's adjuvants.</article-title> <source>Ann Immunol (Paris)</source> <volume>133C</volume> <fpage>57</fpage> <lpage>67</lpage> </element-citation></ref>
</ref-list>

</back>
</article>